[P02BB01, trichlorfon, The therapeutic efficacy of Metrifonate can be decreased when used in combination with Fluticasone.]
[S02DA03, antipyrine, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Antipyrine.]
[A14AA02, stanozolol, The risk or severity of fluid retention can be increased when Fluticasone is combined with Stanozolol.]
[G03XB02, ulipristal, The serum concentration of Fluticasone can be increased when it is combined with Ulipristal.]
[L04AA04, rabbit anti-human T-lymphocyte globulin, The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Fluticasone.]
[L01AD04, streptozocin, The risk or severity of adverse effects can be increased when Streptozocin is combined with Fluticasone.]
[L04AA27, fingolimod, Fluticasone may increase the immunosuppressive activities of Fingolimod.]
[M03AB01, succinylcholine, The risk or severity of myopathy and weakness can be increased when Succinylcholine is combined with Fluticasone.]
[J01EC02, sulfadiazine, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Sulfadiazine.]
[J01EC01, sulfamethoxazole, The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Fluticasone.]
[S01AB02, sulfisoxazole, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Sulfisoxazole.]
[M01AB02, sulindac, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Sulindac.]
[N05AL01, sulpiride, The therapeutic efficacy of Sulpiride can be decreased when used in combination with Fluticasone.]
[A10BB04, glibornuride, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Glibornuride.]
[A10BC01, glymidine, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Glymidine.]
[M01AX04, apazone, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Azapropazone.]
[L01BB02, mercaptopurine, The risk or severity of adverse effects can be increased when Mercaptopurine is combined with Fluticasone.]
[N06DA01, tacrine, The therapeutic efficacy of Tacrine can be decreased when used in combination with Fluticasone.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be increased when combined with Fluticasone.]
[L01CB02, teniposide, The metabolism of Teniposide can be increased when combined with Fluticasone.]
[R03CC03, terbutaline, The therapeutic efficacy of Terbutaline can be decreased when used in combination with Fluticasone.]
[G03BA03, testosterone, The risk or severity of edema formation can be increased when Testosterone is combined with Fluticasone.]
[A04AD10, dronabinol, The serum concentration of Dronabinol can be increased when it is combined with Fluticasone.]
[N04BC07, apomorphine, The metabolism of Apomorphine can be decreased when combined with Fluticasone.]
[L04AX02, thalidomide, The risk or severity of adverse effects can be increased when Thalidomide is combined with Fluticasone.]
[R03DA04, theophylline, The metabolism of Theophylline can be increased when combined with Fluticasone.]
[L01XX41, eribulin, The risk or severity of adverse effects can be increased when Eribulin is combined with Fluticasone.]
[L01AC01, thiotepa, The therapeutic efficacy of Thiotepa can be decreased when used in combination with Fluticasone.]
[L01BB03, thioguanine, The risk or severity of adverse effects can be increased when Tioguanine is combined with Fluticasone.]
[B02AB01, aprotinin, The therapeutic efficacy of Aprotinin can be decreased when used in combination with Fluticasone.]
[A10BB05, tolazamide, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Tolazamide.]
[V04CA01, tolbutamide, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Tolbutamide.]
[M02AA21, tolmetin, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Tolmetin.]
[N02AX02, tramadol, The metabolism of Tramadol can be decreased when combined with Fluticasone.]
[N06AX05, trazodone, The metabolism of Trazodone can be decreased when combined with Fluticasone.]
[L01XF01, tretinoin, The risk or severity of adverse effects can be increased when Tretinoin is combined with Fluticasone.]
[S01BA05, triamcinolone, The risk or severity of adverse effects can be increased when Triamcinolone is combined with Fluticasone.]
[N05CD05, triazolam, The metabolism of Triazolam can be decreased when combined with Fluticasone.]
[C03AA06, trichlormethiazide, The risk or severity of electrolyte imbalance can be increased when Fluticasone is combined with Trichlormethiazide.]
[S01EB04, demecarium, The therapeutic efficacy of Demecarium can be decreased when used in combination with Fluticasone.]
[S01AD02, trifluridine, The risk or severity of adverse effects can be increased when Trifluridine is combined with Fluticasone.]
[N05AA05, triflupromazine, The therapeutic efficacy of Triflupromazine can be decreased when used in combination with Fluticasone.]
[D07AC02, fluclorolone, The risk or severity of adverse effects can be increased when Fluclorolone is combined with Fluticasone.]
[R03BA07, mometasone, The risk or severity of adverse effects can be increased when Mometasone is combined with Fluticasone.]
[N03AC02, trimethadione, The metabolism of Trimethadione can be decreased when combined with Fluticasone.]
[J01FA08, troleandomycin, The metabolism of Fluticasone can be decreased when combined with Troleandomycin.]
[M03AA02, tubocurarine, The therapeutic efficacy of Tubocurarine can be decreased when used in combination with Fluticasone.]
[R03DX07, roflumilast, The serum concentration of Roflumilast can be increased when it is combined with Fluticasone.]
[L04AA26, belimumab, The risk or severity of adverse effects can be increased when Belimumab is combined with Fluticasone.]
[S01AA05, tyrothricin, The therapeutic efficacy of Tyrothricin can be decreased when used in combination with Fluticasone.]
[L01EX04, vandetanib, The metabolism of Vandetanib can be increased when combined with Fluticasone.]
[A10BH05, linagliptin, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Linagliptin.]
[J05AP03, boceprevir, The metabolism of Fluticasone can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Telaprevir can be decreased when combined with Fluticasone.]
[J05AG05, rilpivirine, The serum concentration of Rilpivirine can be decreased when it is combined with Fluticasone.]
[L04AA28, belatacept, The risk or severity of adverse effects can be increased when Belatacept is combined with Fluticasone.]
[B01AF01, rivaroxaban, The metabolism of Rivaroxaban can be decreased when combined with Fluticasone.]
[R03AC18, indacaterol, The risk or severity of hypokalemia can be increased when Fluticasone is combined with Indacaterol.]
[B01AC24, ticagrelor, The metabolism of Ticagrelor can be decreased when combined with Fluticasone.]
[C08DA01, verapamil, The metabolism of Verapamil can be decreased when combined with Fluticasone.]
[N06AX09, viloxazine, The metabolism of Fluticasone can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The metabolism of Vinblastine can be increased when combined with Fluticasone.]
[L01CA02, vincristine, The metabolism of Vincristine can be increased when combined with Fluticasone.]
[L01CA03, vindesine, The metabolism of Vindesine can be increased when combined with Fluticasone.]
[B01AA03, warfarin, Fluticasone may increase the anticoagulant activities of Warfarin.]
[J05AF01, zidovudine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Fluticasone.]
[N05AF05, zuclopenthixol, The metabolism of Zuclopenthixol can be increased when combined with Fluticasone.]
[J05AE02, indinavir, The metabolism of Indinavir can be decreased when combined with Fluticasone.]
[L01EC01, vemurafenib, The metabolism of Vemurafenib can be increased when combined with Fluticasone.]
[L01FX05, brentuximab vedotin, The metabolism of Brentuximab vedotin can be increased when combined with Fluticasone.]
[L01ED01, crizotinib, The metabolism of Crizotinib can be increased when combined with Fluticasone.]
[H05BX03, doxercalciferol, The therapeutic efficacy of Doxercalciferol can be decreased when used in combination with Fluticasone.]
[J01MA13, trovafloxacin, The risk or severity of tendinopathy can be increased when Fluticasone is combined with Trovafloxacin.]
[N05AE04, ziprasidone, The metabolism of Ziprasidone can be increased when combined with Fluticasone.]
[G03AC10, drospirenone, The serum concentration of Fluticasone can be increased when it is combined with Drospirenone.]
[L04AA34, alemtuzumab, The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Fluticasone.]
[N02BA01, aspirin, The risk or severity of adverse effects can be increased when Fluticasone is combined with Acetylsalicylic acid.]
[L01EJ01, ruxolitinib, The metabolism of Ruxolitinib can be increased when combined with Fluticasone.]
[L03AB11, peginterferon alfa-2a, The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluticasone.]
[A11CC03, alfacalcidol, The therapeutic efficacy of Alfacalcidol can be decreased when used in combination with Fluticasone.]
[L01FA01, rituximab, The risk or severity of adverse effects can be increased when Rituximab is combined with Fluticasone.]
[J02AC03, voriconazole, The serum concentration of Fluticasone can be increased when it is combined with Voriconazole.]
[M03AC04, atracurium, The risk or severity of myopathy and weakness can be increased when Atracurium is combined with Fluticasone.]
[L01EK01, axitinib, The metabolism of Axitinib can be increased when combined with Fluticasone.]
[R07AX02, ivacaftor, The metabolism of Ivacaftor can be decreased when combined with Fluticasone.]
[H02AB11, prednylidene, The risk or severity of adverse effects can be increased when Prednylidene is combined with Fluticasone.]
[L01BC07, azacitidine, The risk or severity of adverse effects can be increased when Azacitidine is combined with Fluticasone.]
[L04AX01, azathioprine, The risk or severity of adverse effects can be increased when Azathioprine is combined with Fluticasone.]
[L01BC05, gemcitabine, The risk or severity of adverse effects can be increased when Gemcitabine is combined with Fluticasone.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Fluticasone.]
[J07BK01, varicella-zoster virus vaccine live (Oka-Merck) strain, The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Fluticasone.]
[L01FX02, gemtuzumab ozogamicin, The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Fluticasone.]
[L01XG02, carfilzomib, The risk or severity of adverse effects can be increased when Carfilzomib is combined with Fluticasone.]
[V03AX03, cobicistat, The metabolism of Fluticasone can be decreased when combined with Cobicistat.]
[L02BB04, enzalutamide, The serum concentration of Enzalutamide can be increased when it is combined with Fluticasone.]
[L01EA04, bosutinib, The metabolism of Bosutinib can be increased when combined with Fluticasone.]
[L04AA31, teriflunomide, The risk or severity of adverse effects can be increased when Teriflunomide is combined with Fluticasone.]
[L04AA22, abetimus, The risk or severity of adverse effects can be increased when Abetimus is combined with Fluticasone.]
[H02AA01, aldosterone, The risk or severity of adverse effects can be increased when Aldosterone is combined with Fluticasone.]
[L01EX05, regorafenib, The metabolism of Regorafenib can be increased when combined with Fluticasone.]
[C01AA01, acetyldigitoxin, The risk or severity of adverse effects can be increased when Fluticasone is combined with Acetyldigitoxin.]
[J05AE04, nelfinavir, The metabolism of Fluticasone can be decreased when combined with Nelfinavir.]
[L01AA09, bendamustine, The risk or severity of adverse effects can be increased when Bendamustine is combined with Fluticasone.]
[C08CA13, lercanidipine, The metabolism of Lercanidipine can be decreased when combined with Fluticasone.]
[N06DA02, donepezil, The therapeutic efficacy of Donepezil can be decreased when used in combination with Fluticasone.]
[N03AX22, perampanel, The metabolism of Perampanel can be decreased when combined with Fluticasone.]
[L04AA29, tofacitinib, The metabolism of Tofacitinib can be decreased when combined with Fluticasone.]
[G04BE03, sildenafil, The metabolism of Sildenafil can be decreased when combined with Fluticasone.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be increased when combined with Fluticasone.]
[B01AF02, apixaban, The metabolism of Apixaban can be decreased when combined with Fluticasone.]
[C10AX12, lomitapide, The metabolism of Lomitapide can be increased when combined with Fluticasone.]
[A10BH04, alogliptin, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Alogliptin.]
[A16AX09, glycerol phenylbutyrate, The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Fluticasone.]
[C03AA01, bendroflumethiazide, The risk or severity of electrolyte imbalance can be increased when Fluticasone is combined with Bendroflumethiazide.]
[L04AX06, pomalidomide, The metabolism of Pomalidomide can be increased when combined with Fluticasone.]
[N02BA10, benorilate, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Benorilate.]
[A10BK02, canagliflozin, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Canagliflozin.]
[L04AX07, dimethyl fumarate, The risk or severity of adverse effects can be increased when Dimethyl fumarate is combined with Fluticasone.]
[J01MA15, gemifloxacin, The risk or severity of tendinopathy can be increased when Fluticasone is combined with Gemifloxacin.]
[S01AE07, moxifloxacin, The risk or severity of tendinopathy can be increased when Fluticasone is combined with Moxifloxacin.]
[H03AA04, tiratricol, The therapeutic efficacy of Tiratricol can be decreased when used in combination with Fluticasone.]
[A10AE05, insulin detemir, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Insulin detemir.]
[A10BX05, pramlintide, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Pramlintide.]
[J02AX04, caspofungin, The excretion of Caspofungin can be decreased when combined with Fluticasone.]
[M01AH01, celecoxib, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Celecoxib.]
[L04AA18, everolimus, The metabolism of Everolimus can be increased when combined with Fluticasone.]
[L01EC02, dabrafenib, The serum concentration of Dabrafenib can be increased when it is combined with Fluticasone.]
[R02AX03, benzydamine, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Benzydamine.]
[P03AX06, benzyl alcohol, The metabolism of Benzyl alcohol can be decreased when combined with Fluticasone.]
[N06AX28, levomilnacipran, The metabolism of Levomilnacipran can be decreased when combined with Fluticasone.]
[C02KX05, riociguat, The metabolism of Riociguat can be decreased when combined with Fluticasone.]
[A10BJ03, lixisenatide, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Lixisenatide.]
[A05AA03, cholic acid, The excretion of Cholic Acid can be decreased when combined with Fluticasone.]
[L01EL01, ibrutinib, The metabolism of Ibrutinib can be decreased when combined with Fluticasone.]
[N06AX26, vortioxetine, The metabolism of Vortioxetine can be decreased when combined with Fluticasone.]
[G03AC08, etonogestrel, The serum concentration of Fluticasone can be increased when it is combined with Etonogestrel.]
[J05AP05, simeprevir, The excretion of Simeprevir can be decreased when combined with Fluticasone.]
[A10BK01, dapagliflozin, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Dapagliflozin.]
[C01CA27, droxidopa, The risk or severity of hypokalemia can be increased when Fluticasone is combined with Droxidopa.]
[N05CH03, tasimelteon, The metabolism of Tasimelteon can be increased when combined with Fluticasone.]
[A16AA07, metreleptin, The metabolism of Fluticasone can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Fluticasone can be increased when combined with Apremilast.]
[L02BG02, formestane, The risk or severity of edema formation can be increased when Formestane is combined with Fluticasone.]
[A16AA06, betaine, The therapeutic efficacy of Betaine can be decreased when used in combination with Fluticasone.]
[S03BA03, betamethasone, The risk or severity of adverse effects can be increased when Betamethasone is combined with Fluticasone.]
[A10BJ04, albiglutide, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Albiglutide.]
[L04AC11, siltuximab, The metabolism of Fluticasone can be increased when combined with Siltuximab.]
[L01ED02, ceritinib, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Ceritinib.]
[B01AC26, vorapaxar, The metabolism of Vorapaxar can be increased when combined with Fluticasone.]
[L04AA33, vedolizumab, The risk or severity of adverse effects can be increased when Vedolizumab is combined with Fluticasone.]
[B01AA07, acenocoumarol, Fluticasone may increase the anticoagulant activities of Acenocoumarol.]
[L01XH04, belinostat, The risk or severity of adverse effects can be increased when Belinostat is combined with Fluticasone.]
[L01EM01, idelalisib, The metabolism of Idelalisib can be increased when combined with Fluticasone.]
[A10BK03, empagliflozin, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Empagliflozin.]
[R03AC19, olodaterol, The metabolism of Olodaterol can be decreased when combined with Fluticasone.]
[L03AB13, peginterferon beta-1a, The risk or severity of adverse effects can be increased when Peginterferon beta-1a is combined with Fluticasone.]
[N05CM19, suvorexant, The metabolism of Suvorexant can be increased when combined with Fluticasone.]
[A16AX10, eliglustat, The metabolism of Eliglustat can be decreased when combined with Fluticasone.]
[V04CX03, methacholine, Fluticasone may decrease effectiveness of Methacholine as a diagnostic agent.]
[A10BJ05, dulaglutide, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Dulaglutide.]
[L01BC08, decitabine, The risk or severity of adverse effects can be increased when Decitabine is combined with Fluticasone.]
[L04AX05, pirfenidone, The risk or severity of adverse effects can be increased when Pirfenidone is combined with Fluticasone.]
[L01EX09, nintedanib, The metabolism of Nintedanib can be increased when combined with Fluticasone.]
[L01FX07, blinatumomab, The risk or severity of adverse effects can be increased when Blinatumomab is combined with Fluticasone.]
[J05AP09, dasabuvir, The metabolism of Dasabuvir can be decreased when combined with Fluticasone.]
[L01XK01, olaparib, The metabolism of Olaparib can be increased when combined with Fluticasone.]
[B01AA01, dicumarol, Fluticasone may increase the anticoagulant activities of Dicoumarol.]
[L04AC10, secukinumab, The metabolism of Fluticasone can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The metabolism of Palbociclib can be increased when combined with Fluticasone.]
[L01XH03, panobinostat, The metabolism of Panobinostat can be increased when combined with Fluticasone.]
[J05AP07, daclatasvir, The metabolism of Daclatasvir can be decreased when combined with Fluticasone.]
[L01DC01, bleomycin, The risk or severity of adverse effects can be increased when Bleomycin is combined with Fluticasone.]
[B01AA11, tioclomarol, Fluticasone may increase the anticoagulant activities of Tioclomarol.]
[J05AP06, asunaprevir, The metabolism of Asunaprevir can be decreased when combined with Fluticasone.]
[A07DA06, eluxadoline, The serum concentration of Eluxadoline can be increased when it is combined with Fluticasone.]
[L01XJ02, sonidegib, The metabolism of Sonidegib can be increased when combined with Fluticasone.]
[A10BF01, acarbose, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Acarbose.]
[M02AA25, aceclofenac, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Aceclofenac.]
[M01AB11, acemetacin, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Acemetacin.]
[A10AE06, insulin degludec, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Insulin degludec.]
[A02BC03, lansoprazole, The metabolism of Lansoprazole can be decreased when combined with Fluticasone.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be increased when combined with Fluticasone.]
[R03DX09, mepolizumab, The risk or severity of adverse effects can be increased when Mepolizumab is combined with Fluticasone.]
[J02AC05, isavuconazole, The metabolism of Isavuconazole can be increased when combined with Fluticasone.]
[L01EB04, osimertinib, The metabolism of Osimertinib can be increased when combined with Fluticasone.]
[J05AF13, tenofovir alafenamide, The metabolism of Tenofovir alafenamide can be increased when combined with Fluticasone.]
[L01EE02, cobimetinib, The metabolism of Cobimetinib can be increased when combined with Fluticasone.]
[L01XG03, ixazomib, The metabolism of Ixazomib can be increased when combined with Fluticasone.]
[L01ED03, alectinib, The metabolism of Alectinib can be increased when combined with Fluticasone.]
[B01AC27, selexipag, The metabolism of Selexipag can be decreased when combined with Fluticasone.]
[A10BB31, acetohexamide, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Acetohexamide.]
[G04CA01, alfuzosin, The metabolism of Alfuzosin can be decreased when combined with Fluticasone.]
[J05AP10, elbasvir, The metabolism of Elbasvir can be decreased when combined with Fluticasone.]
[J05AP11, grazoprevir, The excretion of Grazoprevir can be decreased when combined with Fluticasone.]
[M01AE16, alminoprofen, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Alminoprofen.]
[L04AC13, ixekizumab, The risk or severity of adverse effects can be increased when Ixekizumab is combined with Fluticasone.]
[L01XX52, venetoclax, The metabolism of Venetoclax can be increased when combined with Fluticasone.]
[N04BC01, bromocriptine, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Bromocriptine.]
[C08CA01, amlodipine, The metabolism of Amlodipine can be increased when combined with Fluticasone.]
[N05AX17, pimavanserin, The metabolism of Pimavanserin can be increased when combined with Fluticasone.]
[N07BC01, buprenorphine, The metabolism of Buprenorphine can be decreased when combined with Fluticasone.]
[N05BE01, buspirone, The metabolism of Buspirone can be decreased when combined with Fluticasone.]
[L01AB01, busulfan, The metabolism of Busulfan can be increased when combined with Fluticasone.]
[L01XX27, arsenic trioxide, The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Fluticasone.]
[N06DA03, rivastigmine, The therapeutic efficacy of Rivastigmine can be decreased when used in combination with Fluticasone.]
[P01BE02, artemether, The metabolism of Artemether can be decreased when combined with Fluticasone.]
[J01MA09, sparfloxacin, The risk or severity of tendinopathy can be increased when Fluticasone is combined with Sparfloxacin.]
[S01GX07, azelastine, The metabolism of Azelastine can be decreased when combined with Fluticasone.]
[L01XK03, rucaparib, The metabolism of Fluticasone can be decreased when combined with Rucaparib.]
[S01AA26, azithromycin, The metabolism of Azithromycin can be increased when combined with Fluticasone.]
[L04AC12, brodalumab, The risk or severity of adverse effects can be increased when Brodalumab is combined with Fluticasone.]
[L01EF02, ribociclib, The metabolism of Ribociclib can be increased when combined with Fluticasone.]
[A07EC04, balsalazide, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Balsalazide.]
[R03CC12, bambuterol, The therapeutic efficacy of Bambuterol can be decreased when used in combination with Fluticasone.]
[L04AA36, ocrelizumab, The risk or severity of adverse effects can be increased when Ocrelizumab is combined with Fluticasone.]
[N07XX16, deutetrabenazine, The metabolism of Deutetrabenazine can be decreased when combined with Fluticasone.]
[A10BX06, benfluorex, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Benfluorex.]
[H05BX05, calcifediol, The therapeutic efficacy of Calcifediol can be decreased when used in combination with Fluticasone.]
[D05AX03, calcitriol, The therapeutic efficacy of Calcitriol can be decreased when used in combination with Fluticasone.]
[L04AC01, daclizumab, The risk or severity of adverse effects can be increased when Daclizumab is combined with Fluticasone.]
[J01XX08, linezolid, The risk or severity of adverse effects can be increased when Linezolid is combined with Fluticasone.]
[N07XX13, valbenazine, The metabolism of Valbenazine can be decreased when combined with Fluticasone.]
[L04AB02, infliximab, The metabolism of Fluticasone can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Midostaurin can be increased when combined with Fluticasone.]
[L01ED04, brigatinib, The metabolism of Brigatinib can be increased when combined with Fluticasone.]
[L04AC14, sarilumab, The risk or severity of adverse effects can be increased when Sarilumab is combined with Fluticasone.]
[J01MA23, delafloxacin, The risk or severity of tendinopathy can be increased when Fluticasone is combined with Delafloxacin.]
[L04AC16, guselkumab, The risk or severity of adverse effects can be increased when Guselkumab is combined with Fluticasone.]
[L01BC06, capecitabine, The risk or severity of adverse effects can be increased when Capecitabine is combined with Fluticasone.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be increased when combined with Fluticasone.]
[L01EH02, neratinib, The metabolism of Neratinib can be increased when combined with Fluticasone.]
[L01XH01, vorinostat, The risk or severity of adverse effects can be increased when Vorinostat is combined with Fluticasone.]
[L01EM02, copanlisib, The metabolism of Copanlisib can be increased when combined with Fluticasone.]
[L01EF03, abemaciclib, The metabolism of Abemaciclib can be increased when combined with Fluticasone.]
[R03AC17, bitolterol, The risk or severity of hypokalemia can be increased when Fluticasone is combined with Bitolterol.]
[J05AG03, efavirenz, The metabolism of Fluticasone can be increased when combined with Efavirenz.]
[L04AC02, basiliximab, The risk or severity of adverse effects can be increased when Basiliximab is combined with Fluticasone.]
[L01BA03, raltitrexed, The risk or severity of adverse effects can be increased when Raltitrexed is combined with Fluticasone.]
[R03BA02, budesonide, The risk or severity of adverse effects can be increased when Budesonide is combined with Fluticasone.]
[M01AB07, bumadizone, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Bumadizone.]
[L01EL02, acalabrutinib, The metabolism of Acalabrutinib can be increased when combined with Fluticasone.]
[J05AX18, letermovir, The metabolism of Fluticasone can be decreased when combined with Letermovir.]
[C01AA02, acetyldigoxins, The risk or severity of adverse effects can be increased when Fluticasone is combined with Acetyldigoxin.]
[A10BJ06, semaglutide, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Semaglutide.]
[N01BX04, capsaicin, The therapeutic efficacy of Capsaicin can be decreased when used in combination with Fluticasone.]
[A10BK04, ertugliflozin, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Ertugliflozin.]
[V04CD06, macimorelin, The therapeutic efficacy of Macimorelin can be decreased when used in combination with Fluticasone.]
[L02BB05, apalutamide, The serum concentration of Apalutamide can be increased when it is combined with Fluticasone.]
[N03AF01, carbamazepine, The metabolism of Carbamazepine can be increased when combined with Fluticasone.]
[L03AB06, interferon alfa-n1, The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Fluticasone.]
[N03AX24, cannabidiol, The metabolism of Cannabidiol can be decreased when combined with Fluticasone.]
[L04AA37, baricitinib, The risk or severity of adverse effects can be increased when Baricitinib is combined with Fluticasone.]
[C07AB08, celiprolol, The risk or severity of hypokalemia can be increased when Fluticasone is combined with Celiprolol.]
[H01CC03, elagolix, The metabolism of Elagolix can be decreased when combined with Fluticasone.]
[L01XX62, ivosidenib, The metabolism of Fluticasone can be increased when combined with Ivosidenib.]
[N03AX17, stiripentol, The metabolism of Fluticasone can be decreased when combined with Stiripentol.]
[J05AG06, doravirine, The metabolism of Doravirine can be decreased when combined with Fluticasone.]
[L01EM04, duvelisib, The metabolism of Duvelisib can be increased when combined with Fluticasone.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be increased when combined with Fluticasone.]
[A10BB06, carbutamide, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Carbutamide.]
[M01AC05, lornoxicam, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Lornoxicam.]
[R03BB08, revefenacin, Fluticasone may decrease the excretion rate of Revefenacin which could result in a higher serum level.]
[L01ED05, lorlatinib, The metabolism of Lorlatinib can be decreased when combined with Fluticasone.]
[L04AA39, emapalumab, The metabolism of Fluticasone can be increased when combined with Emapalumab.]
[L01AD01, carmustine, The risk or severity of adverse effects can be increased when Carmustine is combined with Fluticasone.]
[L01EX13, gilteritinib, The metabolism of Gilteritinib can be increased when combined with Fluticasone.]
[L01XJ03, glasdegib, The metabolism of Glasdegib can be decreased when combined with Fluticasone.]
[L04AA43, ravulizumab, The risk or severity of adverse effects can be increased when Ravulizumab is combined with Fluticasone.]
[A06AX05, prucalopride, The metabolism of Prucalopride can be decreased when combined with Fluticasone.]
[B01AC23, cilostazol, The metabolism of Cilostazol can be decreased when combined with Fluticasone.]
[L04AA42, siponimod, The metabolism of Siponimod can be increased when combined with Fluticasone.]
[J01FA09, clarithromycin, The metabolism of Fluticasone can be decreased when combined with Clarithromycin.]
[L01EN01, erdafitinib, The metabolism of Erdafitinib can be increased when combined with Fluticasone.]
[H02AB14, cloprednol, The risk or severity of adverse effects can be increased when Cloprednol is combined with Fluticasone.]
[L04AB01, etanercept, The metabolism of Fluticasone can be increased when combined with Etanercept.]
[H02AB17, cortivazol, The risk or severity of adverse effects can be increased when Cortivazol is combined with Fluticasone.]
[L04AC18, risankizumab, The risk or severity of adverse effects can be increased when Fluticasone is combined with Risankizumab.]
[L01EM03, alpelisib, The metabolism of Alpelisib can be increased when combined with Fluticasone.]
[L01EX15, pexidartinib, The metabolism of Pexidartinib can be increased when combined with Fluticasone.]
[L04AA44, upadacitinib, The risk or severity of adverse effects can be increased when Fluticasone is combined with Upadacitinib.]
[L01EX14, entrectinib, The metabolism of Entrectinib can be increased when combined with Fluticasone.]
[N07XX11, pitolisant, The serum concentration of Fluticasone can be decreased when it is combined with Pitolisant.]
[J04AK08, pretomanid, The metabolism of Pretomanid can be increased when combined with Fluticasone.]
[J01XX12, lefamulin, The metabolism of Lefamulin can be increased when combined with Fluticasone.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be decreased when combined with Fluticasone.]
[C03AA09, cyclothiazide, The risk or severity of electrolyte imbalance can be increased when Fluticasone is combined with Cyclothiazide.]
[A10AE03, insulin, regular, pork, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Insulin pork.]
[J01DB01, cephalexin, The metabolism of Cephalexin can be increased when combined with Fluticasone.]
[H02AB13, deflazacort, The risk or severity of adverse effects can be increased when Deflazacort is combined with Fluticasone.]
[G03DB05, demegestone, The serum concentration of Fluticasone can be increased when it is combined with Demegestone.]
[L01FD01, trastuzumab, Trastuzumab may increase the neutropenic activities of Fluticasone.]
[L01FD03, ado-trastuzumab emtansine, The metabolism of Trastuzumab emtansine can be increased when combined with Fluticasone.]
[L04AX09, diroximel fumarate, The risk or severity of adverse effects can be increased when Fluticasone is combined with Diroximel fumarate.]
[L01EL03, zanubrutinib, The metabolism of Zanubrutinib can be increased when combined with Fluticasone.]
[G03AC09, desogestrel, The serum concentration of Fluticasone can be increased when it is combined with Desogestrel.]
[B06AX03, voxelotor, The serum concentration of Voxelotor can be increased when it is combined with Fluticasone.]
[N03AX25, cenobamate, The serum concentration of Fluticasone can be decreased when it is combined with Cenobamate.]
[S01XA12, dexpanthenol, The therapeutic efficacy of Dexpanthenol can be decreased when used in combination with Fluticasone.]
[N05CM21, lemborexant, The metabolism of Lemborexant can be decreased when combined with Fluticasone.]
[L01XX72, tazemetostat, The metabolism of Tazemetostat can be increased when combined with Fluticasone.]
[L04AA53, teprotumumab, The risk or severity of adverse effects can be increased when Teprotumumab is combined with Fluticasone.]
[S01AE06, gatifloxacin, The risk or severity of tendinopathy can be increased when Fluticasone is combined with Gatifloxacin.]
[H02CA02, osilodrostat, The metabolism of Fluticasone can be decreased when combined with Osilodrostat.]
[J05AE05, amprenavir, The metabolism of Amprenavir can be decreased when combined with Fluticasone.]
[G04CB02, dutasteride, The metabolism of Dutasteride can be decreased when combined with Fluticasone.]
[L04AA38, ozanimod, The metabolism of Ozanimod can be decreased when combined with Fluticasone.]
[L01EE04, selumetinib, The metabolism of Selumetinib can be decreased when combined with Fluticasone.]
[G03DB08, dienogest, The serum concentration of Fluticasone can be increased when it is combined with Dienogest.]
[M01AH02, rofecoxib, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Rofecoxib.]
[L01XF03, bexarotene, The risk or severity of adverse effects can be increased when Bexarotene is combined with Fluticasone.]
[C01BD07, dronedarone, The metabolism of Dronedarone can be increased when combined with Fluticasone.]
[L01AA02, chlorambucil, The risk or severity of adverse effects can be increased when Chlorambucil is combined with Fluticasone.]
[S03AA08, chloramphenicol, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Fluticasone.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Fluticasone.]
[D07XB03, fluprednidene, The risk or severity of adverse effects can be increased when Fluprednidene is combined with Fluticasone.]
[M01AC04, droxicam, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Droxicam.]
[M02AA27, dexketoprofen, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Dexketoprofen.]
[L04AA47, inebilizumab, The risk or severity of infection can be increased when Fluticasone is combined with Inebilizumab.]
[R05CB11, stepronin, The risk or severity of adverse effects can be increased when Stepronin is combined with Fluticasone.]
[C08CA17, levamlodipine, The serum concentration of Levamlodipine can be increased when it is combined with Fluticasone.]
[R06AX22, ebastine, The metabolism of Ebastine can be increased when combined with Fluticasone.]
[L01FX15, belantamab mafodotin, The excretion of Belantamab mafodotin can be decreased when combined with Fluticasone.]
[L04AC19, satralizumab, The serum concentration of Fluticasone can be decreased when it is combined with Satralizumab.]
[P01BA01, chloroquine, The metabolism of Chloroquine can be decreased when combined with Fluticasone.]
[L01EX23, pralsetinib, The metabolism of Fluticasone can be decreased when combined with Pralsetinib.]
[C03AA04, chlorothiazide, The risk or severity of electrolyte imbalance can be increased when Fluticasone is combined with Chlorothiazide.]
[R06AB04, chlorpheniramine, The metabolism of Chlorpheniramine can be decreased when combined with Fluticasone.]
[N05AA01, chlorpromazine, The therapeutic efficacy of Chlorpromazine can be decreased when used in combination with Fluticasone.]
[A10BB02, chlorpropamide, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Chlorpropamide.]
[C03BA04, chlorthalidone, Fluticasone may increase the hypokalemic activities of Chlorthalidone.]
[A11CC05, cholecalciferol, The therapeutic efficacy of Cholecalciferol can be decreased when used in combination with Fluticasone.]
[V04CK02, cholecystokinin, The excretion of Cholecystokinin can be decreased when combined with Fluticasone.]
[N02BA07, ethenzamide, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Ethenzamide.]
[C10AC01, cholestyramine resin, Cholestyramine may increase the excretion rate of Fluticasone which could result in a lower serum level and potentially a reduction in efficacy.]
[G03DC06, ethynodiol, The serum concentration of Fluticasone can be increased when it is combined with Etynodiol.]
[M01AB08, etodolac, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Etodolac.]
[M02AA06, etofenamate, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Etofenamate.]
[A16AX20, lonafarnib, The metabolism of Fluticasone can be decreased when combined with Lonafarnib.]
[L01BB05, fludarabine, The risk or severity of adverse effects can be increased when Fludarabine is combined with Fluticasone.]
[L02BX04, relugolix, The metabolism of Relugolix can be decreased when combined with Fluticasone.]
[L04AD03, voclosporin, The risk or severity of adverse effects can be increased when Voclosporin is combined with Fluticasone.]
[P03AX07, abametapir, The serum concentration of Fluticasone can be increased when it is combined with Abametapir.]
[M01AE05, fenbufen, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Fenbufen.]
[G04CB01, finasteride, The metabolism of Finasteride can be decreased when combined with Fluticasone.]
[J01MB07, flumequine, The risk or severity of tendinopathy can be increased when Fluticasone is combined with Flumequine.]
[R03BA03, flunisolide, The risk or severity of adverse effects can be increased when Flunisolide is combined with Fluticasone.]
[A10AF01, insulin, regular, human, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Insulin human.]
[L04AA50, ponesimod, The risk or severity of adverse effects can be increased when Ponesimod is combined with Fluticasone.]
[L03AB10, peginterferon alfa-2b, The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Fluticasone.]
[A02BA01, cimetidine, The metabolism of Fluticasone can be decreased when combined with Cimetidine.]
[J01MB06, cinoxacin, The risk or severity of tendinopathy can be increased when Fluticasone is combined with Cinoxacin.]
[L01XX73, sotorasib, The serum concentration of Fluticasone can be decreased when it is combined with Sotorasib.]
[L01EN03, infigratinib, The metabolism of Infigratinib can be increased when combined with Fluticasone.]
[S03AA07, ciprofloxacin, The risk or severity of tendinopathy can be increased when Fluticasone is combined with Ciprofloxacin.]
[L01XA01, cisplatin, The therapeutic efficacy of Cisplatin can be decreased when used in combination with Fluticasone.]
[L04AA54, pegcetacoplan, The risk or severity of adverse effects can be increased when Fluticasone is combined with Pegcetacoplan.]
[H01AC07, somapacitan, The serum concentration of the active metabolites of Fluticasone can be decreased when Fluticasone is used in combination with Somapacitan.]
[C03DA05, finerenone, The serum concentration of Finerenone can be increased when it is combined with Fluticasone.]
[L04AA48, belumosudil, The risk or severity of adverse effects can be increased when Fluticasone is combined with Belumosudil.]
[P01CA03, fexinidazole, The metabolism of Fexinidazole can be decreased when combined with Fluticasone.]
[L04AA51, anifrolumab, The risk or severity of adverse effects can be increased when Anifrolumab is combined with Fluticasone.]
[H01AC09, lonapegsomatropin, The serum concentration of the active metabolites of Fluticasone can be decreased when Fluticasone is used in combination with Lonapegsomatropin.]
[L01EB10, mobocertinib, The metabolism of Mobocertinib can be decreased when combined with Fluticasone.]
[N02CD07, atogepant, The serum concentration of Atogepant can be increased when it is combined with Fluticasone.]
[A10BB12, glimepiride, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Glimepiride.]
[A10BB08, gliquidone, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Gliquidone.]
[R03CC13, clenbuterol, The risk or severity of hypokalemia can be increased when Fluticasone is combined with Clenbuterol.]
[J01FF01, clindamycin, The metabolism of Clindamycin can be decreased when combined with Fluticasone.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of adverse effects can be increased when Fluticasone is combined with Ropeginterferon alfa-2b.]
[J04BA01, clofazimine, The metabolism of Fluticasone can be decreased when combined with Clofazimine.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be increased when combined with Fluticasone.]
[S01EA04, clonidine, The metabolism of Clonidine can be increased when combined with Fluticasone.]
[J05AB17, brincidofovir, The serum concentration of Brincidofovir can be increased when it is combined with Fluticasone.]
[C01EB24, mavacamten, The serum concentration of Fluticasone can be decreased when it is combined with Mavacamten.]
[A10BX16, tirzepatide, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Tirzepatide.]
[A02BC08, vonoprazan, The metabolism of Vonoprazan can be decreased when combined with Fluticasone.]
[L04AC22, spesolimab, The risk or severity of adverse effects can be increased when Fluticasone is combined with Spesolimab.]
[L04AA56, deucravacitinib, The risk or severity of adverse effects can be increased when Fluticasone is combined with Deucravacitinib.]
[A04AA01, ondansetron, The metabolism of Ondansetron can be decreased when combined with Fluticasone.]
[A10BX01, guar gum, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Guar gum.]
[A10BK06, sotagliflozin, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Sotagliflozin.]
[H01AC08, somatrogon, The serum concentration of the active metabolites of Fluticasone can be reduced when Fluticasone is used in combination with Somatrogon resulting in a loss in efficacy.]
[L04AC21, bimekizumab, The metabolism of Fluticasone can be increased when combined with Bimekizumab.]
[M01AX13, proquazone, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Proquazone.]
[M03AC05, hexafluorenium, The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Fluticasone.]
[M04AC01, colchicine, The metabolism of Colchicine can be decreased when combined with Fluticasone.]
[L04AA13, leflunomide, The risk or severity of adverse effects can be increased when Fluticasone is combined with Leflunomide.]
[A10BX03, nateglinide, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Nateglinide.]
[N02BA16, imidazole-2-hydroxybenzoate, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Imidazole salicylate.]
[H01AC03, mecasermin, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Mecasermin.]
[L01BB07, nelarabine, The risk or severity of adverse effects can be increased when Nelarabine is combined with Fluticasone.]
[A10AE04, insulin glargine, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Insulin glargine.]
[J01FA15, telithromycin, The metabolism of Telithromycin can be decreased when combined with Fluticasone.]
[R03BA08, ciclesonide, The risk or severity of adverse effects can be increased when Ciclesonide is combined with Fluticasone.]
[B01AC10, indobufen, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Indobufen.]
[M01AH03, valdecoxib, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Valdecoxib.]
[H01AX01, pegvisomant, The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Fluticasone.]
[C01AA06, lanatoside C, The risk or severity of adverse effects can be increased when Fluticasone is combined with Lanatoside C.]
[N02CC05, almotriptan, The metabolism of Almotriptan can be decreased when combined with Fluticasone.]
[M01AH04, parecoxib, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Parecoxib.]
[J02AC02, itraconazole, The metabolism of Fluticasone can be decreased when combined with Itraconazole.]
[M01AA06, kebuzone, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Kebuzone.]
[L01EA01, imatinib, The risk or severity of adverse effects can be increased when Imatinib is combined with Fluticasone.]
[S01BA03, cortisone, The metabolism of Fluticasone can be increased when combined with Cortisone.]
[S01AE04, lomefloxacin, The risk or severity of tendinopathy can be increased when Fluticasone is combined with Lomefloxacin.]
[M01AB09, lonazolac, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Lonazolac.]
[M02AA31, loxoprofen, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Loxoprofen.]
[H02AB15, meprednisone, The risk or severity of adverse effects can be increased when Meprednisone is combined with Fluticasone.]
[C03DA04, eplerenone, The metabolism of Eplerenone can be decreased when combined with Fluticasone.]
[L04AA15, alefacept, The risk or severity of adverse effects can be increased when Alefacept is combined with Fluticasone.]
[C03AA07, cyclopenthiazide, The risk or severity of electrolyte imbalance can be increased when Fluticasone is combined with Cyclopenthiazide.]
[A10BF02, miglitol, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Miglitol.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be increased when combined with Fluticasone.]
[N06AX07, minaprine, The therapeutic efficacy of Minaprine can be decreased when used in combination with Fluticasone.]
[S01XA18, cyclosporine, Fluticasone may increase the immunosuppressive activities of Cyclosporine.]
[N06BA07, modafinil, The metabolism of Modafinil can be decreased when combined with Fluticasone.]
[C10AA07, rosuvastatin, The metabolism of Rosuvastatin can be increased when combined with Fluticasone.]
[M02AA02, mofebutazone, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Mofebutazone.]
[M01AX22, morniflumate, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Morniflumate.]
[C03XA02, conivaptan, The metabolism of Conivaptan can be increased when combined with Fluticasone.]
[L01BC01, cytarabine, The risk or severity of adverse effects can be increased when Cytarabine is combined with Fluticasone.]
[G04BE09, vardenafil, The metabolism of Vardenafil can be decreased when combined with Fluticasone.]
[M01AH05, etoricoxib, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Etoricoxib.]
[L01AX04, dacarbazine, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Fluticasone.]
[L01DA01, dactinomycin, The risk or severity of adverse effects can be increased when Dactinomycin is combined with Fluticasone.]
[G03XA01, danazol, The risk or severity of fluid retention can be increased when Fluticasone is combined with Danazol.]
[J04BA02, dapsone, The metabolism of Dapsone can be decreased when combined with Fluticasone.]
[L01DB02, daunorubicin, The risk or severity of adverse effects can be increased when Daunorubicin is combined with Fluticasone.]
[M01AX01, nabumetone, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Nabumetone.]
[C01DX16, nicorandil, The risk or severity of ulceration can be increased when Fluticasone is combined with Nicorandil.]
[G03DB04, nomegestrol, The serum concentration of Fluticasone can be increased when it is combined with Nomegestrol.]
[M03AC11, cisatracurium, The risk or severity of myopathy and weakness can be increased when Cisatracurium is combined with Fluticasone.]
[D11AH02, pimecrolimus, The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Fluticasone.]
[A07EC03, olsalazine, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Olsalazine.]
[C01AA07, deslanoside, The risk or severity of adverse effects can be increased when Fluticasone is combined with Deslanoside.]
[D07XC02, desoximetasone, The risk or severity of adverse effects can be increased when Desoximetasone is combined with Fluticasone.]
[L01XA03, oxaliplatin, The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Fluticasone.]
[M01AE12, oxaprozin, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Oxaprozin.]
[N03AF02, oxcarbazepine, The metabolism of Fluticasone can be increased when combined with Oxcarbazepine.]
[S03BA01, dexamethasone, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Fluticasone.]
[G04BD04, oxybutynin, The metabolism of Oxybutynin can be decreased when combined with Fluticasone.]
[L04AB04, adalimumab, The metabolism of Fluticasone can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, The metabolism of Gefitinib can be decreased when combined with Fluticasone.]
[R05DA09, dextromethorphan, The metabolism of Dextromethorphan can be decreased when combined with Fluticasone.]
[N03AC01, paramethadione, The metabolism of Paramethadione can be decreased when combined with Fluticasone.]
[B01AC04, clopidogrel, The metabolism of Clopidogrel can be decreased when combined with Fluticasone.]
[N05BA01, diazepam, The metabolism of Diazepam can be decreased when combined with Fluticasone.]
[S02DA04, dibucaine, The therapeutic efficacy of Cinchocaine can be decreased when used in combination with Fluticasone.]
[S01BC03, diclofenac, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Diclofenac.]
[A10BG03, pioglitazone, The serum concentration of Pioglitazone can be increased when it is combined with Fluticasone.]
[L01DC04, ixabepilone, The metabolism of Ixabepilone can be increased when combined with Fluticasone.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be increased when combined with Fluticasone.]
[L01DB08, pirarubicin, The risk or severity of adverse effects can be increased when Pirarubicin is combined with Fluticasone.]
[R03CC07, pirbuterol, The risk or severity of hypokalemia can be increased when Fluticasone is combined with Pirbuterol.]
[P02CB02, diethylcarbamazine, The therapeutic efficacy of Diethylcarbamazine can be decreased when used in combination with Fluticasone.]
[L02AA01, diethylstilbestrol, The serum concentration of Fluticasone can be increased when it is combined with Diethylstilbestrol.]
[D07XC04, diflucortolone, The risk or severity of adverse effects can be increased when Difluocortolone is combined with Fluticasone.]
[N02BA11, diflunisal, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Diflunisal.]
[C01AA04, digitoxin, The risk or severity of adverse effects can be increased when Fluticasone is combined with Digitoxin.]
[C01AA05, digoxin, The risk or severity of adverse effects can be increased when Fluticasone is combined with Digoxin.]
[C10AX09, ezetimibe, The excretion of Ezetimibe can be decreased when combined with Fluticasone.]
[L01XX24, pegaspargase, The risk or severity of adverse effects can be increased when Pegaspargase is combined with Fluticasone.]
[C04AE04, dihydroergocristine, The metabolism of Dihydroergocristine can be increased when combined with Fluticasone.]
[N02CA01, dihydroergotamine, The metabolism of Dihydroergotamine can be increased when combined with Fluticasone.]
[L04AX04, lenalidomide, The risk or severity of adverse effects can be increased when Lenalidomide is combined with Fluticasone.]
[A11CC02, dihydrotachysterol, The therapeutic efficacy of Dihydrotachysterol can be decreased when used in combination with Fluticasone.]
[J05AE08, atazanavir, The metabolism of Atazanavir can be increased when combined with Fluticasone.]
[B01AC21, treprostinil, The serum concentration of Treprostinil can be increased when it is combined with Fluticasone.]
[C08DB01, diltiazem, The metabolism of Diltiazem can be decreased when combined with Fluticasone.]
[R03CC08, procaterol, The risk or severity of hypokalemia can be increased when Fluticasone is combined with Procaterol.]
[N02BB04, propyphenazone, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Propyphenazone.]
[M01AB14, proglumetacin, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Proglumetacin.]
[G02AD02, dinoprostone, The excretion of Dinoprostone can be decreased when combined with Fluticasone.]
[A03FA02, cisapride, The metabolism of Cisapride can be decreased when combined with Fluticasone.]
[S01XA23, sirolimus, The metabolism of Sirolimus can be increased when combined with Fluticasone.]
[C01BA03, disopyramide, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Disopyramide.]
[L04AA23, natalizumab, The risk or severity of adverse effects can be increased when Fluticasone is combined with Natalizumab.]
[N07AA03, distigmine, The therapeutic efficacy of Distigmine can be decreased when used in combination with Fluticasone.]
[P03AA04, disulfiram, The metabolism of Disulfiram can be decreased when combined with Fluticasone.]
[N05AX08, risperidone, The metabolism of Risperidone can be decreased when combined with Fluticasone.]
[L04AA21, efalizumab, The risk or severity of adverse effects can be increased when Efalizumab is combined with Fluticasone.]
[J01MB01, rosoxacin, The risk or severity of tendinopathy can be increased when Fluticasone is combined with Rosoxacin.]
[L01EX01, sunitinib, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Sunitinib.]
[A04AD12, aprepitant, The metabolism of Fluticasone can be decreased when combined with Aprepitant.]
[C03XA01, tolvaptan, The metabolism of Tolvaptan can be increased when combined with Fluticasone.]
[L01XG01, bortezomib, The metabolism of Bortezomib can be increased when combined with Fluticasone.]
[G04BE08, tadalafil, The metabolism of Tadalafil can be decreased when combined with Fluticasone.]
[S01BC05, ketorolac, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Ketorolac.]
[C02KX02, ambrisentan, The metabolism of Ambrisentan can be decreased when combined with Fluticasone.]
[N02BA06, salsalate, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Salsalate.]
[C01CA07, dobutamine, The risk or severity of hypokalemia can be increased when Fluticasone is combined with Dobutamine.]
[A03FA03, domperidone, The metabolism of Domperidone can be decreased when combined with Fluticasone.]
[L01DB01, doxorubicin, The metabolism of Doxorubicin can be increased when combined with Fluticasone.]
[C10AA01, simvastatin, The metabolism of Simvastatin can be decreased when combined with Fluticasone.]
[N02CC01, sumatriptan, The excretion of Sumatriptan can be decreased when combined with Fluticasone.]
[V04CX07, edrophonium, The therapeutic efficacy of Edrophonium can be decreased when used in combination with Fluticasone.]
[H01AA01, corticotropin, The risk or severity of adverse effects can be increased when Corticotropin is combined with Fluticasone.]
[J01MA05, temafloxacin, The risk or severity of tendinopathy can be increased when Fluticasone is combined with Temafloxacin.]
[L01AX03, temozolomide, The risk or severity of adverse effects can be increased when Temozolomide is combined with Fluticasone.]
[M01AC02, tenoxicam, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Tenoxicam.]
[D01BA02, terbinafine, The metabolism of Terbinafine can be decreased when combined with Fluticasone.]
[N06AX14, tianeptine, The metabolism of Tianeptine can be increased when combined with Fluticasone.]
[C09AA02, enalapril, The excretion of Enalapril can be decreased when combined with Fluticasone.]
[M01AG02, tolfenamic acid, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Tolfenamic acid.]
[C03CA04, torsemide, The metabolism of Torasemide can be decreased when combined with Fluticasone.]
[H02CA01, trilostane, The risk or severity of edema formation can be increased when Trilostane is combined with Fluticasone.]
[L01AA07, trofosfamide, The risk or severity of adverse effects can be increased when Trofosfamide is combined with Fluticasone.]
[J01MA04, enoxacin, The risk or severity of tendinopathy can be increased when Fluticasone is combined with Enoxacin.]
[L01CA04, vinorelbine, The metabolism of Vinorelbine can be increased when combined with Fluticasone.]
[S01FB02, ephedrine, Ephedrine may increase the excretion rate of Fluticasone which could result in a lower serum level and potentially a reduction in efficacy.]
[S01EA01, epinephrine, The risk or severity of hypokalemia can be increased when Fluticasone is combined with Epinephrine.]
[L01DB03, epirubicin, The risk or severity of adverse effects can be increased when Epirubicin is combined with Fluticasone.]
[N05CF02, zolpidem, The metabolism of Zolpidem can be increased when combined with Fluticasone.]
[M01AB04, zomepirac, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Zomepirac.]
[N03AX15, zonisamide, The metabolism of Zonisamide can be decreased when combined with Fluticasone.]
[A10AB06, insulin glulisine, human, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Insulin glulisine.]
[N05CF01, zopiclone, The metabolism of Zopiclone can be decreased when combined with Fluticasone.]
[L01XA02, carboplatin, The risk or severity of adverse effects can be increased when Carboplatin is combined with Fluticasone.]
[A11CC01, ergocalciferol, The therapeutic efficacy of Ergocalciferol can be decreased when used in combination with Fluticasone.]
[N02CA02, ergotamine, The metabolism of Ergotamine can be increased when combined with Fluticasone.]
[S01AA17, erythromycin, The metabolism of Fluticasone can be decreased when combined with Erythromycin.]
[G03CA03, estradiol, The serum concentration of Fluticasone can be increased when it is combined with Estradiol.]
[L01XX11, estramustine, The risk or severity of adverse effects can be increased when Estramustine is combined with Fluticasone.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Fluticasone.]
[L04AA03, lymphocyte immune globulin, anti-thymocyte globulin, equine, The risk or severity of adverse effects can be increased when Antilymphocyte immunoglobulin (horse) is combined with Fluticasone.]
[J01MB04, pipemidic acid, The risk or severity of tendinopathy can be increased when Fluticasone is combined with Pipemidic acid.]
[S02BA08, fluocinolone acetonide, The risk or severity of adverse effects can be increased when Fluocinolone acetonide is combined with Fluticasone.]
[M01AG01, mefenamic acid, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Mefenamic acid.]
[R03BA09, fluticasone furoate, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Fluticasone.]
[C10AA04, fluvastatin, The metabolism of Fluvastatin can be decreased when combined with Fluticasone.]
[L02AA03, ethinyl estradiol, The serum concentration of Fluticasone can be increased when it is combined with Ethinylestradiol.]
[N04AA05, profenamine, The therapeutic efficacy of Profenamine can be decreased when used in combination with Fluticasone.]
[M01AC06, meloxicam, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Meloxicam.]
[L01CB01, etoposide, The metabolism of Etoposide can be increased when combined with Fluticasone.]
[L04AD02, tacrolimus, The serum concentration of Tacrolimus can be increased when it is combined with Fluticasone.]
[A02BA04, nizatidine, The therapeutic efficacy of Nizatidine can be decreased when used in combination with Fluticasone.]
[J01MA08, fleroxacin, The risk or severity of tendinopathy can be increased when Fluticasone is combined with Fleroxacin.]
[R06AX11, astemizole, The metabolism of Astemizole can be increased when combined with Fluticasone.]
[R06AX12, terfenadine, The metabolism of Terfenadine can be increased when combined with Fluticasone.]
[N06AB08, fluvoxamine, The metabolism of Fluticasone can be decreased when combined with Fluvoxamine.]
[L04AA02, muromonab-CD3, The risk or severity of adverse effects can be increased when Muromonab is combined with Fluticasone.]
[C10AA03, pravastatin, The excretion of Pravastatin can be decreased when combined with Fluticasone.]
[V03AF02, dexrazoxane, The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Fluticasone.]
[P02CA03, albendazole, The metabolism of Albendazole can be increased when combined with Fluticasone.]
[C08CA02, felodipine, The metabolism of Felodipine can be decreased when combined with Fluticasone.]
[M01AE04, fenoprofen, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Fenoprofen.]
[R03CC04, fenoterol, The risk or severity of hypokalemia can be increased when Fluticasone is combined with Fenoterol.]
[N02AB03, fentanyl, The metabolism of Fentanyl can be decreased when combined with Fluticasone.]
[R03CC02, albuterol, The risk or severity of hypokalemia can be increased when Fluticasone is combined with Salbutamol.]
[L01BB06, clofarabine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Fluticasone.]
[L04AA40, cladribine, The risk or severity of adverse effects can be increased when Cladribine is combined with Fluticasone.]
[N02BG04, floctafenine, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Floctafenine.]
[J02AC01, fluconazole, The metabolism of Fluticasone can be decreased when combined with Fluconazole.]
[J02AX01, flucytosine, The risk or severity of adverse effects can be increased when Flucytosine is combined with Fluticasone.]
[H02AA02, fludrocortisone, The risk or severity of adverse effects can be increased when Fludrocortisone is combined with Fluticasone.]
[D07AC08, fluocinonide, The risk or severity of adverse effects can be increased when Fluocinonide is combined with Fluticasone.]
[H02AB03, fluocortolone, The risk or severity of adverse effects can be increased when Fluocortolone is combined with Fluticasone.]
[L01BC09, floxuridine, The risk or severity of adverse effects can be increased when Floxuridine is combined with Fluticasone.]
[S01CB05, fluorometholone, The risk or severity of adverse effects can be increased when Fluorometholone is combined with Fluticasone.]
[L01BC02, fluorouracil, The metabolism of Fluorouracil can be decreased when combined with Fluticasone.]
[G03BA01, fluoxymesterone, The risk or severity of fluid retention can be increased when Fluticasone is combined with Fluoxymesterone.]
[S01BC04, flurbiprofen, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Flurbiprofen.]
[L02BB01, flutamide, The metabolism of Flutamide can be decreased when combined with Fluticasone.]
[L01BC03, tegafur, The metabolism of Tegafur can be decreased when combined with Fluticasone.]
[M03AA01, alcuronium, The risk or severity of myopathy and weakness can be increased when Alcuronium is combined with Fluticasone.]
[N05CF04, eszopiclone, The metabolism of Eszopiclone can be decreased when combined with Fluticasone.]
[N06DA04, galantamine, The therapeutic efficacy of Galantamine can be decreased when used in combination with Fluticasone.]
[M03AC02, gallamine, The risk or severity of myopathy and weakness can be increased when Gallamine is combined with Fluticasone.]
[L01EA02, dasatinib, The metabolism of Dasatinib can be increased when combined with Fluticasone.]
[N04BC06, cabergoline, The metabolism of Cabergoline can be increased when combined with Fluticasone.]
[A10BJ02, liraglutide, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Liraglutide.]
[G03XA02, gestrinone, The serum concentration of Fluticasone can be increased when it is combined with Gestrinone.]
[N01AH02, alfentanil, The metabolism of Alfentanil can be decreased when combined with Fluticasone.]
[L01EH01, lapatinib, The metabolism of Lapatinib can be decreased when combined with Fluticasone.]
[A10BB01, glyburide, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Glyburide.]
[A10BB09, gliclazide, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Gliclazide.]
[A10BB07, glipizide, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Glipizide.]
[C01BD04, dofetilide, The metabolism of Dofetilide can be increased when combined with Fluticasone.]
[C02CA04, doxazosin, The metabolism of Doxazosin can be increased when combined with Fluticasone.]
[H01AB01, thyrotropin alfa, The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Fluticasone.]
[L01EX02, sorafenib, The metabolism of Sorafenib can be increased when combined with Fluticasone.]
[B01AA12, fluindione, Fluticasone may increase the anticoagulant activities of Fluindione.]
[P01BX01, halofantrine, The metabolism of Halofantrine can be decreased when combined with Fluticasone.]
[N05AD01, haloperidol, The serum concentration of Haloperidol can be increased when it is combined with Fluticasone.]
[N05AH04, quetiapine, The metabolism of Quetiapine can be decreased when combined with Fluticasone.]
[A10AD05, insulin aspart, human, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Insulin aspart.]
[L01CE02, irinotecan, The metabolism of Irinotecan can be increased when combined with Fluticasone.]
[G03DC01, allylestrenol, The metabolism of Allylestrenol can be increased when combined with Fluticasone.]
[A07EC02, mesalamine, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Mesalazine.]
[L01XX03, altretamine, The risk or severity of adverse effects can be increased when Altretamine is combined with Fluticasone.]
[R03CC05, hexoprenaline, The risk or severity of hypokalemia can be increased when Fluticasone is combined with Hexoprenaline.]
[J05AG01, nevirapine, The metabolism of Nevirapine can be decreased when combined with Fluticasone.]
[M02AA26, nimesulide, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Nimesulide.]
[C03AA03, hydrochlorothiazide, The risk or severity of electrolyte imbalance can be increased when Fluticasone is combined with Hydrochlorothiazide.]
[S02BA01, hydrocortisone, The metabolism of Hydrocortisone can be decreased when combined with Fluticasone.]
[C03AA02, hydroflumethiazide, The risk or severity of electrolyte imbalance can be increased when Fluticasone is combined with Hydroflumethiazide.]
[P01BA02, hydroxychloroquine, The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Fluticasone.]
[L01XX05, hydroxyurea, The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Fluticasone.]
[N05BB01, hydroxyzine, The metabolism of Hydroxyzine can be decreased when combined with Fluticasone.]
[R02AX02, ibuprofen, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Ibuprofen.]
[L01DB06, idarubicin, The risk or severity of adverse effects can be increased when Idarubicin is combined with Fluticasone.]
[L01AA06, ifosfamide, The metabolism of Ifosfamide can be increased when combined with Fluticasone.]
[N06AA02, imipramine, The metabolism of Fluticasone can be decreased when combined with Imipramine.]
[L01CD01, paclitaxel, The metabolism of Paclitaxel can be increased when combined with Fluticasone.]
[R01AD07, tixocortol, The risk or severity of adverse effects can be increased when Tixocortol is combined with Fluticasone.]
[L01CE01, topotecan, The risk or severity of adverse effects can be increased when Topotecan is combined with Fluticasone.]
[C03BA11, indapamide, Fluticasone may increase the hypokalemic activities of Indapamide.]
[S01BC01, indomethacin, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Indomethacin.]
[L03AB04, interferon alfa-2a, The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Fluticasone.]
[L03AB05, interferon alfa-2b, The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Fluticasone.]
[L04AA25, eculizumab, The risk or severity of adverse effects can be increased when Eculizumab is combined with Fluticasone.]
[A10BH01, sitagliptin, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Sitagliptin.]
[N05BA12, alprazolam, The metabolism of Alprazolam can be decreased when combined with Fluticasone.]
[A10BH02, vildagliptin, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Vildagliptin.]
[C10AA06, cerivastatin, The metabolism of Cerivastatin can be decreased when combined with Fluticasone.]
[C03BA02, quinethazone, Fluticasone may increase the hypokalemic activities of Quinethazone.]
[L03AB09, interferon alfacon-1, The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Fluticasone.]
[R03CC06, isoetharine, The risk or severity of hypokalemia can be increased when Fluticasone is combined with Isoetharine.]
[S01EB07, isoflurophate, The therapeutic efficacy of Isoflurophate can be decreased when used in combination with Fluticasone.]
[J04AC01, isoniazid, The serum concentration of Isoniazid can be decreased when it is combined with Fluticasone.]
[R03CB01, isoproterenol, The therapeutic efficacy of Isoprenaline can be decreased when used in combination with Fluticasone.]
[A10BJ01, exenatide, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Exenatide.]
[H01AC01, somatropin, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Fluticasone.]
[L04AC07, tocilizumab, The metabolism of Fluticasone can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, The therapeutic efficacy of Ketamine can be decreased when used in combination with Fluticasone.]
[J02AB02, ketoconazole, The metabolism of Fluticasone can be decreased when combined with Ketoconazole.]
[M02AA10, ketoprofen, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Ketoprofen.]
[V03AC03, deferasirox, The risk or severity of gastrointestinal ulceration and gastrointestinal irritation can be increased when Fluticasone is combined with Deferasirox.]
[L04AA24, abatacept, The metabolism of Fluticasone can be increased when combined with Abatacept.]
[C01CA22, arbutamine, The risk or severity of hypokalemia can be increased when Fluticasone is combined with Arbutamine.]
[J01MB02, nalidixic acid, The risk or severity of tendinopathy can be increased when Fluticasone is combined with Nalidixic acid.]
[N07AA30, ambenonium, The therapeutic efficacy of Ambenonium can be decreased when used in combination with Fluticasone.]
[N03AX18, lacosamide, The metabolism of Lacosamide can be increased when combined with Fluticasone.]
[L01DC03, mitomycin, The risk or severity of adverse effects can be increased when Mitomycin is combined with Fluticasone.]
[G03AD01, levonorgestrel, The serum concentration of Fluticasone can be increased when it is combined with Levonorgestrel.]
[S02DA01, lidocaine, The metabolism of Lidocaine can be decreased when combined with Fluticasone.]
[N06BA13, armodafinil, The metabolism of Fluticasone can be increased when combined with Armodafinil.]
[D06AX13, retapamulin, The metabolism of Retapamulin can be decreased when combined with Fluticasone.]
[L01AD02, lomustine, The risk or severity of adverse effects can be increased when Lomustine is combined with Fluticasone.]
[A07DA03, loperamide, The metabolism of Loperamide can be decreased when combined with Fluticasone.]
[C10AA02, lovastatin, The metabolism of Lovastatin can be decreased when combined with Fluticasone.]
[G03DC03, lynestrenol, The serum concentration of Fluticasone can be increased when it is combined with Lynestrenol.]
[L01EG01, temsirolimus, The metabolism of Temsirolimus can be increased when combined with Fluticasone.]
[L01BA05, pralatrexate, The risk or severity of adverse effects can be increased when Pralatrexate is combined with Fluticasone.]
[L01EA03, nilotinib, The metabolism of Nilotinib can be increased when combined with Fluticasone.]
[L01AA05, mechlorethamine, The therapeutic efficacy of Mechlorethamine can be decreased when used in combination with Fluticasone.]
[M02AA18, meclofenamic acid, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Meclofenamic acid.]
[C01AA08, medigoxin, The risk or severity of adverse effects can be increased when Fluticasone is combined with Metildigoxin.]
[P01BC02, mefloquine, The therapeutic efficacy of Mefloquine can be decreased when used in combination with Fluticasone.]
[L01AA03, melphalan, The risk or severity of adverse effects can be increased when Melphalan is combined with Fluticasone.]
[N06DX01, memantine, The therapeutic efficacy of Memantine can be decreased when used in combination with Fluticasone.]
[N02AB02, meperidine, The metabolism of Meperidine can be increased when combined with Fluticasone.]
[N03AB04, mephenytoin, The metabolism of Mephenytoin can be decreased when combined with Fluticasone.]
[L02BG01, aminoglutethimide, The therapeutic efficacy of Fluticasone can be decreased when used in combination with Aminoglutethimide.]
[G03BB01, mesterolone, The risk or severity of edema formation can be increased when Mesterolone is combined with Fluticasone.]
[N05AX13, paliperidone, The metabolism of Paliperidone can be decreased when combined with Fluticasone.]
[A10BA02, metformin, The therapeutic efficacy of Metformin can be decreased when used in combination with Fluticasone.]
[A14AA04, methenolone, The risk or severity of edema formation can be increased when Metenolone is combined with Fluticasone.]
[H03BB02, methimazole, The risk or severity of adverse effects can be increased when Methimazole is combined with Fluticasone.]
[L01BA04, pemetrexed, The risk or severity of adverse effects can be increased when Pemetrexed is combined with Fluticasone.]
[L04AX03, methotrexate, The metabolism of Methotrexate can be increased when combined with Fluticasone.]
[C03AA08, methyclothiazide, The risk or severity of electrolyte imbalance can be increased when Fluticasone is combined with Methyclothiazide.]
[V04CG05, methylene blue, The metabolism of Fluticasone can be decreased when combined with Methylene blue.]
[R03DA05, aminophylline, The metabolism of Aminophylline can be increased when combined with Fluticasone.]
[H02AB04, methylprednisolone, The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Fluticasone.]
[G03EK01, methyltestosterone, The risk or severity of edema formation can be increased when Methyltestosterone is combined with Fluticasone.]
[N02CA04, methysergide, The metabolism of Methysergide can be increased when combined with Fluticasone.]
[A03FA01, metoclopramide, The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Fluticasone.]
[C03BA08, metolazone, Fluticasone may increase the hypokalemic activities of Metolazone.]
[P01AB01, metronidazole, The metabolism of Metronidazole can be decreased when combined with Fluticasone.]
[N02BB03, aminopyrine, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Aminophenazone.]
[N05CD08, midazolam, The serum concentration of Midazolam can be increased when it is combined with Fluticasone.]
[G03XB01, mifepristone, The therapeutic efficacy of Fluticasone can be decreased when used in combination with Mifepristone.]
[C09CA03, valsartan, The excretion of Valsartan can be decreased when combined with Fluticasone.]
[L01XX23, mitotane, The serum concentration of Fluticasone can be decreased when it is combined with Mitotane.]
[L01DB07, mitoxantrone, The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Fluticasone.]
[L03AC01, aldesleukin, The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Fluticasone.]
[C01BD01, amiodarone, The metabolism of Amiodarone can be increased when combined with Fluticasone.]
[N06AA09, amitriptyline, The metabolism of Amitriptyline can be decreased when combined with Fluticasone.]
[N02AA01, morphine, The metabolism of Morphine can be decreased when combined with Fluticasone.]
[L04AB05, certolizumab pegol, The metabolism of Fluticasone can be increased when combined with Certolizumab pegol.]
[B02BX05, eltrombopag, The metabolism of Eltrombopag can be decreased when combined with Fluticasone.]
[L04AA52, ofatumumab, The risk or severity of adverse effects can be increased when Ofatumumab is combined with Fluticasone.]
[L01EX03, pazopanib, The metabolism of Pazopanib can be increased when combined with Fluticasone.]
[L04AA06, mycophenolic acid, The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Fluticasone.]
[M03AC03, vecuronium, The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Fluticasone.]
[P01BA06, amodiaquine, The metabolism of Amodiaquine can be decreased when combined with Fluticasone.]
[G03XC01, raloxifene, The excretion of Raloxifene can be decreased when combined with Fluticasone.]
[N03AB05, fosphenytoin, The serum concentration of Fluticasone can be decreased when it is combined with Fosphenytoin.]
[L03AB08, interferon beta-1b, The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Fluticasone.]
[L04AC03, anakinra, The metabolism of Fluticasone can be increased when combined with Anakinra.]
[S01XA11, nandrolone, The risk or severity of edema formation can be increased when Nandrolone phenpropionate is combined with Fluticasone.]
[M02AA12, naproxen, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Naproxen.]
[A10BG01, troglitazone, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Troglitazone.]
[L01CD02, docetaxel, The metabolism of Docetaxel can be increased when combined with Fluticasone.]
[A10BX02, repaglinide, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Repaglinide.]
[S01EB06, neostigmine, The therapeutic efficacy of Neostigmine can be decreased when used in combination with Fluticasone.]
[N05AX14, iloperidone, The metabolism of Iloperidone can be decreased when combined with Fluticasone.]
[J02AA01, amphotericin B, The risk or severity of hypokalemia can be increased when Fluticasone is combined with Amphotericin B.]
[H05BX02, paricalcitol, The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Fluticasone.]
[L01XX01, amsacrine, The risk or severity of adverse effects can be increased when Amsacrine is combined with Fluticasone.]
[C08CA04, nicardipine, The metabolism of Nicardipine can be decreased when combined with Fluticasone.]
[C08CA05, nifedipine, The metabolism of Nifedipine can be decreased when combined with Fluticasone.]
[M02AA17, niflumic acid, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Niflumic acid.]
[C08CA07, nisoldipine, The metabolism of Nisoldipine can be decreased when combined with Fluticasone.]
[C08CA08, nitrendipine, The metabolism of Nitrendipine can be decreased when combined with Fluticasone.]
[N05CF03, zaleplon, The metabolism of Zaleplon can be decreased when combined with Fluticasone.]
[C01CA03, norepinephrine, The risk or severity of hypokalemia can be increased when Fluticasone is combined with Norepinephrine.]
[G03DC02, norethindrone, The serum concentration of Fluticasone can be increased when it is combined with Norethisterone.]
[S01AE02, norfloxacin, The risk or severity of tendinopathy can be increased when Fluticasone is combined with Norfloxacin.]
[G03AC07, norgestrienone, The serum concentration of Fluticasone can be increased when it is combined with Norgestrienone.]
[C02KX01, bosentan, The excretion of Bosentan can be decreased when combined with Fluticasone.]
[N06AA10, nortriptyline, The metabolism of Nortriptyline can be increased when combined with Fluticasone.]
[S02AA16, ofloxacin, The risk or severity of tendinopathy can be increased when Fluticasone is combined with Ofloxacin.]
[L04AC04, rilonacept, The metabolism of Fluticasone can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Omeprazole can be decreased when combined with Fluticasone.]
[R03CB03, metaproterenol, The risk or severity of hypokalemia can be increased when Fluticasone is combined with Orciprenaline.]
[C01AC01, ouabain, The excretion of Ouabain can be decreased when combined with Fluticasone.]
[A14AA08, oxandrolone, The risk or severity of fluid retention can be increased when Fluticasone is combined with Oxandrolone.]
[J01MB05, oxolinic acid, The risk or severity of tendinopathy can be increased when Fluticasone is combined with Oxolinic acid.]
[N02AA05, oxycodone, The metabolism of Oxycodone can be decreased when combined with Fluticasone.]
[S01GA04, oxymetazoline, The absorption of Fluticasone can be decreased when combined with Oxymetazoline.]
[A14AA05, oxymetholone, The risk or severity of fluid retention can be increased when Fluticasone is combined with Oxymetholone.]
[S01BC02, oxyphenbutazone, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Oxyphenbutazone.]
[M03AC01, pancuronium, The therapeutic efficacy of Pancuronium can be decreased when used in combination with Fluticasone.]
[G03DB06, chlormadinone, The serum concentration of Fluticasone can be increased when it is combined with Chlormadinone.]
[H02AB05, paramethasone, The risk or severity of adverse effects can be increased when Paramethasone is combined with Fluticasone.]
[J01MA03, pefloxacin, The risk or severity of tendinopathy can be increased when Fluticasone is combined with Pefloxacin.]
[M01CC01, penicillamine, The risk or severity of adverse effects can be increased when Penicillamine is combined with Fluticasone.]
[S01AA14, penicillin G, The excretion of Benzylpenicillin can be decreased when combined with Fluticasone.]
[J07AF01, diphtheria toxoid vaccine, inactivated, The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Fluticasone.]
[J07AM01, tetanus toxoid vaccine, inactivated, The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Fluticasone.]
[L01XX08, pentostatin, The risk or severity of adverse effects can be increased when Pentostatin is combined with Fluticasone.]
[J07AJ, pertussis vaccine, The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Fluticasone.]
[A10BA01, phenformin, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Phenformin.]
[B01AA02, phenindione, Fluticasone may increase the anticoagulant activities of Phenindione.]
[N03AA02, phenobarbital, The metabolism of Fluticasone can be increased when combined with Phenobarbital.]
[B01AA04, phenprocoumon, Fluticasone may increase the anticoagulant activities of Phenprocoumon.]
[M02AA01, phenylbutazone, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Phenylbutazone.]
[S01GA05, phenylephrine, The risk or severity of hypertension can be increased when Fluticasone is combined with Phenylephrine.]
[R01BA01, phenylpropanolamine, The risk or severity of hypokalemia can be increased when Fluticasone is combined with Phenylpropanolamine.]
[N03AB02, phenytoin, The serum concentration of Fluticasone can be decreased when it is combined with Phenytoin.]
[L04AB06, golimumab, The metabolism of Fluticasone can be increased when combined with Golimumab.]
[S01AE05, levofloxacin, The risk or severity of tendinopathy can be increased when Fluticasone is combined with Levofloxacin.]
[V03AB19, physostigmine, The therapeutic efficacy of Physostigmine can be decreased when used in combination with Fluticasone.]
[L02BB03, bicalutamide, The metabolism of Bicalutamide can be increased when combined with Fluticasone.]
[C08CX01, mibefradil, The metabolism of Fluticasone can be decreased when combined with Mibefradil.]
[N05AG02, pimozide, The metabolism of Pimozide can be increased when combined with Fluticasone.]
[C10AA05, atorvastatin, The metabolism of Atorvastatin can be decreased when combined with Fluticasone.]
[J05AE01, saquinavir, The metabolism of Fluticasone can be decreased when combined with Saquinavir.]
[S01BC06, piroxicam, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Piroxicam.]
[J01MA11, grepafloxacin, The risk or severity of tendinopathy can be increased when Fluticasone is combined with Grepafloxacin.]
[J05AG02, delavirdine, The metabolism of Fluticasone can be decreased when combined with Delavirdine.]
[C09CA04, irbesartan, The metabolism of Irbesartan can be decreased when combined with Fluticasone.]
[D05AX05, tazarotene, The metabolism of Tazarotene can be decreased when combined with Fluticasone.]
[A10BG02, rosiglitazone, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Rosiglitazone.]
[L02BG03, anastrozole, The metabolism of Anastrozole can be decreased when combined with Fluticasone.]
[L04AC08, canakinumab, The metabolism of Fluticasone can be increased when combined with Canakinumab.]
[C03AA05, polythiazide, The risk or severity of electrolyte imbalance can be increased when Fluticasone is combined with Polythiazide.]
[J05AE03, ritonavir, The serum concentration of Fluticasone can be increased when it is combined with Ritonavir.]
[A10BH03, saxagliptin, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Saxagliptin.]
[A10AD04, insulin lispro, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Insulin lispro.]
[C10AA08, pitavastatin, The metabolism of Pitavastatin can be decreased when combined with Fluticasone.]
[P02BA01, praziquantel, The metabolism of Praziquantel can be decreased when combined with Fluticasone.]
[S03BA02, prednisolone, The risk or severity of adverse effects can be increased when Prednisolone is combined with Fluticasone.]
[H02AB07, prednisone, The risk or severity of adverse effects can be increased when Prednisone is combined with Fluticasone.]
[C01BA02, procainamide, The therapeutic efficacy of Procainamide can be decreased when used in combination with Fluticasone.]
[S01HA05, procaine, The therapeutic efficacy of Procaine can be decreased when used in combination with Fluticasone.]
[L01XB01, procarbazine, The risk or severity of adverse effects can be increased when Procarbazine is combined with Fluticasone.]
[C10AB05, fenofibrate, The metabolism of Fenofibrate can be increased when combined with Fluticasone.]
[G03DA04, progesterone, The serum concentration of Fluticasone can be increased when it is combined with Progesterone.]
[R06AX26, fexofenadine, The excretion of Fexofenadine can be decreased when combined with Fluticasone.]
[L01XH02, romidepsin, The metabolism of Romidepsin can be increased when combined with Fluticasone.]
[N01AX10, propofol, The metabolism of Propofol can be decreased when combined with Fluticasone.]
[C07AA05, propranolol, The metabolism of Propranolol can be decreased when combined with Fluticasone.]
[H03BA02, propylthiouracil, The risk or severity of adverse effects can be increased when Propylthiouracil is combined with Fluticasone.]
[R03DC03, montelukast, The metabolism of Montelukast can be decreased when combined with Fluticasone.]
[N05AX12, aripiprazole, The metabolism of Aripiprazole can be decreased when combined with Fluticasone.]
[P02CC01, pyrantel, The risk or severity of myopathy and weakness can be increased when Pyrantel is combined with Fluticasone.]
[J06BB05, rabies immune globulin, human, The therapeutic efficacy of Rabies immune globulin, human can be decreased when used in combination with Fluticasone.]
[N07AA02, pyridostigmine, The therapeutic efficacy of Pyridostigmine can be decreased when used in combination with Fluticasone.]
[P01AX05, quinacrine, The metabolism of Quinacrine can be decreased when combined with Fluticasone.]
[C01BA01, quinidine, The metabolism of Quinidine can be increased when combined with Fluticasone.]
[P01BC01, quinine, The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Quinine.]
[C02AA02, reserpine, The metabolism of Fluticasone can be increased when combined with Reserpine.]
[J04AB02, rifampin, The metabolism of Fluticasone can be increased when combined with Rifampicin.]
[G02CA01, ritodrine, The risk or severity of hypokalemia can be increased when Fluticasone is combined with Ritodrine.]
[N02BA05, salicylamide, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Salicylamide.]
[A07EC01, sulfasalazine, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Sulfasalazine.]
[S01BC08, salicylic acid, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Salicylic acid.]
[N04BD01, selegiline, The metabolism of Selegiline can be decreased when combined with Fluticasone.]
[L01FA03, obinutuzumab, The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Fluticasone.]
[M05BX04, denosumab, The risk or severity of adverse effects can be increased when Denosumab is combined with Fluticasone.]
[L01CD04, cabazitaxel, The metabolism of Cabazitaxel can be increased when combined with Fluticasone.]
[L03AX17, sipuleucel-T, The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Fluticasone.]
[D07AB02, hydrocortisone butyrate, The risk or severity of adverse effects can be increased when Fluticasone is combined with Hydrocortisone butyrate.]
[M01AE11, tiaprofenic acid, The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Tiaprofenic acid.]
[P02BB01, trichlorfon, The therapeutic efficacy of Metrifonate can be decreased when used in combination with Fluticasone propionate.]
[S02DA03, antipyrine, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Antipyrine.]
[A14AA02, stanozolol, The risk or severity of fluid retention can be increased when Fluticasone propionate is combined with Stanozolol.]
[G03XB02, ulipristal, The serum concentration of Fluticasone propionate can be increased when it is combined with Ulipristal.]
[L04AA04, rabbit anti-human T-lymphocyte globulin, The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Fluticasone propionate.]
[L01AD04, streptozocin, The risk or severity of adverse effects can be increased when Streptozocin is combined with Fluticasone propionate.]
[L04AA27, fingolimod, Fluticasone propionate may increase the immunosuppressive activities of Fingolimod.]
[M03AB01, succinylcholine, The risk or severity of adverse effects can be increased when Succinylcholine is combined with Fluticasone propionate.]
[J01EC02, sulfadiazine, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Sulfadiazine.]
[J01EC01, sulfamethoxazole, The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Fluticasone propionate.]
[S01AB02, sulfisoxazole, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Sulfisoxazole.]
[M01AB02, sulindac, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Sulindac.]
[N05AL01, sulpiride, The therapeutic efficacy of Sulpiride can be decreased when used in combination with Fluticasone propionate.]
[N03AX03, sulthiame, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Sulthiame.]
[A10BB04, glibornuride, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Glibornuride.]
[A10BC01, glymidine, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Glymidine.]
[M01AX04, apazone, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Azapropazone.]
[L01BB02, mercaptopurine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Mercaptopurine.]
[N06DA01, tacrine, The therapeutic efficacy of Tacrine can be decreased when used in combination with Fluticasone propionate.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Fluticasone propionate.]
[N05CD07, temazepam, The risk or severity of adverse effects can be increased when Temazepam is combined with Fluticasone propionate.]
[L01CB02, teniposide, The metabolism of Teniposide can be decreased when combined with Fluticasone propionate.]
[R03CC03, terbutaline, The therapeutic efficacy of Terbutaline can be decreased when used in combination with Fluticasone propionate.]
[G03BA03, testosterone, The risk or severity of edema formation can be increased when Testosterone is combined with Fluticasone propionate.]
[S01HA03, tetracaine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Tetracaine.]
[N05AE05, lurasidone, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Lurasidone.]
[A04AD10, dronabinol, The serum concentration of Dronabinol can be increased when it is combined with Fluticasone propionate.]
[N04BC07, apomorphine, The metabolism of Apomorphine can be decreased when combined with Fluticasone propionate.]
[L04AX02, thalidomide, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.]
[R03DA04, theophylline, The metabolism of Theophylline can be decreased when combined with Fluticasone propionate.]
[L01XX41, eribulin, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Eribulin.]
[R06AD03, thiethylperazine, The risk or severity of adverse effects can be increased when Thiethylperazine is combined with Fluticasone propionate.]
[L01AC01, thiotepa, The therapeutic efficacy of Thiotepa can be decreased when used in combination with Fluticasone propionate.]
[L01BB03, thioguanine, The risk or severity of adverse effects can be increased when Tioguanine is combined with Fluticasone propionate.]
[N05CA19, thiopental, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Thiopental.]
[N05AB08, thioproperazine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Thioproperazine.]
[N05AC02, thioridazine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Thioridazine.]
[N05AF04, thiothixene, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Thiothixene.]
[B02AB01, aprotinin, The therapeutic efficacy of Aprotinin can be decreased when used in combination with Fluticasone propionate.]
[N05AL03, tiapride, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Tiapride.]
[N02AX01, tilidine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Tilidine.]
[A10BB05, tolazamide, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Tolazamide.]
[V04CA01, tolbutamide, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Tolbutamide.]
[M02AA21, tolmetin, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Tolmetin.]
[M03BX04, tolperisone, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Tolperisone.]
[N02AX02, tramadol, The metabolism of Tramadol can be decreased when combined with Fluticasone propionate.]
[N06AF04, tranylcypromine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Tranylcypromine.]
[N06AX05, trazodone, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Trazodone.]
[L01XF01, tretinoin, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Tretinoin.]
[S01BA05, triamcinolone, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Triamcinolone.]
[N05CD05, triazolam, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Triazolam.]
[C03AA06, trichlormethiazide, The risk or severity of electrolyte imbalance can be increased when Fluticasone propionate is combined with Trichlormethiazide.]
[A03AB12, mepenzolate, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Mepenzolate.]
[S01EB04, demecarium, The therapeutic efficacy of Demecarium can be decreased when used in combination with Fluticasone propionate.]
[N05AB06, trifluoperazine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Trifluoperazine.]
[S01AD02, trifluridine, The risk or severity of adverse effects can be increased when Trifluridine is combined with Fluticasone propionate.]
[N05AD02, trifluperidol, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Trifluperidol.]
[N05AA05, triflupromazine, The therapeutic efficacy of Triflupromazine can be decreased when used in combination with Fluticasone propionate.]
[D07AC02, fluclorolone, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Fluclorolone.]
[N04AA01, trihexyphenidyl, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl.]
[R03BA07, mometasone, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Mometasone.]
[A03AA05, trimebutine, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Trimebutine.]
[R06AD01, trimeprazine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Alimemazine.]
[N03AC02, trimethadione, The metabolism of Trimethadione can be decreased when combined with Fluticasone propionate.]
[N06AA06, trimipramine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Trimipramine.]
[R06AX07, triprolidine, The risk or severity of adverse effects can be increased when Triprolidine is combined with Fluticasone propionate.]
[A03BB01, butylscopolamine, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Butylscopolamine.]
[J01FA08, troleandomycin, The serum concentration of Fluticasone propionate can be increased when it is combined with Troleandomycin.]
[N06AX24, vilazodone, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Vilazodone.]
[N06AX02, tryptophan, The risk or severity of adverse effects can be increased when Tryptophan is combined with Fluticasone propionate.]
[M03AA02, tubocurarine, The therapeutic efficacy of Tubocurarine can be decreased when used in combination with Fluticasone propionate.]
[R03DX07, roflumilast, The serum concentration of Roflumilast can be increased when it is combined with Fluticasone propionate.]
[L04AA26, belimumab, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Belimumab.]
[S01AA05, tyrothricin, The therapeutic efficacy of Tyrothricin can be decreased when used in combination with Fluticasone propionate.]
[L01EX04, vandetanib, The metabolism of Vandetanib can be decreased when combined with Fluticasone propionate.]
[A10BH05, linagliptin, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Linagliptin.]
[J05AP03, boceprevir, The serum concentration of Fluticasone propionate can be increased when it is combined with Boceprevir.]
[J05AP02, telaprevir, The serum concentration of Fluticasone propionate can be increased when it is combined with Telaprevir.]
[J05AG05, rilpivirine, The serum concentration of Rilpivirine can be decreased when it is combined with Fluticasone propionate.]
[L04AA28, belatacept, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Belatacept.]
[N03AX21, ezogabine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Ezogabine.]
[B01AF01, rivaroxaban, The metabolism of Rivaroxaban can be decreased when combined with Fluticasone propionate.]
[R03AC18, indacaterol, The risk or severity of hypokalemia can be increased when Fluticasone propionate is combined with Indacaterol.]
[B01AC24, ticagrelor, The metabolism of Ticagrelor can be decreased when combined with Fluticasone propionate.]
[C08DA01, verapamil, The metabolism of Verapamil can be decreased when combined with Fluticasone propionate.]
[N06AX09, viloxazine, The metabolism of Fluticasone propionate can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The metabolism of Vinblastine can be decreased when combined with Fluticasone propionate.]
[L01CA02, vincristine, The metabolism of Vincristine can be decreased when combined with Fluticasone propionate.]
[L01CA03, vindesine, The metabolism of Vindesine can be decreased when combined with Fluticasone propionate.]
[B01AA03, warfarin, Fluticasone propionate may increase the anticoagulant activities of Warfarin.]
[S01AA13, fusidic acid, The metabolism of Fluticasone propionate can be decreased when combined with Fusidic acid.]
[J05AF01, zidovudine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Fluticasone propionate.]
[N05AF05, zuclopenthixol, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Zuclopenthixol.]
[J05AE02, indinavir, The serum concentration of Fluticasone propionate can be increased when it is combined with Indinavir.]
[N03AX14, levetiracetam, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Levetiracetam.]
[L01EC01, vemurafenib, The metabolism of Vemurafenib can be decreased when combined with Fluticasone propionate.]
[L01FX05, brentuximab vedotin, The metabolism of Brentuximab vedotin can be decreased when combined with Fluticasone propionate.]
[L01ED01, crizotinib, The metabolism of Crizotinib can be decreased when combined with Fluticasone propionate.]
[H05BX03, doxercalciferol, The therapeutic efficacy of Doxercalciferol can be decreased when used in combination with Fluticasone propionate.]
[J01MA13, trovafloxacin, The risk or severity of tendinopathy can be increased when Fluticasone propionate is combined with Trovafloxacin.]
[N05AE04, ziprasidone, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Ziprasidone.]
[G03AC10, drospirenone, The serum concentration of Fluticasone propionate can be increased when it is combined with Drospirenone.]
[L04AA34, alemtuzumab, The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Fluticasone propionate.]
[N02BA01, aspirin, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Acetylsalicylic acid.]
[L01EJ01, ruxolitinib, The metabolism of Ruxolitinib can be decreased when combined with Fluticasone propionate.]
[G04BD07, tolterodine, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Tolterodine.]
[L03AB11, peginterferon alfa-2a, The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluticasone propionate.]
[A11CC03, alfacalcidol, The therapeutic efficacy of Alfacalcidol can be decreased when used in combination with Fluticasone propionate.]
[L01FA01, rituximab, The risk or severity of adverse effects can be increased when Rituximab is combined with Fluticasone propionate.]
[J02AC03, voriconazole, The serum concentration of Fluticasone propionate can be increased when it is combined with Voriconazole.]
[M03AC04, atracurium, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Atracurium.]
[S01FA01, atropine, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Atropine.]
[L01EK01, axitinib, The metabolism of Axitinib can be decreased when combined with Fluticasone propionate.]
[R07AX02, ivacaftor, The metabolism of Ivacaftor can be decreased when combined with Fluticasone propionate.]
[H02AB11, prednylidene, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Prednylidene.]
[L01BC07, azacitidine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Azacitidine.]
[L04AX01, azathioprine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Azathioprine.]
[L01BC05, gemcitabine, The risk or severity of adverse effects can be increased when Gemcitabine is combined with Fluticasone propionate.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Fluticasone propionate.]
[M03BX01, baclofen, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Fluticasone propionate.]
[J07BK01, varicella-zoster virus vaccine live (Oka-Merck) strain, The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Fluticasone propionate.]
[L01FX02, gemtuzumab ozogamicin, The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Fluticasone propionate.]
[A08AA11, lorcaserin, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Lorcaserin.]
[L01XG02, carfilzomib, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Carfilzomib.]
[V03AX03, cobicistat, The serum concentration of Fluticasone propionate can be increased when it is combined with Cobicistat.]
[J05AJ02, elvitegravir, The serum concentration of Fluticasone propionate can be increased when it is combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Enzalutamide can be increased when it is combined with Fluticasone propionate.]
[L01EA04, bosutinib, The metabolism of Bosutinib can be decreased when combined with Fluticasone propionate.]
[L04AA31, teriflunomide, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Teriflunomide.]
[A02AA05, magnesium silicate, The bioavailability of Fluticasone propionate can be decreased when combined with Magnesium silicate.]
[A02AC02, calcium silicate, The bioavailability of Fluticasone propionate can be decreased when combined with Calcium silicate.]
[L04AA22, abetimus, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Abetimus.]
[H02AA01, aldosterone, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Aldosterone.]
[L01EX05, regorafenib, The metabolism of Regorafenib can be decreased when combined with Fluticasone propionate.]
[N05CA04, barbital, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Barbital.]
[C01AA01, acetyldigitoxin, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Acetyldigitoxin.]
[J05AE04, nelfinavir, The serum concentration of Fluticasone propionate can be increased when it is combined with Nelfinavir.]
[L01AA09, bendamustine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Bendamustine.]
[S01GA07, brimonidine, Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Fluticasone propionate.]
[N04BD02, rasagiline, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Rasagiline.]
[C08CA13, lercanidipine, The metabolism of Lercanidipine can be decreased when combined with Fluticasone propionate.]
[A03FA09, mosapride, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Mosapride.]
[N06DA02, donepezil, The therapeutic efficacy of Donepezil can be decreased when used in combination with Fluticasone propionate.]
[N03AX22, perampanel, Perampanel may increase the central nervous system depressant (CNS depressant) activities of Fluticasone propionate.]
[L04AA29, tofacitinib, The metabolism of Tofacitinib can be decreased when combined with Fluticasone propionate.]
[N02CC03, zolmitriptan, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Fluticasone propionate.]
[R06AC06, thonzylamine, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Thonzylamine.]
[G04BD10, darifenacin, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Darifenacin.]
[N01AA01, ethyl ether, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Diethyl ether.]
[G04BE03, sildenafil, The metabolism of Sildenafil can be decreased when combined with Fluticasone propionate.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Fluticasone propionate.]
[B01AF02, apixaban, The metabolism of Apixaban can be decreased when combined with Fluticasone propionate.]
[C10AX12, lomitapide, The metabolism of Lomitapide can be decreased when combined with Fluticasone propionate.]
[A10BH04, alogliptin, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Alogliptin.]
[A16AX09, glycerol phenylbutyrate, The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Fluticasone propionate.]
[C03AA01, bendroflumethiazide, The risk or severity of electrolyte imbalance can be increased when Fluticasone propionate is combined with Bendroflumethiazide.]
[L04AX06, pomalidomide, The metabolism of Pomalidomide can be decreased when combined with Fluticasone propionate.]
[N02BA10, benorilate, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Benorilate.]
[N05AD07, benperidol, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Benperidol.]
[A10BK02, canagliflozin, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Canagliflozin.]
[L04AX07, dimethyl fumarate, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Dimethyl fumarate.]
[J01MA15, gemifloxacin, The risk or severity of tendinopathy can be increased when Fluticasone propionate is combined with Gemifloxacin.]
[S01AE07, moxifloxacin, The risk or severity of tendinopathy can be increased when Fluticasone propionate is combined with Moxifloxacin.]
[H03AA04, tiratricol, The therapeutic efficacy of Tiratricol can be decreased when used in combination with Fluticasone propionate.]
[A10AE05, insulin detemir, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Insulin detemir.]
[R02AD01, benzocaine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Benzocaine.]
[A10BX05, pramlintide, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Pramlintide.]
[J02AX04, caspofungin, The excretion of Caspofungin can be decreased when combined with Fluticasone propionate.]
[M01AH01, celecoxib, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Celecoxib.]
[N02CC02, naratriptan, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Naratriptan.]
[L04AA18, everolimus, The metabolism of Everolimus can be decreased when combined with Fluticasone propionate.]
[N04AC01, benztropine, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.]
[L01EC02, dabrafenib, The serum concentration of Dabrafenib can be increased when it is combined with Fluticasone propionate.]
[R02AX03, benzydamine, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Benzydamine.]
[P03AX06, benzyl alcohol, The metabolism of Benzyl alcohol can be decreased when combined with Fluticasone propionate.]
[N06AX28, levomilnacipran, The metabolism of Levomilnacipran can be decreased when combined with Fluticasone propionate.]
[C02KX05, riociguat, The metabolism of Riociguat can be decreased when combined with Fluticasone propionate.]
[A10BJ03, lixisenatide, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Lixisenatide.]
[A05AA03, cholic acid, The excretion of Cholic Acid can be decreased when combined with Fluticasone propionate.]
[L01EL01, ibrutinib, The metabolism of Ibrutinib can be decreased when combined with Fluticasone propionate.]
[N06AX26, vortioxetine, The metabolism of Vortioxetine can be decreased when combined with Fluticasone propionate.]
[G03AC08, etonogestrel, The serum concentration of Fluticasone propionate can be increased when it is combined with Etonogestrel.]
[N03AF04, eslicarbazepine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Eslicarbazepine.]
[J05AP05, simeprevir, The metabolism of Fluticasone propionate can be decreased when combined with Simeprevir.]
[N03AG04, vigabatrin, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Vigabatrin.]
[A10BK01, dapagliflozin, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Dapagliflozin.]
[C01CA27, droxidopa, The risk or severity of hypokalemia can be increased when Fluticasone propionate is combined with Droxidopa.]
[N05CH03, tasimelteon, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Tasimelteon.]
[A16AA07, metreleptin, The metabolism of Fluticasone propionate can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Fluticasone propionate can be increased when combined with Apremilast.]
[L02BG02, formestane, The risk or severity of edema formation can be increased when Formestane is combined with Fluticasone propionate.]
[A16AA06, betaine, The therapeutic efficacy of Betaine can be decreased when used in combination with Fluticasone propionate.]
[S03BA03, betamethasone, The risk or severity of adverse effects can be increased when Betamethasone is combined with Fluticasone propionate.]
[A10BJ04, albiglutide, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Albiglutide.]
[L04AC11, siltuximab, The metabolism of Fluticasone propionate can be increased when combined with Siltuximab.]
[L01ED02, ceritinib, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Ceritinib.]
[B01AC26, vorapaxar, The metabolism of Vorapaxar can be decreased when combined with Fluticasone propionate.]
[L04AA33, vedolizumab, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Vedolizumab.]
[A03BA03, hyoscyamine, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine.]
[B01AA07, acenocoumarol, Fluticasone propionate may increase the anticoagulant activities of Acenocoumarol.]
[L01XH04, belinostat, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Belinostat.]
[L01EM01, idelalisib, The metabolism of Idelalisib can be decreased when combined with Fluticasone propionate.]
[N01AX05, alfaxalone, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Alfaxalone.]
[A10BK03, empagliflozin, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Empagliflozin.]
[R03AC19, olodaterol, The metabolism of Olodaterol can be decreased when combined with Fluticasone propionate.]
[L03AB13, peginterferon beta-1a, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Peginterferon beta-1a.]
[D11AA01, glycopyrronium, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.]
[N05CM19, suvorexant, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A16AX10, eliglustat, The metabolism of Eliglustat can be decreased when combined with Fluticasone propionate.]
[N05AA04, acepromazine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Acepromazine.]
[V04CX03, methacholine, Fluticasone propionate may decrease effectiveness of Methacholine as a diagnostic agent.]
[A10BJ05, dulaglutide, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Dulaglutide.]
[L01BC08, decitabine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Decitabine.]
[N04AA02, biperiden, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Biperiden.]
[L04AX05, pirfenidone, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Pirfenidone.]
[L01EX09, nintedanib, The metabolism of Nintedanib can be decreased when combined with Fluticasone propionate.]
[L01FX07, blinatumomab, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Blinatumomab.]
[J05AP09, dasabuvir, The metabolism of Dasabuvir can be decreased when combined with Fluticasone propionate.]
[L01XK01, olaparib, The metabolism of Olaparib can be decreased when combined with Fluticasone propionate.]
[B01AA01, dicumarol, Fluticasone propionate may increase the anticoagulant activities of Dicoumarol.]
[N06AX11, mirtazapine, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.]
[L04AC10, secukinumab, The metabolism of Fluticasone propionate can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The metabolism of Palbociclib can be decreased when combined with Fluticasone propionate.]
[L01XH03, panobinostat, The metabolism of Panobinostat can be decreased when combined with Fluticasone propionate.]
[J05AP07, daclatasvir, The metabolism of Daclatasvir can be decreased when combined with Fluticasone propionate.]
[L01DC01, bleomycin, The risk or severity of adverse effects can be increased when Bleomycin is combined with Fluticasone propionate.]
[A03AA09, difemerine, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Difemerine.]
[B01AA11, tioclomarol, Fluticasone propionate may increase the anticoagulant activities of Tioclomarol.]
[J05AP06, asunaprevir, The metabolism of Asunaprevir can be decreased when combined with Fluticasone propionate.]
[A07DA06, eluxadoline, The serum concentration of Eluxadoline can be increased when it is combined with Fluticasone propionate.]
[N05AX16, brexpiprazole, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Brexpiprazole.]
[L01XJ02, sonidegib, The metabolism of Sonidegib can be decreased when combined with Fluticasone propionate.]
[G02CX02, flibanserin, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Flibanserin.]
[A06AD03, magnesium peroxide, The bioavailability of Fluticasone propionate can be decreased when combined with Magnesium peroxide.]
[N05AX15, cariprazine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Cariprazine.]
[A10BF01, acarbose, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Acarbose.]
[M02AA25, aceclofenac, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Aceclofenac.]
[M01AB11, acemetacin, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Acemetacin.]
[S01EC01, acetazolamide, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Acetazolamide.]
[A10AE06, insulin degludec, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Insulin degludec.]
[N05AB07, acetophenazine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Acetophenazine.]
[A02BC03, lansoprazole, The metabolism of Lansoprazole can be decreased when combined with Fluticasone propionate.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Fluticasone propionate.]
[R03DX09, mepolizumab, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Mepolizumab.]
[J02AC05, isavuconazole, The metabolism of Fluticasone propionate can be decreased when combined with Isavuconazole.]
[L01EB04, osimertinib, The metabolism of Osimertinib can be decreased when combined with Fluticasone propionate.]
[J05AF13, tenofovir alafenamide, The metabolism of Tenofovir alafenamide can be decreased when combined with Fluticasone propionate.]
[L01EE02, cobimetinib, The metabolism of Cobimetinib can be decreased when combined with Fluticasone propionate.]
[L01XG03, ixazomib, The metabolism of Ixazomib can be decreased when combined with Fluticasone propionate.]
[L01ED03, alectinib, The metabolism of Alectinib can be decreased when combined with Fluticasone propionate.]
[B01AC27, selexipag, The metabolism of Selexipag can be decreased when combined with Fluticasone propionate.]
[A10BB31, acetohexamide, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Acetohexamide.]
[G04CA01, alfuzosin, The metabolism of Alfuzosin can be decreased when combined with Fluticasone propionate.]
[J05AP10, elbasvir, The metabolism of Elbasvir can be decreased when combined with Fluticasone propionate.]
[J05AP11, grazoprevir, The excretion of Grazoprevir can be decreased when combined with Fluticasone propionate.]
[N05CA05, aprobarbital, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Aprobarbital.]
[M01AE16, alminoprofen, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Alminoprofen.]
[A02AB06, aloglutamol, The bioavailability of Fluticasone propionate can be decreased when combined with Aloglutamol.]
[N03AX23, brivaracetam, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Brivaracetam.]
[L04AC13, ixekizumab, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Ixekizumab.]
[L01XX52, venetoclax, The metabolism of Venetoclax can be decreased when combined with Fluticasone propionate.]
[N05BA08, bromazepam, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Bromazepam.]
[N04BC01, bromocriptine, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Bromocriptine.]
[A02AD05, aluminum magnesium silicate, The bioavailability of Fluticasone propionate can be decreased when combined with Almasilate.]
[A02AB03, aluminum phosphate, The bioavailability of Fluticasone propionate can be decreased when combined with Aluminium phosphate.]
[A03AX08, alverine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Alverine.]
[R06AB01, brompheniramine, The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Fluticasone propionate.]
[N06AA19, amineptin, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Amineptine.]
[N05AX17, pimavanserin, The metabolism of Pimavanserin can be decreased when combined with Fluticasone propionate.]
[N06BX11, aniracetam, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Aniracetam.]
[C03CA02, bumetanide, The risk or severity of hypokalemia can be increased when Fluticasone propionate is combined with Bumetanide.]
[N01BB01, bupivacaine, The risk or severity of adverse effects can be increased when Bupivacaine is combined with Fluticasone propionate.]
[N07BC01, buprenorphine, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.]
[N05BE01, buspirone, The risk or severity of adverse effects can be increased when Buspirone is combined with Fluticasone propionate.]
[L01AB01, busulfan, The metabolism of Busulfan can be decreased when combined with Fluticasone propionate.]
[L01XX27, arsenic trioxide, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Arsenic trioxide.]
[N06DA03, rivastigmine, The therapeutic efficacy of Rivastigmine can be decreased when used in combination with Fluticasone propionate.]
[P01BE02, artemether, The metabolism of Artemether can be decreased when combined with Fluticasone propionate.]
[N02AF01, butorphanol, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Butorphanol.]
[J01MA09, sparfloxacin, The risk or severity of tendinopathy can be increased when Fluticasone propionate is combined with Sparfloxacin.]
[L01XK03, rucaparib, The metabolism of Fluticasone propionate can be decreased when combined with Rucaparib.]
[S01AA26, azithromycin, The metabolism of Azithromycin can be decreased when combined with Fluticasone propionate.]
[L04AC12, brodalumab, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Brodalumab.]
[L01EF02, ribociclib, The serum concentration of Fluticasone propionate can be increased when it is combined with Ribociclib.]
[A07EC04, balsalazide, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Balsalazide.]
[R03CC12, bambuterol, The therapeutic efficacy of Bambuterol can be decreased when used in combination with Fluticasone propionate.]
[L04AA36, ocrelizumab, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Ocrelizumab.]
[N07XX16, deutetrabenazine, The metabolism of Deutetrabenazine can be decreased when combined with Fluticasone propionate.]
[N02BF02, pregabalin, The therapeutic efficacy of Fluticasone propionate can be increased when used in combination with Pregabalin.]
[N03AX30, beclamide, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Beclamide.]
[A10BX06, benfluorex, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Benfluorex.]
[S01HA02, benoxinate, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Oxybuprocaine.]
[H05BX05, calcifediol, The therapeutic efficacy of Calcifediol can be decreased when used in combination with Fluticasone propionate.]
[D05AX03, calcitriol, The therapeutic efficacy of Calcitriol can be decreased when used in combination with Fluticasone propionate.]
[A12AA04, calcium carbonate, The bioavailability of Fluticasone propionate can be decreased when combined with Calcium carbonate.]
[L04AC01, daclizumab, The risk or severity of adverse effects can be increased when Daclizumab is combined with Fluticasone propionate.]
[J01XX08, linezolid, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Linezolid.]
[J05AE09, tipranavir, The serum concentration of Fluticasone propionate can be increased when it is combined with Tipranavir.]
[N07XX13, valbenazine, The metabolism of Valbenazine can be decreased when combined with Fluticasone propionate.]
[L04AB02, infliximab, The metabolism of Fluticasone propionate can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The serum concentration of Fluticasone propionate can be increased when it is combined with Midostaurin.]
[L01ED04, brigatinib, The metabolism of Brigatinib can be decreased when combined with Fluticasone propionate.]
[N04BD03, safinamide, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Safinamide.]
[L04AC14, sarilumab, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Sarilumab.]
[J01MA23, delafloxacin, The risk or severity of tendinopathy can be increased when Fluticasone propionate is combined with Delafloxacin.]
[L04AC16, guselkumab, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Guselkumab.]
[L01BC06, capecitabine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Capecitabine.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be decreased when combined with Fluticasone propionate.]
[L01EH02, neratinib, The metabolism of Neratinib can be decreased when combined with Fluticasone propionate.]
[L01XH01, vorinostat, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Vorinostat.]
[L01EM02, copanlisib, The metabolism of Copanlisib can be decreased when combined with Fluticasone propionate.]
[L01EF03, abemaciclib, The metabolism of Abemaciclib can be decreased when combined with Fluticasone propionate.]
[R03AC17, bitolterol, The risk or severity of hypokalemia can be increased when Fluticasone propionate is combined with Bitolterol.]
[J05AG03, efavirenz, The serum concentration of Fluticasone propionate can be increased when it is combined with Efavirenz.]
[N04AA11, bornaprine, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Bornaprine.]
[L04AC02, basiliximab, The risk or severity of adverse effects can be increased when Basiliximab is combined with Fluticasone propionate.]
[L01BA03, raltitrexed, The risk or severity of adverse effects can be increased when Raltitrexed is combined with Fluticasone propionate.]
[N05AD06, bromperidol, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Bromperidol.]
[N05CD09, brotizolam, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Brotizolam.]
[R03BA02, budesonide, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Budesonide.]
[M01AB07, bumadizone, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Bumadizone.]
[L01EL02, acalabrutinib, The metabolism of Acalabrutinib can be decreased when combined with Fluticasone propionate.]
[N05CA03, butobarbital, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Butobarbital.]
[J05AX18, letermovir, The metabolism of Fluticasone propionate can be decreased when combined with Letermovir.]
[N06AA15, butriptyline, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Butriptyline.]
[C01AA02, acetyldigoxins, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Acetyldigoxin.]
[A10BJ06, semaglutide, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Semaglutide.]
[N01BX04, capsaicin, The therapeutic efficacy of Capsaicin can be decreased when used in combination with Fluticasone propionate.]
[A10BK04, ertugliflozin, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Ertugliflozin.]
[N05CA08, butylvinal, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Vinylbital.]
[V04CD06, macimorelin, The therapeutic efficacy of Macimorelin can be decreased when used in combination with Fluticasone propionate.]
[L02BB05, apalutamide, The serum concentration of Apalutamide can be increased when it is combined with Fluticasone propionate.]
[N03AF01, carbamazepine, The metabolism of Carbamazepine can be decreased when combined with Fluticasone propionate.]
[A03AA03, camylofine, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Camylofin.]
[R06AA08, carbinoxamine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Carbinoxamine.]
[L03AB06, interferon alfa-n1, The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Fluticasone propionate.]
[N03AX24, cannabidiol, The risk or severity of adverse effects can be increased when Cannabidiol is combined with Fluticasone propionate.]
[L04AA37, baricitinib, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Baricitinib.]
[C07AB08, celiprolol, The risk or severity of hypokalemia can be increased when Fluticasone propionate is combined with Celiprolol.]
[H01CC03, elagolix, The metabolism of Elagolix can be decreased when combined with Fluticasone propionate.]
[L01XX62, ivosidenib, The metabolism of Fluticasone propionate can be increased when combined with Ivosidenib.]
[N03AX17, stiripentol, The serum concentration of Fluticasone propionate can be increased when it is combined with Stiripentol.]
[J05AG06, doravirine, The metabolism of Doravirine can be decreased when combined with Fluticasone propionate.]
[L01EM04, duvelisib, The metabolism of Duvelisib can be decreased when combined with Fluticasone propionate.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be decreased when combined with Fluticasone propionate.]
[S01GX12, cetirizine, The risk or severity of adverse effects can be increased when Cetirizine is combined with Fluticasone propionate.]
[N05CM04, carbromal, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Carbromal.]
[A10BB06, carbutamide, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Carbutamide.]
[N01BA04, chloroprocaine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Chloroprocaine.]
[R06AA06, chlorphenoxamine, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Chlorphenoxamine.]
[M01AC05, lornoxicam, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Lornoxicam.]
[M03BA02, carisoprodol, The risk or severity of adverse effects can be increased when Carisoprodol is combined with Fluticasone propionate.]
[R03BB08, revefenacin, Fluticasone propionate may decrease the excretion rate of Revefenacin which could result in a higher serum level.]
[L01ED05, lorlatinib, The metabolism of Lorlatinib can be decreased when combined with Fluticasone propionate.]
[L04AA39, emapalumab, The metabolism of Fluticasone propionate can be increased when combined with Emapalumab.]
[L01AD01, carmustine, The risk or severity of adverse effects can be increased when Carmustine is combined with Fluticasone propionate.]
[L01EX13, gilteritinib, The metabolism of Gilteritinib can be decreased when combined with Fluticasone propionate.]
[L01XJ03, glasdegib, The metabolism of Glasdegib can be decreased when combined with Fluticasone propionate.]
[L04AA43, ravulizumab, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Ravulizumab.]
[A06AX05, prucalopride, The metabolism of Prucalopride can be decreased when combined with Fluticasone propionate.]
[B01AC23, cilostazol, The metabolism of Cilostazol can be decreased when combined with Fluticasone propionate.]
[A03FA08, cinitapride, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Cinitapride.]
[N06AX27, esketamine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Esketamine.]
[L04AA42, siponimod, The metabolism of Siponimod can be decreased when combined with Fluticasone propionate.]
[J01FA09, clarithromycin, The serum concentration of Fluticasone propionate can be increased when it is combined with Clarithromycin.]
[N06BA14, solriamfetol, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Solriamfetol.]
[N06AX29, brexanolone, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Brexanolone.]
[L01EN01, erdafitinib, The metabolism of Erdafitinib can be decreased when combined with Fluticasone propionate.]
[N05BA09, clobazam, The risk or severity of adverse effects can be increased when Clobazam is combined with Fluticasone propionate.]
[H02AB14, cloprednol, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Cloprednol.]
[N05BA22, cloxazolam, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Cloxazolam.]
[L04AB01, etanercept, The metabolism of Fluticasone propionate can be increased when combined with Etanercept.]
[H02AB17, cortivazol, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Cortivazol.]
[L04AC18, risankizumab, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Risankizumab.]
[L01EM03, alpelisib, The metabolism of Alpelisib can be decreased when combined with Fluticasone propionate.]
[L01EX15, pexidartinib, The metabolism of Pexidartinib can be decreased when combined with Fluticasone propionate.]
[N05AA06, cyamemazine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Cyamemazine.]
[M03BX08, cyclobenzaprine, The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Fluticasone propionate.]
[L04AA44, upadacitinib, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Upadacitinib.]
[L01EX14, entrectinib, The metabolism of Entrectinib can be decreased when combined with Fluticasone propionate.]
[N07XX11, pitolisant, The serum concentration of Fluticasone propionate can be decreased when it is combined with Pitolisant.]
[J04AK08, pretomanid, The metabolism of Pretomanid can be decreased when combined with Fluticasone propionate.]
[J01XX12, lefamulin, The metabolism of Lefamulin can be decreased when combined with Fluticasone propionate.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be decreased when combined with Fluticasone propionate.]
[C03AA09, cyclothiazide, The risk or severity of electrolyte imbalance can be increased when Fluticasone propionate is combined with Cyclothiazide.]
[G04BE04, yohimbine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Yohimbine.]
[A10AE03, insulin, regular, pork, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Insulin pork.]
[J01DB01, cephalexin, The metabolism of Cephalexin can be decreased when combined with Fluticasone propionate.]
[H02AB13, deflazacort, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Deflazacort.]
[G03DB05, demegestone, The serum concentration of Fluticasone propionate can be increased when it is combined with Demegestone.]
[L01FD01, trastuzumab, Trastuzumab may increase the neutropenic activities of Fluticasone propionate.]
[L01FD03, ado-trastuzumab emtansine, The metabolism of Trastuzumab emtansine can be decreased when combined with Fluticasone propionate.]
[N02CC08, lasmiditan, The risk or severity of adverse effects can be increased when Lasmiditan is combined with Fluticasone propionate.]
[L04AX09, diroximel fumarate, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Diroximel fumarate.]
[L01EL03, zanubrutinib, The metabolism of Zanubrutinib can be decreased when combined with Fluticasone propionate.]
[G03AC09, desogestrel, The serum concentration of Fluticasone propionate can be increased when it is combined with Desogestrel.]
[B06AX03, voxelotor, The serum concentration of Voxelotor can be increased when it is combined with Fluticasone propionate.]
[N03AX25, cenobamate, The serum concentration of Fluticasone propionate can be decreased when it is combined with Cenobamate.]
[R06AB06, dexbrompheniramine, The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Fluticasone propionate.]
[S01XA12, dexpanthenol, The therapeutic efficacy of Dexpanthenol can be decreased when used in combination with Fluticasone propionate.]
[N02AX03, dezocine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Dezocine.]
[N05CM21, lemborexant, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Lemborexant.]
[L01XX72, tazemetostat, The metabolism of Tazemetostat can be decreased when combined with Fluticasone propionate.]
[L04AA53, teprotumumab, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Teprotumumab.]
[N05AD10, lumateperone, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Lumateperone.]
[S01AE06, gatifloxacin, The risk or severity of tendinopathy can be increased when Fluticasone propionate is combined with Gatifloxacin.]
[H02CA02, osilodrostat, The metabolism of Fluticasone propionate can be decreased when combined with Osilodrostat.]
[J05AE05, amprenavir, The serum concentration of Fluticasone propionate can be increased when it is combined with Amprenavir.]
[N02CC07, frovatriptan, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Frovatriptan.]
[G04CB02, dutasteride, The metabolism of Dutasteride can be decreased when combined with Fluticasone propionate.]
[L04AA38, ozanimod, The metabolism of Ozanimod can be decreased when combined with Fluticasone propionate.]
[N05CC04, dichloralphenazone, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Dichloralphenazone.]
[L01EE04, selumetinib, The metabolism of Selumetinib can be decreased when combined with Fluticasone propionate.]
[G03DB08, dienogest, The serum concentration of Fluticasone propionate can be increased when it is combined with Dienogest.]
[A07DA04, difenoxin, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Difenoxin.]
[N02AA08, dihydrocodeine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Dihydrocodeine.]
[N02CC06, eletriptan, The risk or severity of adverse effects can be increased when Eletriptan is combined with Fluticasone propionate.]
[M01AH02, rofecoxib, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Rofecoxib.]
[L01XF03, bexarotene, The risk or severity of adverse effects can be increased when Bexarotene is combined with Fluticasone propionate.]
[C01BD07, dronedarone, The metabolism of Dronedarone can be decreased when combined with Fluticasone propionate.]
[N03AG02, dipropylacetamide, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Valpromide.]
[L01AA02, chlorambucil, The risk or severity of adverse effects can be increased when Chlorambucil is combined with Fluticasone propionate.]
[S03AA08, chloramphenicol, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Fluticasone propionate.]
[N05BA02, chlordiazepoxide, The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Fluticasone propionate.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Fluticasone propionate.]
[A03AA08, dihexyverine, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Dihexyverine.]
[D07XB03, fluprednidene, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Fluprednidene.]
[G04BD09, trospium, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Trospium.]
[M01AC04, droxicam, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Droxicam.]
[M02AA27, dexketoprofen, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Dexketoprofen.]
[N05CM02, chlormethiazole, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Clomethiazole.]
[M03BB02, chlormezanone, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Chlormezanone.]
[L04AA47, inebilizumab, The risk or severity of infection can be increased when Fluticasone propionate is combined with Inebilizumab.]
[R02AD04, dyclonine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Dyclonine.]
[R05CB11, stepronin, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Stepronin.]
[C08CA17, levamlodipine, The serum concentration of Levamlodipine can be increased when it is combined with Fluticasone propionate.]
[R06AX22, ebastine, The metabolism of Ebastine can be decreased when combined with Fluticasone propionate.]
[N05CD14, remimazolam, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Remimazolam.]
[L01FX15, belantamab mafodotin, The excretion of Belantamab mafodotin can be decreased when combined with Fluticasone propionate.]
[L04AC19, satralizumab, The serum concentration of Fluticasone propionate can be decreased when it is combined with Satralizumab.]
[N02AX07, oliceridine, The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Fluticasone propionate is combined with Oliceridine.]
[P01BA01, chloroquine, The metabolism of Chloroquine can be decreased when combined with Fluticasone propionate.]
[L01EX23, pralsetinib, The metabolism of Fluticasone propionate can be decreased when combined with Pralsetinib.]
[C03AA04, chlorothiazide, The risk or severity of electrolyte imbalance can be increased when Fluticasone propionate is combined with Chlorothiazide.]
[R06AB04, chlorpheniramine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Chlorpheniramine.]
[N05AA01, chlorpromazine, The therapeutic efficacy of Chlorpromazine can be decreased when used in combination with Fluticasone propionate.]
[A10BB02, chlorpropamide, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Chlorpropamide.]
[N05AF03, chlorprothixene, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Chlorprothixene.]
[C03BA04, chlorthalidone, Fluticasone propionate may increase the hypokalemic activities of Chlorthalidone.]
[M03BB03, chlorzoxazone, The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Fluticasone propionate.]
[A11CC05, cholecalciferol, The therapeutic efficacy of Cholecalciferol can be decreased when used in combination with Fluticasone propionate.]
[V04CK02, cholecystokinin, The excretion of Cholecystokinin can be decreased when combined with Fluticasone propionate.]
[N05BX03, etifoxine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Etifoxine.]
[N02BA07, ethenzamide, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Ethenzamide.]
[C10AC01, cholestyramine resin, Cholestyramine may increase the excretion rate of Fluticasone propionate which could result in a lower serum level and potentially a reduction in efficacy.]
[N06BX18, vinpocetine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Vinpocetine.]
[N05BA18, ethyl loflazepate, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Ethyl loflazepate.]
[G03DC06, ethynodiol, The serum concentration of Fluticasone propionate can be increased when it is combined with Etynodiol.]
[M01AB08, etodolac, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Etodolac.]
[M02AA06, etofenamate, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Etofenamate.]
[B06AC06, berotralstat, The metabolism of Fluticasone propionate can be decreased when combined with Berotralstat.]
[A16AX20, lonafarnib, The serum concentration of Fluticasone propionate can be increased when it is combined with Lonafarnib.]
[L01BB05, fludarabine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Fludarabine.]
[L02BX04, relugolix, The metabolism of Relugolix can be decreased when combined with Fluticasone propionate.]
[L04AD03, voclosporin, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Voclosporin.]
[P03AX07, abametapir, The serum concentration of Fluticasone propionate can be increased when it is combined with Abametapir.]
[M03BA05, febarbamate, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Febarbamate.]
[N03AX10, felbamate, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Felbamate.]
[M01AE05, fenbufen, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Fenbufen.]
[G04CB01, finasteride, The metabolism of Finasteride can be decreased when combined with Fluticasone propionate.]
[J01MB07, flumequine, The risk or severity of tendinopathy can be increased when Fluticasone propionate is combined with Flumequine.]
[R03BA03, flunisolide, The risk or severity of adverse effects can be increased when Flunisolide is combined with Fluticasone propionate.]
[S02BA08, fluocinolone acetonide, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Fluocinolone acetonide.]
[A10AF01, insulin, regular, human, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Insulin human.]
[L04AA50, ponesimod, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Ponesimod.]
[N01AB05, trichloroethylene, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Trichloroethylene.]
[L03AB10, peginterferon alfa-2b, The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Fluticasone propionate.]
[A02BA01, cimetidine, The metabolism of Fluticasone propionate can be decreased when combined with Cimetidine.]
[N02BF01, gabapentin, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Gabapentin.]
[J01MB06, cinoxacin, The risk or severity of tendinopathy can be increased when Fluticasone propionate is combined with Cinoxacin.]
[L01XX73, sotorasib, The serum concentration of Fluticasone propionate can be decreased when it is combined with Sotorasib.]
[L01EN03, infigratinib, The metabolism of Infigratinib can be decreased when combined with Fluticasone propionate.]
[S03AA07, ciprofloxacin, The risk or severity of tendinopathy can be increased when Fluticasone propionate is combined with Ciprofloxacin.]
[L01XA01, cisplatin, The therapeutic efficacy of Cisplatin can be decreased when used in combination with Fluticasone propionate.]
[N06AB04, citalopram, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Citalopram.]
[L04AA54, pegcetacoplan, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Pegcetacoplan.]
[H01AC07, somapacitan, The serum concentration of the active metabolites of Fluticasone propionate can be decreased when Fluticasone propionate is used in combination with Somapacitan.]
[C03DA05, finerenone, The serum concentration of Finerenone can be increased when it is combined with Fluticasone propionate.]
[L04AA48, belumosudil, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Belumosudil.]
[P01CA03, fexinidazole, The metabolism of Fexinidazole can be decreased when combined with Fluticasone propionate.]
[L04AA51, anifrolumab, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Anifrolumab.]
[H01AC09, lonapegsomatropin, The serum concentration of the active metabolites of Fluticasone propionate can be decreased when Fluticasone propionate is used in combination with Lonapegsomatropin.]
[L01EB10, mobocertinib, The metabolism of Mobocertinib can be decreased when combined with Fluticasone propionate.]
[N02CD07, atogepant, The serum concentration of Atogepant can be increased when it is combined with Fluticasone propionate.]
[R06AA04, clemastine, The risk or severity of adverse effects can be increased when Clemastine is combined with Fluticasone propionate.]
[A10BB12, glimepiride, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Glimepiride.]
[A10BB08, gliquidone, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Gliquidone.]
[R03CC13, clenbuterol, The risk or severity of hypokalemia can be increased when Fluticasone propionate is combined with Clenbuterol.]
[J01FF01, clindamycin, The metabolism of Clindamycin can be decreased when combined with Fluticasone propionate.]
[N06AX25, St. John's wort extract, The metabolism of Fluticasone propionate can be increased when combined with St. John's Wort.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of neuropsychiatric effects can be increased when Ropeginterferon alfa-2b is combined with Fluticasone propionate.]
[J04BA01, clofazimine, The metabolism of Fluticasone propionate can be decreased when combined with Clofazimine.]
[N01BB10, levobupivacaine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Levobupivacaine.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be decreased when combined with Fluticasone propionate.]
[N03AE01, clonazepam, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Clonazepam.]
[S01EA04, clonidine, The risk or severity of sedation can be increased when Clonidine is combined with Fluticasone propionate.]
[J05AB17, brincidofovir, The serum concentration of Brincidofovir can be increased when it is combined with Fluticasone propionate.]
[C01EB24, mavacamten, The serum concentration of Fluticasone propionate can be decreased when it is combined with Mavacamten.]
[A10BX16, tirzepatide, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Tirzepatide.]
[A02BC08, vonoprazan, The metabolism of Vonoprazan can be decreased when combined with Fluticasone propionate.]
[L04AC22, spesolimab, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Spesolimab.]
[L04AA56, deucravacitinib, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Deucravacitinib.]
[N05AH06, clothiapine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Clothiapine.]
[N05BA21, clotiazepam, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Clotiazepam.]
[A04AA01, ondansetron, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Ondansetron.]
[A04AA02, granisetron, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Granisetron.]
[N05AH02, clozapine, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Clozapine.]
[A10BX01, guar gum, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Guar gum.]
[A10BK06, sotagliflozin, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Sotagliflozin.]
[N05BA13, halazepam, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Halazepam.]
[H01AC08, somatrogon, The serum concentration of the active metabolites of Fluticasone propionate can be reduced when Fluticasone propionate is used in combination with Somatrogon resulting in a loss in efficacy.]
[S02DA02, cocaine, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[C02KB01, metyrosine, Fluticasone propionate may increase the sedative activities of Metyrosine.]
[L04AC21, bimekizumab, The metabolism of Fluticasone propionate can be increased when combined with Bimekizumab.]
[M01AX13, proquazone, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Proquazone.]
[R05DA04, codeine, The risk or severity of adverse effects can be increased when Codeine is combined with Fluticasone propionate.]
[M03AC05, hexafluorenium, The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Fluticasone propionate.]
[M04AC01, colchicine, The metabolism of Colchicine can be decreased when combined with Fluticasone propionate.]
[A03AB10, hexocyclium, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Hexocyclium.]
[A03BB06, homatropine methylbromide, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Homatropine methylbromide.]
[L04AA13, leflunomide, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Leflunomide.]
[A02AD04, hydrotalcite, The bioavailability of Fluticasone propionate can be decreased when combined with Hydrotalcite.]
[N01AB07, desflurane, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Desflurane.]
[A04AA03, tropisetron, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Tropisetron.]
[C04AX28, ifenprodil, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Ifenprodil.]
[A10BX03, nateglinide, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Nateglinide.]
[N02BA16, imidazole-2-hydroxybenzoate, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Imidazole salicylate.]
[H01AC03, mecasermin, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Mecasermin.]
[L01BB07, nelarabine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Nelarabine.]
[A10AE04, insulin glargine, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Insulin glargine.]
[J01FA15, telithromycin, The serum concentration of Fluticasone propionate can be increased when it is combined with Telithromycin.]
[R03BA08, ciclesonide, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Ciclesonide.]
[B01AC10, indobufen, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Indobufen.]
[R06AX27, desloratadine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Desloratadine.]
[M01AH03, valdecoxib, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Valdecoxib.]
[H01AX01, pegvisomant, The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Fluticasone propionate.]
[C01AA06, lanatoside C, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Lanatoside C.]
[N02CC05, almotriptan, The metabolism of Almotriptan can be decreased when combined with Fluticasone propionate.]
[M01AH04, parecoxib, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Parecoxib.]
[J02AC02, itraconazole, The serum concentration of Fluticasone propionate can be increased when it is combined with Itraconazole.]
[N05BA10, ketazolam, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Ketazolam.]
[M01AA06, kebuzone, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Kebuzone.]
[L01EA01, imatinib, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Imatinib.]
[J02AC04, posaconazole, The serum concentration of Fluticasone propionate can be increased when it is combined with Posaconazole.]
[N03AX09, lamotrigine, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Lamotrigine.]
[S01BA03, cortisone, The metabolism of Fluticasone propionate can be increased when combined with Cortisone.]
[N07BC04, lofexidine, The therapeutic efficacy of Fluticasone propionate can be increased when used in combination with Lofexidine.]
[S01AE04, lomefloxacin, The risk or severity of tendinopathy can be increased when Fluticasone propionate is combined with Lomefloxacin.]
[M01AB09, lonazolac, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Lonazolac.]
[N05CD06, lormetazepam, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Lormetazepam.]
[M02AA31, loxoprofen, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Loxoprofen.]
[A02AD02, magaldrate, The bioavailability of Fluticasone propionate can be decreased when combined with Magaldrate.]
[A06AD01, magnesium carbonate, The bioavailability of Fluticasone propionate can be decreased when combined with Magnesium carbonate.]
[A03AA04, mebeverine, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Mebeverine.]
[N06AX13, medifoxamine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Medifoxamine.]
[H02AB15, meprednisone, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Meprednisone.]
[N04AA03, methixene, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Metixene.]
[R06AE03, cyclizine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Cyclizine.]
[N05CA10, cyclobarbital, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Cyclobarbital.]
[C03DA04, eplerenone, The metabolism of Eplerenone can be decreased when combined with Fluticasone propionate.]
[N05AD03, metylperon, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Melperone.]
[L04AA15, alefacept, The risk or severity of adverse effects can be increased when Alefacept is combined with Fluticasone propionate.]
[C03AA07, cyclopenthiazide, The risk or severity of electrolyte imbalance can be increased when Fluticasone propionate is combined with Cyclopenthiazide.]
[A10BF02, miglitol, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Miglitol.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be decreased when combined with Fluticasone propionate.]
[N06AX07, minaprine, The therapeutic efficacy of Minaprine can be decreased when used in combination with Fluticasone propionate.]
[S01XA18, cyclosporine, Fluticasone propionate may increase the immunosuppressive activities of Cyclosporine.]
[N06AG02, moclobemide, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Moclobemide.]
[N06BA07, modafinil, The metabolism of Modafinil can be decreased when combined with Fluticasone propionate.]
[R06AX02, cyproheptadine, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Cyproheptadine.]
[C10AA07, rosuvastatin, The metabolism of Rosuvastatin can be decreased when combined with Fluticasone propionate.]
[M02AA02, mofebutazone, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Mofebutazone.]
[M01AX22, morniflumate, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Morniflumate.]
[C03XA02, conivaptan, The serum concentration of Fluticasone propionate can be increased when it is combined with Conivaptan.]
[L01BC01, cytarabine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Cytarabine.]
[G04BE09, vardenafil, The metabolism of Vardenafil can be decreased when combined with Fluticasone propionate.]
[M01AH05, etoricoxib, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Etoricoxib.]
[L01AX04, dacarbazine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Dacarbazine.]
[L01DA01, dactinomycin, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Dactinomycin.]
[G03XA01, danazol, The serum concentration of Fluticasone propionate can be increased when it is combined with Danazol.]
[M03CA01, dantrolene, The therapeutic efficacy of Dantrolene can be increased when used in combination with Fluticasone propionate.]
[J04BA02, dapsone, The metabolism of Dapsone can be decreased when combined with Fluticasone propionate.]
[L01DB02, daunorubicin, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Daunorubicin.]
[N06BX04, deanol, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Deanol.]
[A04AD11, nabilone, Nabilone may increase the central nervous system depressant (CNS depressant) activities of Fluticasone propionate.]
[M01AX01, nabumetone, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Nabumetone.]
[N05BA16, nordazepam, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Nordazepam.]
[N06AX06, nefazodone, The serum concentration of Fluticasone propionate can be increased when it is combined with Nefazodone.]
[N05CM16, niaprazine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Niaprazine.]
[C01DX16, nicorandil, The risk or severity of ulceration can be increased when Fluticasone propionate is combined with Nicorandil.]
[N03AG06, tiagabine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Tiagabine.]
[G03DB04, nomegestrol, The serum concentration of Fluticasone propionate can be increased when it is combined with Nomegestrol.]
[M03AC11, cisatracurium, The risk or severity of adverse effects can be increased when Cisatracurium is combined with Fluticasone propionate.]
[R05DA06, normethadone, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Normethadone.]
[D11AH02, pimecrolimus, The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Fluticasone propionate.]
[N06AB10, escitalopram, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Escitalopram.]
[G04BD08, solifenacin, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Solifenacin.]
[A07EC03, olsalazine, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Olsalazine.]
[N06AA01, desipramine, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Desipramine.]
[C01AA07, deslanoside, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Deslanoside.]
[D07XC02, desoximetasone, The risk or severity of adverse effects can be increased when Desoximetasone is combined with Fluticasone propionate.]
[L01XA03, oxaliplatin, The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Fluticasone propionate.]
[M01AE12, oxaprozin, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Oxaprozin.]
[N03AF02, oxcarbazepine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Oxcarbazepine.]
[S03BA01, dexamethasone, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Dexamethasone.]
[N06BX07, oxiracetam, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Oxiracetam.]
[N04AA08, dexetimide, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Dexetimide.]
[G04BD04, oxybutynin, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Oxybutynin.]
[A03AA01, oxyphencyclimine, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Oxyphencyclimine.]
[L04AB04, adalimumab, The metabolism of Fluticasone propionate can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, The metabolism of Gefitinib can be decreased when combined with Fluticasone propionate.]
[R05DA09, dextromethorphan, The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Fluticasone propionate.]
[N03AC01, paramethadione, The metabolism of Paramethadione can be decreased when combined with Fluticasone propionate.]
[N02AC01, dextromoramide, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Dextromoramide.]
[N06AB05, paroxetine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Paroxetine.]
[B01AC04, clopidogrel, The metabolism of Clopidogrel can be decreased when combined with Fluticasone propionate.]
[N07BC06, heroin, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Diamorphine.]
[N05BA01, diazepam, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Diazepam.]
[N03AX07, phenacemide, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Phenacemide.]
[N03AD02, phensuximide, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Phensuximide.]
[N06AA08, dibenzepin, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Dibenzepin.]
[S02DA04, dibucaine, The therapeutic efficacy of Cinchocaine can be decreased when used in combination with Fluticasone propionate.]
[S01BC03, diclofenac, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Diclofenac.]
[A03AA07, dicyclomine, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.]
[A10BG03, pioglitazone, The serum concentration of Pioglitazone can be increased when it is combined with Fluticasone propionate.]
[N05AD05, pipamperone, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Pipamperone.]
[A03AB14, pipenzolate, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Pipenzolate.]
[L01DC04, ixabepilone, The metabolism of Ixabepilone can be decreased when combined with Fluticasone propionate.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be decreased when combined with Fluticasone propionate.]
[L01DB08, pirarubicin, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Pirarubicin.]
[R03CC07, pirbuterol, The risk or severity of hypokalemia can be increased when Fluticasone propionate is combined with Pirbuterol.]
[C03CA03, piretanide, The risk or severity of hypokalemia can be increased when Fluticasone propionate is combined with Piretanide.]
[P02CB02, diethylcarbamazine, The therapeutic efficacy of Diethylcarbamazine can be decreased when used in combination with Fluticasone propionate.]
[A08AA03, diethylpropion, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Diethylpropion.]
[L02AA01, diethylstilbestrol, The serum concentration of Fluticasone propionate can be increased when it is combined with Diethylstilbestrol.]
[C08CA03, isradipine, The metabolism of Fluticasone propionate can be decreased when combined with Isradipine.]
[D07XC04, diflucortolone, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Difluocortolone.]
[A03AB11, poldine, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Poldine.]
[N02BA11, diflunisal, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Diflunisal.]
[C01AA04, digitoxin, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Digitoxin.]
[C01AA05, digoxin, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Digoxin.]
[C10AX09, ezetimibe, The excretion of Ezetimibe can be decreased when combined with Fluticasone propionate.]
[L01XX24, pegaspargase, The risk or severity of adverse effects can be increased when Pegaspargase is combined with Fluticasone propionate.]
[C04AE04, dihydroergocristine, The metabolism of Dihydroergocristine can be decreased when combined with Fluticasone propionate.]
[N02CA01, dihydroergotamine, The metabolism of Dihydroergotamine can be decreased when combined with Fluticasone propionate.]
[N02AA03, hydromorphone, The risk or severity of adverse effects can be increased when Hydromorphone is combined with Fluticasone propionate.]
[L04AX04, lenalidomide, The risk or severity of adverse effects can be increased when Lenalidomide is combined with Fluticasone propionate.]
[A11CC02, dihydrotachysterol, The therapeutic efficacy of Dihydrotachysterol can be decreased when used in combination with Fluticasone propionate.]
[J05AE08, atazanavir, The serum concentration of Fluticasone propionate can be increased when it is combined with Atazanavir.]
[B01AC21, treprostinil, The serum concentration of Treprostinil can be increased when it is combined with Fluticasone propionate.]
[D04AB07, pramoxine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Pramocaine.]
[C08DB01, diltiazem, The metabolism of Diltiazem can be decreased when combined with Fluticasone propionate.]
[R06AA11, dimenhydrinate, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Dimenhydrinate.]
[M03BX03, pridinol, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Pridinol.]
[R06AB03, dimethindene, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Dimetindene.]
[R03CC08, procaterol, The risk or severity of hypokalemia can be increased when Fluticasone propionate is combined with Procaterol.]
[N03AG05, progabide, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Progabide.]
[N02BB04, propyphenazone, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Propyphenazone.]
[M01AB14, proglumetacin, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Proglumetacin.]
[G02AD02, dinoprostone, The excretion of Dinoprostone can be decreased when combined with Fluticasone propionate.]
[R06AA02, diphenhydramine, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Diphenhydramine.]
[A07DA01, diphenoxylate, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Diphenoxylate.]
[N05CD10, quazepam, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Quazepam.]
[N06BA11, dexmethylphenidate, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Dexmethylphenidate.]
[N06AA23, quinupramine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Quinupramine.]
[A03FA02, cisapride, The metabolism of Cisapride can be decreased when combined with Fluticasone propionate.]
[S01XA23, sirolimus, The metabolism of Sirolimus can be decreased when combined with Fluticasone propionate.]
[N05AL04, remoxipride, The risk or severity of adverse effects can be increased when Remoxipride is combined with Fluticasone propionate.]
[C01BA03, disopyramide, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Disopyramide.]
[L04AA23, natalizumab, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Natalizumab.]
[N07AA03, distigmine, The therapeutic efficacy of Distigmine can be decreased when used in combination with Fluticasone propionate.]
[P03AA04, disulfiram, The metabolism of Disulfiram can be decreased when combined with Fluticasone propionate.]
[S02AA12, rifamycin SV, The metabolism of Fluticasone propionate can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Fluticasone propionate can be increased when combined with Rifapentine.]
[N07XX02, riluzole, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Riluzole.]
[N05AX08, risperidone, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Risperidone.]
[R06AE09, levocetirizine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Levocetirizine.]
[L04AA21, efalizumab, The risk or severity of adverse effects can be increased when Efalizumab is combined with Fluticasone propionate.]
[N01BB09, ropivacaine, The risk or severity of adverse effects can be increased when Ropivacaine is combined with Fluticasone propionate.]
[J01MB01, rosoxacin, The risk or severity of tendinopathy can be increased when Fluticasone propionate is combined with Rosoxacin.]
[L01EX01, sunitinib, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Sunitinib.]
[A04AD12, aprepitant, The metabolism of Fluticasone propionate can be decreased when combined with Aprepitant.]
[C03XA01, tolvaptan, The metabolism of Tolvaptan can be decreased when combined with Fluticasone propionate.]
[L01XG01, bortezomib, The metabolism of Bortezomib can be decreased when combined with Fluticasone propionate.]
[G04BE08, tadalafil, The metabolism of Tadalafil can be decreased when combined with Fluticasone propionate.]
[S01BC05, ketorolac, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Ketorolac.]
[C02KX02, ambrisentan, The metabolism of Ambrisentan can be decreased when combined with Fluticasone propionate.]
[N02BA06, salsalate, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Salsalate.]
[C01CA07, dobutamine, The risk or severity of hypokalemia can be increased when Fluticasone propionate is combined with Dobutamine.]
[A03FA03, domperidone, The metabolism of Domperidone can be decreased when combined with Fluticasone propionate.]
[N06AA16, dothiepin, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Dosulepin.]
[N06AA12, doxepin, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Doxepin.]
[L01DB01, doxorubicin, The metabolism of Doxorubicin can be decreased when combined with Fluticasone propionate.]
[R06AA09, doxylamine, Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Fluticasone propionate.]
[N06AB06, sertraline, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Sertraline.]
[N01AB08, sevoflurane, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Sevoflurane.]
[N05AD08, droperidol, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Fluticasone propionate.]
[A08AA10, sibutramine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Sibutramine.]
[C10AA01, simvastatin, The metabolism of Simvastatin can be decreased when combined with Fluticasone propionate.]
[B05XA02, sodium bicarbonate, The bioavailability of Fluticasone propionate can be decreased when combined with Sodium bicarbonate.]
[N05AL02, sultopride, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Sultopride.]
[N02CC01, sumatriptan, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Sumatriptan.]
[V04CX07, edrophonium, The therapeutic efficacy of Edrophonium can be decreased when used in combination with Fluticasone propionate.]
[H01AA01, corticotropin, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Corticotropin.]
[J01MA05, temafloxacin, The risk or severity of tendinopathy can be increased when Fluticasone propionate is combined with Temafloxacin.]
[L01AX03, temozolomide, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Temozolomide.]
[M01AC02, tenoxicam, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Tenoxicam.]
[D01BA02, terbinafine, The metabolism of Terbinafine can be decreased when combined with Fluticasone propionate.]
[M03BX07, tetrazepam, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Tetrazepam.]
[M03BX05, thiocolchicoside, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Thiocolchicoside.]
[N05AB05, thiopropazate, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Thiopropazate.]
[G04BD01, emepronium, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Emepronium.]
[N06AX14, tianeptine, The metabolism of Tianeptine can be decreased when combined with Fluticasone propionate.]
[C09AA02, enalapril, The excretion of Enalapril can be decreased when combined with Fluticasone propionate.]
[N05BA23, tofisopam, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Tofisopam.]
[M01AG02, tolfenamic acid, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Tolfenamic acid.]
[N06AG03, toloxatone, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Toloxatone.]
[N03AX11, topiramate, The risk or severity of adverse effects can be increased when Topiramate is combined with Fluticasone propionate.]
[C03CA04, torsemide, The metabolism of Torasemide can be decreased when combined with Fluticasone propionate.]
[N05CD11, triazulenone, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Loprazolam.]
[N05CC01, chloral hydrate, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Chloral hydrate.]
[N05CM07, triclofos, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Triclofos.]
[A03AB08, tridihexethyl, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Tridihexethyl.]
[H02CA01, trilostane, The risk or severity of edema formation can be increased when Trilostane is combined with Fluticasone propionate.]
[R06AA10, trimethobenzamide, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Trimethobenzamide.]
[L01AA07, trofosfamide, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Trofosfamide.]
[N04AA12, tropatepine, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Tropatepine.]
[N01AB04, enflurane, The risk or severity of adverse effects can be increased when Enflurane is combined with Fluticasone propionate.]
[C02CA06, urapidil, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Urapidil.]
[J01MA04, enoxacin, The risk or severity of tendinopathy can be increased when Fluticasone propionate is combined with Enoxacin.]
[N05AL06, veralipride, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Veralipride.]
[L01CA04, vinorelbine, The metabolism of Vinorelbine can be decreased when combined with Fluticasone propionate.]
[S01FB02, ephedrine, Ephedrine may increase the excretion rate of Fluticasone propionate which could result in a lower serum level and potentially a reduction in efficacy.]
[S01GX10, epinastine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Epinastine.]
[N06AX16, venlafaxine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Fluticasone propionate.]
[C08CA12, mepirodipine, The metabolism of Fluticasone propionate can be decreased when combined with Barnidipine.]
[S01EA01, epinephrine, The risk or severity of hypokalemia can be increased when Fluticasone propionate is combined with Epinephrine.]
[L01DB03, epirubicin, The risk or severity of adverse effects can be increased when Epirubicin is combined with Fluticasone propionate.]
[N05CF02, zolpidem, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.]
[M01AB04, zomepirac, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Zomepirac.]
[N03AX15, zonisamide, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Zonisamide.]
[A10AB06, insulin glulisine, human, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Insulin glulisine.]
[N05CF01, zopiclone, The metabolism of Zopiclone can be decreased when combined with Fluticasone propionate.]
[N05AX11, zotepine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Zotepine.]
[L01XA02, carboplatin, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Carboplatin.]
[C02AC02, guanfacine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Guanfacine.]
[C01BG01, moricizine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Moricizine.]
[A11CC01, ergocalciferol, The therapeutic efficacy of Ergocalciferol can be decreased when used in combination with Fluticasone propionate.]
[G02AB03, ergonovine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Ergometrine.]
[C04AE01, ergoloid mesylates, USP, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Ergoloid mesylate.]
[N02CA02, ergotamine, The serum concentration of Fluticasone propionate can be increased when it is combined with Ergotamine.]
[N03AG01, valproic acid, The risk or severity of adverse effects can be increased when Valproic acid is combined with Fluticasone propionate.]
[N05CD04, estazolam, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Estazolam.]
[G03CA03, estradiol, The serum concentration of Fluticasone propionate can be increased when it is combined with Estradiol.]
[L01XX11, estramustine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Estramustine.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Fluticasone propionate.]
[L04AA03, lymphocyte immune globulin, anti-thymocyte globulin, equine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Antilymphocyte immunoglobulin (horse).]
[J01MB04, pipemidic acid, The risk or severity of tendinopathy can be increased when Fluticasone propionate is combined with Pipemidic acid.]
[N07XX04, sodium oxybate, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.]
[M01AG01, mefenamic acid, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Mefenamic acid.]
[P01BX01, halofantrine, The metabolism of Halofantrine can be decreased when combined with Fluticasone propionate.]
[N05AD01, haloperidol, The risk or severity of CNS depression can be increased when Haloperidol is combined with Fluticasone propionate.]
[N01AB01, halothane, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Halothane.]
[N05AH04, quetiapine, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.]
[A10AD05, insulin aspart, human, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Insulin aspart.]
[N02CX03, iprazochrome, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Iprazochrome.]
[L01CE02, irinotecan, The metabolism of Irinotecan can be decreased when combined with Fluticasone propionate.]
[N05CA21, allobarbital, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Allobarbital.]
[S01XA14, heparin, The therapeutic efficacy of Heparin can be increased when used in combination with Fluticasone propionate.]
[G03DC01, allylestrenol, The metabolism of Allylestrenol can be decreased when combined with Fluticasone propionate.]
[A07EC02, mesalamine, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Mesalazine.]
[L01XX03, altretamine, The risk or severity of adverse effects can be increased when Altretamine is combined with Fluticasone propionate.]
[N05CA16, hexobarbital, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Hexobarbital.]
[R03CC05, hexoprenaline, The risk or severity of hypokalemia can be increased when Fluticasone propionate is combined with Hexoprenaline.]
[J05AG01, nevirapine, The metabolism of Nevirapine can be decreased when combined with Fluticasone propionate.]
[C08CA10, nilvadipine, The metabolism of Fluticasone propionate can be decreased when combined with Nilvadipine.]
[M02AA26, nimesulide, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Nimesulide.]
[C03AA03, hydrochlorothiazide, The risk or severity of electrolyte imbalance can be increased when Fluticasone propionate is combined with Hydrochlorothiazide.]
[R05DA03, hydrocodone, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.]
[S02BA01, hydrocortisone, The metabolism of Hydrocortisone can be decreased when combined with Fluticasone propionate.]
[C03AA02, hydroflumethiazide, The risk or severity of electrolyte imbalance can be increased when Fluticasone propionate is combined with Hydroflumethiazide.]
[G04BD06, propiverine, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Propiverine.]
[P01BA02, hydroxychloroquine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Hydroxychloroquine.]
[N05AX07, prothipendyl, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Prothipendyl.]
[L01XX05, hydroxyurea, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Hydroxyurea.]
[N05BB01, hydroxyzine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Fluticasone propionate.]
[R02AX02, ibuprofen, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Ibuprofen.]
[L01DB06, idarubicin, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Idarubicin.]
[L01AA06, ifosfamide, The metabolism of Ifosfamide can be decreased when combined with Fluticasone propionate.]
[N01AH03, sufentanil, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Sufentanil.]
[N06AA02, imipramine, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Imipramine.]
[L01CD01, paclitaxel, The metabolism of Paclitaxel can be decreased when combined with Fluticasone propionate.]
[R01AD07, tixocortol, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Tixocortol.]
[M03BX02, tizanidine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Tizanidine.]
[L01CE01, topotecan, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Topotecan.]
[C03BA11, indapamide, Fluticasone propionate may increase the hypokalemic activities of Indapamide.]
[S01BC01, indomethacin, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Indomethacin.]
[L03AB04, interferon alfa-2a, The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Fluticasone propionate.]
[L03AB05, interferon alfa-2b, The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Fluticasone propionate.]
[N06AX17, milnacipran, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Milnacipran.]
[A03AA30, piperidolate, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Piperidolate.]
[L04AA25, eculizumab, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Eculizumab.]
[N01BB08, articaine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Articaine.]
[A10BH01, sitagliptin, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Sitagliptin.]
[N05BA12, alprazolam, The metabolism of Alprazolam can be decreased when combined with Fluticasone propionate.]
[N05CH02, ramelteon, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Ramelteon.]
[R06AE01, buclizine, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Buclizine.]
[A10BH02, vildagliptin, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Vildagliptin.]
[C10AA06, cerivastatin, The metabolism of Cerivastatin can be decreased when combined with Fluticasone propionate.]
[C07AA01, alprenolol, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Alprenolol.]
[C03BA02, quinethazone, Fluticasone propionate may increase the hypokalemic activities of Quinethazone.]
[L03AB09, interferon alfacon-1, The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Fluticasone propionate.]
[N06AA13, iprindole, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Iprindole.]
[N06AF05, iproniazid, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Iproniazid.]
[N05AA07, chlorproethazine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Chlorproethazine.]
[N06AF01, isocarboxazid, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Isocarboxazid.]
[R03CC06, isoetharine, The risk or severity of hypokalemia can be increased when Fluticasone propionate is combined with Isoetharine.]
[N01AB06, isoflurane, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Isoflurane.]
[S01EB07, isoflurophate, The therapeutic efficacy of Isoflurophate can be decreased when used in combination with Fluticasone propionate.]
[N04BX02, entacapone, The risk or severity of adverse effects can be increased when Entacapone is combined with Fluticasone propionate.]
[J04AC01, isoniazid, The serum concentration of Isoniazid can be decreased when it is combined with Fluticasone propionate.]
[R03CB01, isoproterenol, The therapeutic efficacy of Isoprenaline can be decreased when used in combination with Fluticasone propionate.]
[A10BJ01, exenatide, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Exenatide.]
[N06AX18, reboxetine, The risk or severity of adverse effects can be increased when Reboxetine is combined with Fluticasone propionate.]
[H01AC01, somatropin, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Fluticasone propionate.]
[A02AB01, aluminum hydroxide, The bioavailability of Fluticasone propionate can be decreased when combined with Aluminum hydroxide.]
[L04AC07, tocilizumab, The metabolism of Fluticasone propionate can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, The therapeutic efficacy of Ketamine can be decreased when used in combination with Fluticasone propionate.]
[C02KD01, ketanserin, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Ketanserin.]
[J02AB02, ketoconazole, The serum concentration of Fluticasone propionate can be increased when it is combined with Ketoconazole.]
[N05AH03, olanzapine, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Olanzapine.]
[M02AA10, ketoprofen, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Ketoprofen.]
[V03AC03, deferasirox, The risk or severity of gastrointestinal ulceration and gastrointestinal irritation can be increased when Fluticasone propionate is combined with Deferasirox.]
[L04AA24, abatacept, The metabolism of Fluticasone propionate can be increased when combined with Abatacept.]
[C01CA22, arbutamine, The risk or severity of hypokalemia can be increased when Fluticasone propionate is combined with Arbutamine.]
[N04BC09, rotigotine, Fluticasone propionate may increase the sedative activities of Rotigotine.]
[J01MB02, nalidixic acid, The risk or severity of tendinopathy can be increased when Fluticasone propionate is combined with Nalidixic acid.]
[N07AA30, ambenonium, The therapeutic efficacy of Ambenonium can be decreased when used in combination with Fluticasone propionate.]
[N03AX18, lacosamide, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Lacosamide.]
[L01DC03, mitomycin, The risk or severity of adverse effects can be increased when Mitomycin is combined with Fluticasone propionate.]
[G03AD01, levonorgestrel, The serum concentration of Fluticasone propionate can be increased when it is combined with Levonorgestrel.]
[N04BA01, levodopa, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Levodopa.]
[S02DA01, lidocaine, The risk or severity of adverse effects can be increased when Lidocaine is combined with Fluticasone propionate.]
[N06BA13, armodafinil, The metabolism of Fluticasone propionate can be increased when combined with Armodafinil.]
[D06AX13, retapamulin, The metabolism of Retapamulin can be decreased when combined with Fluticasone propionate.]
[N02CA07, lisuride, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Lisuride.]
[N06AA07, lofepramine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Lofepramine.]
[L01AD02, lomustine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Lomustine.]
[A07DA03, loperamide, The metabolism of Loperamide can be decreased when combined with Fluticasone propionate.]
[N05BA06, lorazepam, The risk or severity of adverse effects can be increased when Lorazepam is combined with Fluticasone propionate.]
[C10AA02, lovastatin, The metabolism of Lovastatin can be decreased when combined with Fluticasone propionate.]
[N05AH01, loxapine, The therapeutic efficacy of Fluticasone propionate can be decreased when used in combination with Loxapine.]
[G03DC03, lynestrenol, The serum concentration of Fluticasone propionate can be increased when it is combined with Lynestrenol.]
[L01EG01, temsirolimus, The metabolism of Temsirolimus can be decreased when combined with Fluticasone propionate.]
[G04BX01, magnesium hydroxide, The bioavailability of Fluticasone propionate can be decreased when combined with Magnesium hydroxide.]
[A12CC10, magnesium oxide, The bioavailability of Fluticasone propionate can be decreased when combined with Magnesium oxide.]
[V04CC02, magnesium sulfate, The therapeutic efficacy of Fluticasone propionate can be increased when used in combination with Magnesium sulfate.]
[L01BA05, pralatrexate, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Pralatrexate.]
[L01EA03, nilotinib, The serum concentration of Fluticasone propionate can be increased when it is combined with Nilotinib.]
[N06AA21, maprotiline, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Maprotiline.]
[A08AA05, mazindol, The risk or severity of adverse effects can be increased when Mazindol is combined with Fluticasone propionate.]
[L01AA05, mechlorethamine, The therapeutic efficacy of Mechlorethamine can be decreased when used in combination with Fluticasone propionate.]
[R06AE05, meclizine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Meclizine.]
[M02AA18, meclofenamic acid, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Meclofenamic acid.]
[N05BA03, medazepam, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Medazepam.]
[C01AA08, medigoxin, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Metildigoxin.]
[P01BC02, mefloquine, The therapeutic efficacy of Mefloquine can be decreased when used in combination with Fluticasone propionate.]
[N05CH01, melatonin, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Melatonin.]
[L01AA03, melphalan, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Melphalan.]
[N06DX01, memantine, The therapeutic efficacy of Memantine can be decreased when used in combination with Fluticasone propionate.]
[N02AB02, meperidine, The risk or severity of adverse effects can be increased when Meperidine is combined with Fluticasone propionate.]
[N03AB04, mephenytoin, The metabolism of Mephenytoin can be decreased when combined with Fluticasone propionate.]
[N03AA01, mephobarbital, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Methylphenobarbital.]
[N01BB03, mepivacaine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Mepivacaine.]
[N05BC01, meprobamate, The risk or severity of adverse effects can be increased when Meprobamate is combined with Fluticasone propionate.]
[N02AX05, meptazinol, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Meptazinol.]
[L02BG01, aminoglutethimide, The therapeutic efficacy of Fluticasone propionate can be decreased when used in combination with Aminoglutethimide.]
[N05AC03, mesoridazine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Mesoridazine.]
[G03BB01, mesterolone, The risk or severity of edema formation can be increased when Mesterolone is combined with Fluticasone propionate.]
[N05AX13, paliperidone, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Paliperidone.]
[A10BA02, metformin, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Metformin.]
[A04AA04, dolasetron, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Dolasetron.]
[N07BC02, methadone, The risk or severity of adverse effects can be increased when Methadone is combined with Fluticasone propionate.]
[N06BA03, methamphetamine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Metamfetamine.]
[A03AB07, methantheline, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Methantheline.]
[R06AC05, methapyrilene, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Methapyrilene.]
[N05CM01, methaqualone, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Methaqualone.]
[N03AA30, metharbital, The risk or severity of adverse effects can be increased when Metharbital is combined with Fluticasone propionate.]
[A14AA04, methenolone, The risk or severity of edema formation can be increased when Metenolone is combined with Fluticasone propionate.]
[G02CB05, metergoline, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Metergoline.]
[H03BB02, methimazole, The serum concentration of Fluticasone propionate can be increased when it is combined with Methimazole.]
[L01BA04, pemetrexed, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Pemetrexed.]
[M03BA03, methocarbamol, The risk or severity of adverse effects can be increased when Methocarbamol is combined with Fluticasone propionate.]
[N05CA15, methohexital, The risk or severity of adverse effects can be increased when Methohexital is combined with Fluticasone propionate.]
[N02BG08, ziconotide, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Ziconotide.]
[L04AX03, methotrexate, The metabolism of Methotrexate can be decreased when combined with Fluticasone propionate.]
[N05AA02, methotrimeprazine, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.]
[N02BG09, methoxyflurane, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Methoxyflurane.]
[C03AA08, methyclothiazide, The risk or severity of electrolyte imbalance can be increased when Fluticasone propionate is combined with Methyclothiazide.]
[V04CG05, methylene blue, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Methylene blue.]
[R03DA05, aminophylline, The metabolism of Aminophylline can be decreased when combined with Fluticasone propionate.]
[H02AB04, methylprednisolone, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Methylprednisolone.]
[N03AF03, rufinamide, The risk or severity of adverse effects can be increased when Rufinamide is combined with Fluticasone propionate.]
[G03EK01, methyltestosterone, The risk or severity of edema formation can be increased when Methyltestosterone is combined with Fluticasone propionate.]
[N05CE02, methyprylon, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Methyprylon.]
[N02CA04, methysergide, The risk or severity of adverse effects can be increased when Methysergide is combined with Fluticasone propionate.]
[A03FA01, metoclopramide, The risk or severity of sedation can be increased when Metoclopramide is combined with Fluticasone propionate.]
[C03BA08, metolazone, Fluticasone propionate may increase the hypokalemic activities of Metolazone.]
[P01AB01, metronidazole, The metabolism of Metronidazole can be decreased when combined with Fluticasone propionate.]
[N06AX03, mianserin, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Mianserin.]
[S02AA13, miconazole, The metabolism of Fluticasone propionate can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Aminophenazone.]
[N05CD08, midazolam, The serum concentration of Midazolam can be increased when it is combined with Fluticasone propionate.]
[G03XB01, mifepristone, The therapeutic efficacy of Fluticasone propionate can be decreased when used in combination with Mifepristone.]
[C09CA03, valsartan, The excretion of Valsartan can be decreased when combined with Fluticasone propionate.]
[J01AA08, minocycline, Minocycline may increase the central nervous system depressant (CNS depressant) activities of Fluticasone propionate.]
[L01XX23, mitotane, The serum concentration of Fluticasone propionate can be decreased when it is combined with Mitotane.]
[L01DB07, mitoxantrone, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Mitoxantrone.]
[N05AE02, molindone, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Molindone.]
[L03AC01, aldesleukin, The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Fluticasone propionate.]
[C01BD01, amiodarone, The serum concentration of Fluticasone propionate can be increased when it is combined with Amiodarone.]
[N06AA09, amitriptyline, The metabolism of Amitriptyline can be decreased when combined with Fluticasone propionate.]
[N02AA01, morphine, The metabolism of Morphine can be decreased when combined with Fluticasone propionate.]
[A04AA05, palonosetron, The risk or severity of adverse effects can be increased when Palonosetron is combined with Fluticasone propionate.]
[L04AB05, certolizumab pegol, The metabolism of Fluticasone propionate can be increased when combined with Certolizumab pegol.]
[B02BX05, eltrombopag, The metabolism of Eltrombopag can be decreased when combined with Fluticasone propionate.]
[L04AA52, ofatumumab, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Ofatumumab.]
[L01EX03, pazopanib, The metabolism of Pazopanib can be decreased when combined with Fluticasone propionate.]
[L04AA06, mycophenolic acid, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Mycophenolic acid.]
[M03AC03, vecuronium, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Vecuronium.]
[N05CA02, amobarbital, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Amobarbital.]
[P01BA06, amodiaquine, The metabolism of Amodiaquine can be decreased when combined with Fluticasone propionate.]
[G03XC01, raloxifene, The excretion of Raloxifene can be decreased when combined with Fluticasone propionate.]
[N06AA17, amoxapine, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.]
[N03AB05, fosphenytoin, The serum concentration of Fluticasone propionate can be decreased when it is combined with Fosphenytoin.]
[L03AB08, interferon beta-1b, The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Fluticasone propionate.]
[N04BC04, ropinirole, Fluticasone propionate may increase the sedative activities of Ropinirole.]
[C04AX21, nafronyl, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Naftidrofuryl.]
[N02AF02, nalbuphine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Nalbuphine.]
[V03AB15, naloxone, The serum concentration of Fluticasone propionate can be increased when it is combined with Naloxone.]
[L04AC03, anakinra, The metabolism of Fluticasone propionate can be increased when combined with Anakinra.]
[S01XA11, nandrolone, The risk or severity of edema formation can be increased when Nandrolone phenpropionate is combined with Fluticasone propionate.]
[M02AA12, naproxen, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Naproxen.]
[A10BG01, troglitazone, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Troglitazone.]
[N06AX21, duloxetine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Duloxetine.]
[N04BX01, tolcapone, The risk or severity of adverse effects can be increased when Tolcapone is combined with Fluticasone propionate.]
[L01CD02, docetaxel, The metabolism of Docetaxel can be decreased when combined with Fluticasone propionate.]
[N01AH06, remifentanil, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Remifentanil.]
[A10BX02, repaglinide, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Repaglinide.]
[S01EB06, neostigmine, The therapeutic efficacy of Neostigmine can be decreased when used in combination with Fluticasone propionate.]
[N05AX14, iloperidone, The metabolism of Iloperidone can be decreased when combined with Fluticasone propionate.]
[J02AA01, amphotericin B, The risk or severity of hypokalemia can be increased when Fluticasone propionate is combined with Amphotericin B.]
[N06AX23, desvenlafaxine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Desvenlafaxine.]
[H05BX02, paricalcitol, The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Fluticasone propionate.]
[L01XX01, amsacrine, The risk or severity of adverse effects can be increased when Amsacrine is combined with Fluticasone propionate.]
[N06AF02, nialamide, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Nialamide.]
[C08CA04, nicardipine, The metabolism of Nicardipine can be decreased when combined with Fluticasone propionate.]
[C08CA05, nifedipine, The metabolism of Nifedipine can be decreased when combined with Fluticasone propionate.]
[M02AA17, niflumic acid, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Niflumic acid.]
[C08CA07, nisoldipine, The metabolism of Nisoldipine can be decreased when combined with Fluticasone propionate.]
[N05CD02, nitrazepam, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Nitrazepam.]
[C08CA08, nitrendipine, The metabolism of Nitrendipine can be decreased when combined with Fluticasone propionate.]
[J01XE01, nitrofurantoin, The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Fluticasone propionate.]
[N05CF03, zaleplon, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Zaleplon.]
[N04BC05, pramipexole, Fluticasone propionate may increase the sedative activities of Pramipexole.]
[N01AX13, nitrous oxide, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Nitrous oxide.]
[N06AX04, nomifensine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Nomifensine.]
[C01CA03, norepinephrine, The risk or severity of hypokalemia can be increased when Fluticasone propionate is combined with Norepinephrine.]
[G03DC02, norethindrone, The serum concentration of Fluticasone propionate can be increased when it is combined with Norethisterone.]
[S01AE02, norfloxacin, The risk or severity of tendinopathy can be increased when Fluticasone propionate is combined with Norfloxacin.]
[G03AC07, norgestrienone, The serum concentration of Fluticasone propionate can be increased when it is combined with Norgestrienone.]
[C02KX01, bosentan, The excretion of Bosentan can be decreased when combined with Fluticasone propionate.]
[N06AA10, nortriptyline, The metabolism of Nortriptyline can be decreased when combined with Fluticasone propionate.]
[S02AA16, ofloxacin, The risk or severity of tendinopathy can be increased when Fluticasone propionate is combined with Ofloxacin.]
[L04AC04, rilonacept, The metabolism of Fluticasone propionate can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Omeprazole can be decreased when combined with Fluticasone propionate.]
[N06AA05, opipramol, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Opipramol.]
[N02AA02, opium, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Opium.]
[R03CB03, metaproterenol, The risk or severity of hypokalemia can be increased when Fluticasone propionate is combined with Orciprenaline.]
[C01AC01, ouabain, The excretion of Ouabain can be decreased when combined with Fluticasone propionate.]
[A14AA08, oxandrolone, The risk or severity of fluid retention can be increased when Fluticasone propionate is combined with Oxandrolone.]
[N05BA04, oxazepam, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Oxazepam.]
[J01MB05, oxolinic acid, The risk or severity of tendinopathy can be increased when Fluticasone propionate is combined with Oxolinic acid.]
[C07AA02, oxprenolol, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Oxprenolol.]
[N02AA05, oxycodone, The risk or severity of adverse effects can be increased when Oxycodone is combined with Fluticasone propionate.]
[A14AA05, oxymetholone, The risk or severity of fluid retention can be increased when Fluticasone propionate is combined with Oxymetholone.]
[N02AA11, oxymorphone, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Oxymorphone.]
[N05AE01, oxypertine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Oxypertine.]
[S01BC02, oxyphenbutazone, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Oxyphenbutazone.]
[A03AB03, oxyphenonium, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.]
[N05AH05, asenapine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Asenapine.]
[N02AX06, tapentadol, Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Fluticasone propionate.]
[M03AC01, pancuronium, The therapeutic efficacy of Pancuronium can be decreased when used in combination with Fluticasone propionate.]
[G03DB06, chlormadinone, The serum concentration of Fluticasone propionate can be increased when it is combined with Chlormadinone.]
[N05CC05, paraldehyde, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.]
[H02AB05, paramethasone, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Paramethasone.]
[C02KC01, pargyline, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Pargyline.]
[J01MA03, pefloxacin, The risk or severity of tendinopathy can be increased when Fluticasone propionate is combined with Pefloxacin.]
[G04BD11, fesoterodine, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Fesoterodine.]
[C07AA23, penbutolol, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Penbutolol.]
[N05AG03, penfluridol, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Penfluridol.]
[M01CC01, penicillamine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Penicillamine.]
[S01AA14, penicillin G, The excretion of Benzylpenicillin can be decreased when combined with Fluticasone propionate.]
[J07AF01, diphtheria toxoid vaccine, inactivated, The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Fluticasone propionate.]
[J07AM01, tetanus toxoid vaccine, inactivated, The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Fluticasone propionate.]
[N02AD01, pentazocine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Pentazocine.]
[N05CA01, pentobarbital, The metabolism of Fluticasone propionate can be increased when combined with Pentobarbital.]
[L01XX08, pentostatin, The risk or severity of adverse effects can be increased when Pentostatin is combined with Fluticasone propionate.]
[N05AB10, perazine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Perazine.]
[N04BC02, pergolide, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Pergolide.]
[N05AB03, perphenazine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Perphenazine.]
[J07AJ, pertussis vaccine, The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Fluticasone propionate.]
[N02AD02, phenazocine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Phenazocine.]
[N06AF03, phenelzine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Phenelzine.]
[A10BA01, phenformin, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Phenformin.]
[B01AA02, phenindione, Fluticasone propionate may increase the anticoagulant activities of Phenindione.]
[N03AA02, phenobarbital, The metabolism of Fluticasone propionate can be increased when combined with Phenobarbital.]
[N01AH04, phenoperidine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Phenoperidine.]
[B01AA04, phenprocoumon, Fluticasone propionate may increase the anticoagulant activities of Phenprocoumon.]
[M02AA01, phenylbutazone, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Phenylbutazone.]
[S01GA05, phenylephrine, The risk or severity of hypertension can be increased when Fluticasone propionate is combined with Phenylephrine.]
[R01BA01, phenylpropanolamine, The risk or severity of hypokalemia can be increased when Fluticasone propionate is combined with Phenylpropanolamine.]
[N03AB02, phenytoin, The serum concentration of Fluticasone propionate can be decreased when it is combined with Phenytoin.]
[L04AB06, golimumab, The metabolism of Fluticasone propionate can be increased when combined with Golimumab.]
[S01AE05, levofloxacin, The risk or severity of tendinopathy can be increased when Fluticasone propionate is combined with Levofloxacin.]
[V03AB19, physostigmine, The therapeutic efficacy of Physostigmine can be decreased when used in combination with Fluticasone propionate.]
[L02BB03, bicalutamide, The metabolism of Bicalutamide can be decreased when combined with Fluticasone propionate.]
[C08CX01, mibefradil, The metabolism of Fluticasone propionate can be decreased when combined with Mibefradil.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Fluticasone propionate.]
[C07AA03, pindolol, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Pindolol.]
[C10AA05, atorvastatin, The metabolism of Atorvastatin can be decreased when combined with Fluticasone propionate.]
[J05AE01, saquinavir, The serum concentration of Fluticasone propionate can be increased when it is combined with Saquinavir.]
[N05AC04, pipothiazine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Pipotiazine.]
[A02BX03, pirenzepine, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Pirenzepine.]
[N02AC03, pirinitramide, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Piritramide.]
[S01BC06, piroxicam, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Piroxicam.]
[J01MA11, grepafloxacin, The risk or severity of tendinopathy can be increased when Fluticasone propionate is combined with Grepafloxacin.]
[N02CX01, pizotyline, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Pizotifen.]
[J05AG02, delavirdine, The serum concentration of Fluticasone propionate can be increased when it is combined with Delavirdine.]
[C09CA04, irbesartan, The metabolism of Irbesartan can be decreased when combined with Fluticasone propionate.]
[N05CA22, proxibarbal, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Proxibarbal.]
[D05AX05, tazarotene, The metabolism of Tazarotene can be decreased when combined with Fluticasone propionate.]
[A10BG02, rosiglitazone, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Rosiglitazone.]
[L02BG03, anastrozole, The metabolism of Anastrozole can be decreased when combined with Fluticasone propionate.]
[A03AE01, alosetron, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Alosetron.]
[L04AC08, canakinumab, The metabolism of Fluticasone propionate can be increased when combined with Canakinumab.]
[C03AA05, polythiazide, The risk or severity of electrolyte imbalance can be increased when Fluticasone propionate is combined with Polythiazide.]
[J05AE03, ritonavir, The serum concentration of Fluticasone propionate can be increased when it is combined with Ritonavir.]
[A10BH03, saxagliptin, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Saxagliptin.]
[A10AD04, insulin lispro, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Insulin lispro.]
[C10AA08, pitavastatin, The metabolism of Pitavastatin can be decreased when combined with Fluticasone propionate.]
[N05BA11, prazepam, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Prazepam.]
[P02BA01, praziquantel, The metabolism of Praziquantel can be decreased when combined with Fluticasone propionate.]
[S03BA02, prednisolone, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Prednisolone.]
[H02AB07, prednisone, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Prednisone.]
[N01BB04, prilocaine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Prilocaine.]
[P01BA03, primaquine, The metabolism of Fluticasone propionate can be decreased when combined with Primaquine.]
[N03AA03, primidone, The metabolism of Fluticasone propionate can be increased when combined with Primidone.]
[C01BA02, procainamide, The therapeutic efficacy of Procainamide can be decreased when used in combination with Fluticasone propionate.]
[S01HA05, procaine, The therapeutic efficacy of Procaine can be decreased when used in combination with Fluticasone propionate.]
[L01XB01, procarbazine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Procarbazine.]
[C10AB05, fenofibrate, The metabolism of Fenofibrate can be decreased when combined with Fluticasone propionate.]
[N05AB04, prochlorperazine, The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Fluticasone propionate.]
[N04AA04, procyclidine, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Procyclidine.]
[G03DA04, progesterone, The serum concentration of Fluticasone propionate can be increased when it is combined with Progesterone.]
[N05AA03, promazine, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Promazine.]
[R06AD02, promethazine, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Promethazine.]
[N01AX04, propanidid, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Propanidid.]
[A03AB05, propantheline, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Propantheline.]
[R06AX26, fexofenadine, The excretion of Fexofenadine can be decreased when combined with Fluticasone propionate.]
[N05AC01, periciazine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Periciazine.]
[N05CM06, propiomazine, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Propiomazine.]
[L01XH02, romidepsin, The metabolism of Romidepsin can be decreased when combined with Fluticasone propionate.]
[N01AX10, propofol, The metabolism of Propofol can be decreased when combined with Fluticasone propionate.]
[N02AC04, propoxyphene, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Dextropropoxyphene.]
[C07AA05, propranolol, The metabolism of Propranolol can be decreased when combined with Fluticasone propionate.]
[H03BA02, propylthiouracil, The risk or severity of adverse effects can be increased when Propylthiouracil is combined with Fluticasone propionate.]
[N02CC04, rizatriptan, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Rizatriptan.]
[R03DC03, montelukast, The metabolism of Montelukast can be decreased when combined with Fluticasone propionate.]
[N06AA11, protriptyline, The risk or severity of adverse effects can be increased when Protriptyline is combined with Fluticasone propionate.]
[N05AX12, aripiprazole, The metabolism of Aripiprazole can be decreased when combined with Fluticasone propionate.]
[A03AB15, diphemanil, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Diphemanil.]
[A03AB09, isopropamide, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Isopropamide.]
[S01FA03, methscopolamine, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Methscopolamine.]
[N05CA07, talbutal, The risk or severity of adverse effects can be increased when Talbutal is combined with Fluticasone propionate.]
[N05CA09, vinbarbital, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Vinbarbital.]
[N05BB02, captodiamine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Captodiame.]
[M03BA04, styramate, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Styramate.]
[P02CC01, pyrantel, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Pyrantel.]
[J06BB05, rabies immune globulin, human, The therapeutic efficacy of Rabies immune globulin, human can be decreased when used in combination with Fluticasone propionate.]
[N07AA02, pyridostigmine, The therapeutic efficacy of Pyridostigmine can be decreased when used in combination with Fluticasone propionate.]
[R06AC01, pyrilamine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Mepyramine.]
[P01AX05, quinacrine, The metabolism of Quinacrine can be decreased when combined with Fluticasone propionate.]
[C01BA01, quinidine, The metabolism of Quinidine can be decreased when combined with Fluticasone propionate.]
[P01BC01, quinine, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Quinine.]
[C02AA02, reserpine, The risk or severity of adverse effects can be increased when Reserpine is combined with Fluticasone propionate.]
[J04AB02, rifampin, The metabolism of Fluticasone propionate can be increased when combined with Rifampicin.]
[G02CA01, ritodrine, The risk or severity of hypokalemia can be increased when Fluticasone propionate is combined with Ritodrine.]
[N06AX01, 5-hydroxytryptophan, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Oxitriptan.]
[N02BA05, salicylamide, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Salicylamide.]
[A07EC01, sulfasalazine, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Sulfasalazine.]
[S01BC08, salicylic acid, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Salicylic acid.]
[S01FA02, scopolamine, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Scopolamine.]
[N05CA06, secobarbital, The risk or severity of adverse effects can be increased when Secobarbital is combined with Fluticasone propionate.]
[N04BD01, selegiline, The metabolism of Selegiline can be decreased when combined with Fluticasone propionate.]
[L01FA03, obinutuzumab, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Obinutuzumab.]
[M05BX04, denosumab, The risk or severity of adverse effects can be increased when Denosumab is combined with Fluticasone propionate.]
[L01CD04, cabazitaxel, The metabolism of Cabazitaxel can be decreased when combined with Fluticasone propionate.]
[L03AX17, sipuleucel-T, The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Fluticasone propionate.]
[C10AA04, fluvastatin, The metabolism of Fluvastatin can be decreased when combined with Fluticasone propionate.]
[N05CM08, ethchlorvynol, The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Fluticasone propionate.]
[L02AA03, ethinyl estradiol, The serum concentration of Fluticasone propionate can be increased when it is combined with Ethinylestradiol.]
[N04AA05, profenamine, The therapeutic efficacy of Profenamine can be decreased when used in combination with Fluticasone propionate.]
[N03AD01, ethosuximide, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Ethosuximide.]
[N03AB01, ethotoin, The therapeutic efficacy of Ethotoin can be increased when used in combination with Fluticasone propionate.]
[M01AC06, meloxicam, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Meloxicam.]
[S01XA06, ethylmorphine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Ethylmorphine.]
[N01AX07, etomidate, The risk or severity of adverse effects can be increased when Etomidate is combined with Fluticasone propionate.]
[L01CB01, etoposide, The metabolism of Etoposide can be decreased when combined with Fluticasone propionate.]
[N05AE03, sertindole, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Sertindole.]
[L04AD02, tacrolimus, The serum concentration of Tacrolimus can be increased when it is combined with Fluticasone propionate.]
[A02BA04, nizatidine, The therapeutic efficacy of Nizatidine can be decreased when used in combination with Fluticasone propionate.]
[J01MA08, fleroxacin, The risk or severity of tendinopathy can be increased when Fluticasone propionate is combined with Fleroxacin.]
[R06AX11, astemizole, The metabolism of Astemizole can be decreased when combined with Fluticasone propionate.]
[R06AX12, terfenadine, The serum concentration of Fluticasone propionate can be increased when it is combined with Terfenadine.]
[N06AX12, bupropion, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Bupropion.]
[N06AB08, fluvoxamine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Fluvoxamine.]
[L04AA02, muromonab-CD3, The risk or severity of adverse effects can be increased when Muromonab is combined with Fluticasone propionate.]
[C10AA03, pravastatin, The excretion of Pravastatin can be decreased when combined with Fluticasone propionate.]
[V03AF02, dexrazoxane, The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Fluticasone propionate.]
[P02CA03, albendazole, The metabolism of Albendazole can be decreased when combined with Fluticasone propionate.]
[C08CA02, felodipine, The metabolism of Felodipine can be decreased when combined with Fluticasone propionate.]
[N03AX26, fenfluramine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Fluticasone propionate.]
[M01AE04, fenoprofen, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Fenoprofen.]
[R03CC04, fenoterol, The risk or severity of hypokalemia can be increased when Fluticasone propionate is combined with Fenoterol.]
[N02AB03, fentanyl, The metabolism of Fentanyl can be decreased when combined with Fluticasone propionate.]
[R03CC02, albuterol, The risk or severity of hypokalemia can be increased when Fluticasone propionate is combined with Salbutamol.]
[L01BB06, clofarabine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Clofarabine.]
[L04AA40, cladribine, The risk or severity of adverse effects can be increased when Cladribine is combined with Fluticasone propionate.]
[G04BD02, flavoxate, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.]
[N02BG04, floctafenine, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Floctafenine.]
[J02AC01, fluconazole, The metabolism of Fluticasone propionate can be decreased when combined with Fluconazole.]
[J02AX01, flucytosine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Flucytosine.]
[H02AA02, fludrocortisone, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Fludrocortisone.]
[N07CA03, flunarizine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Flunarizine.]
[N05CD03, flunitrazepam, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Flunitrazepam.]
[D07AC08, fluocinonide, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Fluocinonide.]
[N06AA14, melitracen, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Melitracen.]
[H02AB03, fluocortolone, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Fluocortolone.]
[V03AZ01, ethanol, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Ethanol.]
[L01BC09, floxuridine, The risk or severity of adverse effects can be increased when Floxuridine is combined with Fluticasone propionate.]
[S01CB05, fluorometholone, The risk or severity of adverse effects can be increased when Fluorometholone is combined with Fluticasone propionate.]
[L01BC02, fluorouracil, The metabolism of Fluorouracil can be decreased when combined with Fluticasone propionate.]
[N06AB03, fluoxetine, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Fluoxetine.]
[G03BA01, fluoxymesterone, The risk or severity of fluid retention can be increased when Fluticasone propionate is combined with Fluoxymesterone.]
[N05AF01, flupenthixol, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Flupentixol.]
[N05AB02, fluphenazine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Fluphenazine.]
[N05CD01, flurazepam, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Flurazepam.]
[S01BC04, flurbiprofen, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Flurbiprofen.]
[N05AG01, fluspirilene, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Fluspirilene.]
[L02BB01, flutamide, The metabolism of Flutamide can be decreased when combined with Fluticasone propionate.]
[L01BC03, tegafur, The metabolism of Tegafur can be decreased when combined with Fluticasone propionate.]
[M03AA01, alcuronium, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Alcuronium.]
[G01AX06, furazolidone, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Furazolidone.]
[J05AE10, darunavir, The serum concentration of Fluticasone propionate can be increased when it is combined with Darunavir.]
[C03CA01, furosemide, The therapeutic efficacy of Furosemide can be increased when used in combination with Fluticasone propionate.]
[N05CF04, eszopiclone, The risk or severity of CNS depression can be increased when Fluticasone propionate is combined with Eszopiclone.]
[N05AL05, amisulpride, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Amisulpride.]
[N06DA04, galantamine, The therapeutic efficacy of Galantamine can be decreased when used in combination with Fluticasone propionate.]
[M03AC02, gallamine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Gallamine.]
[N03AA04, barbexaclone, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Barbexaclone.]
[N06AX08, bifemelane, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Bifemelane.]
[L01EA02, dasatinib, The metabolism of Dasatinib can be decreased when combined with Fluticasone propionate.]
[N04BC06, cabergoline, The metabolism of Cabergoline can be decreased when combined with Fluticasone propionate.]
[A10BJ02, liraglutide, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Liraglutide.]
[N03AD03, methsuximide, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Methsuximide.]
[G03XA02, gestrinone, The serum concentration of Fluticasone propionate can be increased when it is combined with Gestrinone.]
[N01AH02, alfentanil, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Alfentanil.]
[L01EH01, lapatinib, The metabolism of Lapatinib can be decreased when combined with Fluticasone propionate.]
[A10BB01, glyburide, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Glyburide.]
[A10BB09, gliclazide, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Gliclazide.]
[A10BB07, glipizide, The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Glipizide.]
[N05CM18, dexmedetomidine, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Dexmedetomidine.]
[N05CE01, glutethimide, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Glutethimide.]
[C01BD04, dofetilide, The metabolism of Dofetilide can be decreased when combined with Fluticasone propionate.]
[C02CA04, doxazosin, The metabolism of Doxazosin can be decreased when combined with Fluticasone propionate.]
[H01AB01, thyrotropin alfa, The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Fluticasone propionate.]
[L01EX02, sorafenib, The metabolism of Sorafenib can be decreased when combined with Fluticasone propionate.]
[B01AA12, fluindione, Fluticasone propionate may increase the anticoagulant activities of Fluindione.]
[D07AB02, hydrocortisone butyrate, The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Hydrocortisone butyrate.]
[H02CA04, levoketoconazole, The serum concentration of Fluticasone propionate can be increased when it is combined with Levoketoconazole.]
[M01AE11, tiaprofenic acid, The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Tiaprofenic acid.]
[C03CC01, ethacrynic acid, The risk or severity of hypokalemia can be increased when Fluticasone propionate is combined with Etacrynic acid.]
[R03BB01, ipratropium bromide, Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Ipratropium.]
[P02BB01, trichlorfon, The therapeutic efficacy of Metrifonate can be decreased when used in combination with Fluticasone furoate.]
[S02DA03, antipyrine, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Antipyrine.]
[A14AA02, stanozolol, The risk or severity of fluid retention can be increased when Fluticasone furoate is combined with Stanozolol.]
[G03XB02, ulipristal, The serum concentration of Fluticasone furoate can be increased when it is combined with Ulipristal.]
[L04AA04, rabbit anti-human T-lymphocyte globulin, The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Fluticasone furoate.]
[L01AD04, streptozocin, The risk or severity of adverse effects can be increased when Streptozocin is combined with Fluticasone furoate.]
[L04AA27, fingolimod, Fluticasone furoate may increase the immunosuppressive activities of Fingolimod.]
[M03AB01, succinylcholine, The risk or severity of myopathy and weakness can be increased when Succinylcholine is combined with Fluticasone furoate.]
[J01EC02, sulfadiazine, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Sulfadiazine.]
[J01EC01, sulfamethoxazole, The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Fluticasone furoate.]
[S01AB02, sulfisoxazole, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Sulfisoxazole.]
[M01AB02, sulindac, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Sulindac.]
[N05AL01, sulpiride, The therapeutic efficacy of Sulpiride can be decreased when used in combination with Fluticasone furoate.]
[A10BB04, glibornuride, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Glibornuride.]
[A10BC01, glymidine, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Glymidine.]
[M01AX04, apazone, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Azapropazone.]
[L01BB02, mercaptopurine, The risk or severity of adverse effects can be increased when Mercaptopurine is combined with Fluticasone furoate.]
[N06DA01, tacrine, The therapeutic efficacy of Tacrine can be decreased when used in combination with Fluticasone furoate.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be increased when combined with Fluticasone furoate.]
[L01CB02, teniposide, The metabolism of Teniposide can be increased when combined with Fluticasone furoate.]
[R03CC03, terbutaline, The therapeutic efficacy of Terbutaline can be decreased when used in combination with Fluticasone furoate.]
[G03BA03, testosterone, The risk or severity of edema formation can be increased when Testosterone is combined with Fluticasone furoate.]
[A04AD10, dronabinol, The serum concentration of Dronabinol can be increased when it is combined with Fluticasone furoate.]
[N04BC07, apomorphine, The metabolism of Apomorphine can be decreased when combined with Fluticasone furoate.]
[L04AX02, thalidomide, The risk or severity of adverse effects can be increased when Thalidomide is combined with Fluticasone furoate.]
[R03DA04, theophylline, The metabolism of Theophylline can be increased when combined with Fluticasone furoate.]
[L01XX41, eribulin, The risk or severity of adverse effects can be increased when Eribulin is combined with Fluticasone furoate.]
[L01AC01, thiotepa, The therapeutic efficacy of Thiotepa can be decreased when used in combination with Fluticasone furoate.]
[L01BB03, thioguanine, The risk or severity of adverse effects can be increased when Tioguanine is combined with Fluticasone furoate.]
[B02AB01, aprotinin, The therapeutic efficacy of Aprotinin can be decreased when used in combination with Fluticasone furoate.]
[A10BB05, tolazamide, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Tolazamide.]
[V04CA01, tolbutamide, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Tolbutamide.]
[M02AA21, tolmetin, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Tolmetin.]
[N02AX02, tramadol, The metabolism of Tramadol can be decreased when combined with Fluticasone furoate.]
[N06AX05, trazodone, The metabolism of Trazodone can be decreased when combined with Fluticasone furoate.]
[L01XF01, tretinoin, The risk or severity of adverse effects can be increased when Tretinoin is combined with Fluticasone furoate.]
[S01BA05, triamcinolone, The risk or severity of adverse effects can be increased when Triamcinolone is combined with Fluticasone furoate.]
[N05CD05, triazolam, The metabolism of Triazolam can be decreased when combined with Fluticasone furoate.]
[C03AA06, trichlormethiazide, The risk or severity of electrolyte imbalance can be increased when Fluticasone furoate is combined with Trichlormethiazide.]
[S01EB04, demecarium, The therapeutic efficacy of Demecarium can be decreased when used in combination with Fluticasone furoate.]
[S01AD02, trifluridine, The risk or severity of adverse effects can be increased when Trifluridine is combined with Fluticasone furoate.]
[N05AA05, triflupromazine, The therapeutic efficacy of Triflupromazine can be decreased when used in combination with Fluticasone furoate.]
[D07AC02, fluclorolone, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Fluclorolone.]
[R03BA07, mometasone, The risk or severity of adverse effects can be increased when Mometasone is combined with Fluticasone furoate.]
[N03AC02, trimethadione, The metabolism of Trimethadione can be decreased when combined with Fluticasone furoate.]
[J01FA08, troleandomycin, The metabolism of Fluticasone furoate can be decreased when combined with Troleandomycin.]
[M03AA02, tubocurarine, The therapeutic efficacy of Tubocurarine can be decreased when used in combination with Fluticasone furoate.]
[R03DX07, roflumilast, The serum concentration of Roflumilast can be increased when it is combined with Fluticasone furoate.]
[L04AA26, belimumab, The risk or severity of adverse effects can be increased when Belimumab is combined with Fluticasone furoate.]
[S01AA05, tyrothricin, The therapeutic efficacy of Tyrothricin can be decreased when used in combination with Fluticasone furoate.]
[L01EX04, vandetanib, The metabolism of Vandetanib can be increased when combined with Fluticasone furoate.]
[A10BH05, linagliptin, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Linagliptin.]
[J05AP03, boceprevir, The metabolism of Fluticasone furoate can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Fluticasone furoate can be decreased when combined with Telaprevir.]
[J05AG05, rilpivirine, The serum concentration of Rilpivirine can be decreased when it is combined with Fluticasone furoate.]
[L04AA28, belatacept, The risk or severity of adverse effects can be increased when Belatacept is combined with Fluticasone furoate.]
[B01AF01, rivaroxaban, The metabolism of Rivaroxaban can be decreased when combined with Fluticasone furoate.]
[R03AC18, indacaterol, The risk or severity of hypokalemia can be increased when Fluticasone furoate is combined with Indacaterol.]
[B01AC24, ticagrelor, The metabolism of Ticagrelor can be decreased when combined with Fluticasone furoate.]
[C08DA01, verapamil, The metabolism of Verapamil can be decreased when combined with Fluticasone furoate.]
[N06AX09, viloxazine, The metabolism of Fluticasone furoate can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The metabolism of Vinblastine can be increased when combined with Fluticasone furoate.]
[L01CA02, vincristine, The metabolism of Vincristine can be increased when combined with Fluticasone furoate.]
[L01CA03, vindesine, The metabolism of Vindesine can be increased when combined with Fluticasone furoate.]
[B01AA03, warfarin, Fluticasone furoate may increase the anticoagulant activities of Warfarin.]
[S01AA13, fusidic acid, The metabolism of Fluticasone furoate can be decreased when combined with Fusidic acid.]
[J05AF01, zidovudine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Fluticasone furoate.]
[N05AF05, zuclopenthixol, The metabolism of Zuclopenthixol can be increased when combined with Fluticasone furoate.]
[J05AE02, indinavir, The metabolism of Fluticasone furoate can be decreased when combined with Indinavir.]
[L01EC01, vemurafenib, The metabolism of Vemurafenib can be increased when combined with Fluticasone furoate.]
[L01FX05, brentuximab vedotin, The metabolism of Brentuximab vedotin can be increased when combined with Fluticasone furoate.]
[L01ED01, crizotinib, The metabolism of Crizotinib can be increased when combined with Fluticasone furoate.]
[H05BX03, doxercalciferol, The therapeutic efficacy of Doxercalciferol can be decreased when used in combination with Fluticasone furoate.]
[J01MA13, trovafloxacin, The risk or severity of tendinopathy can be increased when Fluticasone furoate is combined with Trovafloxacin.]
[N05AE04, ziprasidone, The metabolism of Fluticasone furoate can be decreased when combined with Ziprasidone.]
[G03AC10, drospirenone, The serum concentration of Fluticasone furoate can be increased when it is combined with Drospirenone.]
[L04AA34, alemtuzumab, The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Fluticasone furoate.]
[N02BA01, aspirin, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Acetylsalicylic acid.]
[L01EJ01, ruxolitinib, The metabolism of Ruxolitinib can be increased when combined with Fluticasone furoate.]
[L03AB11, peginterferon alfa-2a, The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluticasone furoate.]
[A11CC03, alfacalcidol, The therapeutic efficacy of Alfacalcidol can be decreased when used in combination with Fluticasone furoate.]
[L01FA01, rituximab, The risk or severity of adverse effects can be increased when Rituximab is combined with Fluticasone furoate.]
[J02AC03, voriconazole, The serum concentration of Fluticasone furoate can be increased when it is combined with Voriconazole.]
[M03AC04, atracurium, The risk or severity of myopathy and weakness can be increased when Atracurium is combined with Fluticasone furoate.]
[L01EK01, axitinib, The metabolism of Axitinib can be increased when combined with Fluticasone furoate.]
[R07AX02, ivacaftor, The metabolism of Ivacaftor can be decreased when combined with Fluticasone furoate.]
[H02AB11, prednylidene, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Prednylidene.]
[L01BC07, azacitidine, The risk or severity of adverse effects can be increased when Azacitidine is combined with Fluticasone furoate.]
[L04AX01, azathioprine, The risk or severity of adverse effects can be increased when Azathioprine is combined with Fluticasone furoate.]
[L01BC05, gemcitabine, The risk or severity of adverse effects can be increased when Gemcitabine is combined with Fluticasone furoate.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Fluticasone furoate.]
[J07BK01, varicella-zoster virus vaccine live (Oka-Merck) strain, The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Fluticasone furoate.]
[L01FX02, gemtuzumab ozogamicin, The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Fluticasone furoate.]
[L01XG02, carfilzomib, The risk or severity of adverse effects can be increased when Carfilzomib is combined with Fluticasone furoate.]
[V03AX03, cobicistat, The metabolism of Fluticasone furoate can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Fluticasone furoate can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Enzalutamide can be increased when it is combined with Fluticasone furoate.]
[L01EA04, bosutinib, The metabolism of Bosutinib can be increased when combined with Fluticasone furoate.]
[L04AA31, teriflunomide, The risk or severity of adverse effects can be increased when Teriflunomide is combined with Fluticasone furoate.]
[A02AA05, magnesium silicate, The bioavailability of Fluticasone furoate can be decreased when combined with Magnesium silicate.]
[A02AC02, calcium silicate, The bioavailability of Fluticasone furoate can be decreased when combined with Calcium silicate.]
[L04AA22, abetimus, The risk or severity of adverse effects can be increased when Abetimus is combined with Fluticasone furoate.]
[H02AA01, aldosterone, The risk or severity of adverse effects can be increased when Aldosterone is combined with Fluticasone furoate.]
[L01EX05, regorafenib, The metabolism of Regorafenib can be increased when combined with Fluticasone furoate.]
[C01AA01, acetyldigitoxin, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Acetyldigitoxin.]
[J05AE04, nelfinavir, The metabolism of Fluticasone furoate can be decreased when combined with Nelfinavir.]
[L01AA09, bendamustine, The risk or severity of adverse effects can be increased when Bendamustine is combined with Fluticasone furoate.]
[C08CA13, lercanidipine, The metabolism of Lercanidipine can be decreased when combined with Fluticasone furoate.]
[N06DA02, donepezil, The therapeutic efficacy of Donepezil can be decreased when used in combination with Fluticasone furoate.]
[N03AX22, perampanel, The metabolism of Perampanel can be decreased when combined with Fluticasone furoate.]
[L04AA29, tofacitinib, The metabolism of Tofacitinib can be decreased when combined with Fluticasone furoate.]
[G04BE03, sildenafil, The metabolism of Sildenafil can be decreased when combined with Fluticasone furoate.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be increased when combined with Fluticasone furoate.]
[B01AF02, apixaban, The metabolism of Apixaban can be decreased when combined with Fluticasone furoate.]
[C10AX12, lomitapide, The metabolism of Lomitapide can be increased when combined with Fluticasone furoate.]
[A10BH04, alogliptin, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Alogliptin.]
[A16AX09, glycerol phenylbutyrate, The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Fluticasone furoate.]
[C03AA01, bendroflumethiazide, The risk or severity of electrolyte imbalance can be increased when Fluticasone furoate is combined with Bendroflumethiazide.]
[L04AX06, pomalidomide, The metabolism of Pomalidomide can be increased when combined with Fluticasone furoate.]
[N02BA10, benorilate, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Benorilate.]
[A10BK02, canagliflozin, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Canagliflozin.]
[L04AX07, dimethyl fumarate, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Dimethyl fumarate.]
[J01MA15, gemifloxacin, The risk or severity of tendinopathy can be increased when Fluticasone furoate is combined with Gemifloxacin.]
[S01AE07, moxifloxacin, The risk or severity of tendinopathy can be increased when Fluticasone furoate is combined with Moxifloxacin.]
[H03AA04, tiratricol, The therapeutic efficacy of Tiratricol can be decreased when used in combination with Fluticasone furoate.]
[A10AE05, insulin detemir, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Insulin detemir.]
[A10BX05, pramlintide, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Pramlintide.]
[J02AX04, caspofungin, The excretion of Caspofungin can be decreased when combined with Fluticasone furoate.]
[M01AH01, celecoxib, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Celecoxib.]
[L04AA18, everolimus, The metabolism of Everolimus can be increased when combined with Fluticasone furoate.]
[L01EC02, dabrafenib, The serum concentration of Dabrafenib can be increased when it is combined with Fluticasone furoate.]
[R02AX03, benzydamine, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Benzydamine.]
[P03AX06, benzyl alcohol, The metabolism of Benzyl alcohol can be decreased when combined with Fluticasone furoate.]
[N06AX28, levomilnacipran, The metabolism of Levomilnacipran can be decreased when combined with Fluticasone furoate.]
[C02KX05, riociguat, The metabolism of Riociguat can be decreased when combined with Fluticasone furoate.]
[A10BJ03, lixisenatide, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Lixisenatide.]
[A05AA03, cholic acid, The excretion of Cholic Acid can be decreased when combined with Fluticasone furoate.]
[L01EL01, ibrutinib, The metabolism of Ibrutinib can be decreased when combined with Fluticasone furoate.]
[N06AX26, vortioxetine, The metabolism of Vortioxetine can be decreased when combined with Fluticasone furoate.]
[G03AC08, etonogestrel, The serum concentration of Fluticasone furoate can be increased when it is combined with Etonogestrel.]
[J05AP05, simeprevir, The metabolism of Fluticasone furoate can be decreased when combined with Simeprevir.]
[A10BK01, dapagliflozin, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Dapagliflozin.]
[C01CA27, droxidopa, The risk or severity of hypokalemia can be increased when Fluticasone furoate is combined with Droxidopa.]
[N05CH03, tasimelteon, The metabolism of Tasimelteon can be increased when combined with Fluticasone furoate.]
[A16AA07, metreleptin, The metabolism of Fluticasone furoate can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Fluticasone furoate can be increased when combined with Apremilast.]
[L02BG02, formestane, The risk or severity of edema formation can be increased when Formestane is combined with Fluticasone furoate.]
[A16AA06, betaine, The therapeutic efficacy of Betaine can be decreased when used in combination with Fluticasone furoate.]
[S03BA03, betamethasone, The risk or severity of adverse effects can be increased when Betamethasone is combined with Fluticasone furoate.]
[A10BJ04, albiglutide, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Albiglutide.]
[L04AC11, siltuximab, The metabolism of Fluticasone furoate can be increased when combined with Siltuximab.]
[L01ED02, ceritinib, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Ceritinib.]
[B01AC26, vorapaxar, The metabolism of Vorapaxar can be increased when combined with Fluticasone furoate.]
[L04AA33, vedolizumab, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Vedolizumab.]
[B01AA07, acenocoumarol, Fluticasone furoate may increase the anticoagulant activities of Acenocoumarol.]
[L01XH04, belinostat, The risk or severity of adverse effects can be increased when Belinostat is combined with Fluticasone furoate.]
[L01EM01, idelalisib, The metabolism of Idelalisib can be increased when combined with Fluticasone furoate.]
[A10BK03, empagliflozin, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Empagliflozin.]
[R03AC19, olodaterol, The metabolism of Olodaterol can be decreased when combined with Fluticasone furoate.]
[L03AB13, peginterferon beta-1a, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Peginterferon beta-1a.]
[N05CM19, suvorexant, The metabolism of Suvorexant can be increased when combined with Fluticasone furoate.]
[A16AX10, eliglustat, The metabolism of Eliglustat can be decreased when combined with Fluticasone furoate.]
[V04CX03, methacholine, Fluticasone furoate may decrease effectiveness of Methacholine as a diagnostic agent.]
[A10BJ05, dulaglutide, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Dulaglutide.]
[L01BC08, decitabine, The risk or severity of adverse effects can be increased when Decitabine is combined with Fluticasone furoate.]
[L04AX05, pirfenidone, The risk or severity of adverse effects can be increased when Pirfenidone is combined with Fluticasone furoate.]
[L01EX09, nintedanib, The metabolism of Nintedanib can be increased when combined with Fluticasone furoate.]
[L01FX07, blinatumomab, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Blinatumomab.]
[J05AP09, dasabuvir, The metabolism of Dasabuvir can be decreased when combined with Fluticasone furoate.]
[L01XK01, olaparib, The metabolism of Olaparib can be increased when combined with Fluticasone furoate.]
[B01AA01, dicumarol, Fluticasone furoate may increase the anticoagulant activities of Dicoumarol.]
[L04AC10, secukinumab, The metabolism of Fluticasone furoate can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The metabolism of Palbociclib can be increased when combined with Fluticasone furoate.]
[L01XH03, panobinostat, The metabolism of Panobinostat can be increased when combined with Fluticasone furoate.]
[J05AP07, daclatasvir, The metabolism of Daclatasvir can be decreased when combined with Fluticasone furoate.]
[L01DC01, bleomycin, The risk or severity of adverse effects can be increased when Bleomycin is combined with Fluticasone furoate.]
[B01AA11, tioclomarol, Fluticasone furoate may increase the anticoagulant activities of Tioclomarol.]
[J05AP06, asunaprevir, The metabolism of Asunaprevir can be decreased when combined with Fluticasone furoate.]
[A07DA06, eluxadoline, The serum concentration of Eluxadoline can be increased when it is combined with Fluticasone furoate.]
[L01XJ02, sonidegib, The metabolism of Sonidegib can be increased when combined with Fluticasone furoate.]
[A06AD03, magnesium peroxide, The bioavailability of Fluticasone furoate can be decreased when combined with Magnesium peroxide.]
[A10BF01, acarbose, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Acarbose.]
[M02AA25, aceclofenac, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Aceclofenac.]
[M01AB11, acemetacin, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Acemetacin.]
[A10AE06, insulin degludec, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Insulin degludec.]
[A02BC03, lansoprazole, The metabolism of Lansoprazole can be decreased when combined with Fluticasone furoate.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be increased when combined with Fluticasone furoate.]
[R03DX09, mepolizumab, The risk or severity of adverse effects can be increased when Mepolizumab is combined with Fluticasone furoate.]
[J02AC05, isavuconazole, The metabolism of Fluticasone furoate can be decreased when combined with Isavuconazole.]
[L01EB04, osimertinib, The metabolism of Osimertinib can be increased when combined with Fluticasone furoate.]
[J05AF13, tenofovir alafenamide, The metabolism of Tenofovir alafenamide can be increased when combined with Fluticasone furoate.]
[L01EE02, cobimetinib, The metabolism of Cobimetinib can be increased when combined with Fluticasone furoate.]
[L01XG03, ixazomib, The metabolism of Ixazomib can be increased when combined with Fluticasone furoate.]
[L01ED03, alectinib, The metabolism of Alectinib can be increased when combined with Fluticasone furoate.]
[B01AC27, selexipag, The metabolism of Selexipag can be decreased when combined with Fluticasone furoate.]
[A10BB31, acetohexamide, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Acetohexamide.]
[G04CA01, alfuzosin, The metabolism of Alfuzosin can be decreased when combined with Fluticasone furoate.]
[J05AP10, elbasvir, The metabolism of Elbasvir can be decreased when combined with Fluticasone furoate.]
[J05AP11, grazoprevir, The excretion of Grazoprevir can be decreased when combined with Fluticasone furoate.]
[M01AE16, alminoprofen, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Alminoprofen.]
[A02AB06, aloglutamol, The bioavailability of Fluticasone furoate can be decreased when combined with Aloglutamol.]
[L04AC13, ixekizumab, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Ixekizumab.]
[L01XX52, venetoclax, The metabolism of Venetoclax can be increased when combined with Fluticasone furoate.]
[N04BC01, bromocriptine, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Bromocriptine.]
[A02AD05, aluminum magnesium silicate, The bioavailability of Fluticasone furoate can be decreased when combined with Almasilate.]
[A02AB03, aluminum phosphate, The bioavailability of Fluticasone furoate can be decreased when combined with Aluminium phosphate.]
[C08CA01, amlodipine, The metabolism of Amlodipine can be increased when combined with Fluticasone furoate.]
[N05AX17, pimavanserin, The metabolism of Pimavanserin can be increased when combined with Fluticasone furoate.]
[C03CA02, bumetanide, The risk or severity of hypokalemia can be increased when Fluticasone furoate is combined with Bumetanide.]
[N07BC01, buprenorphine, The metabolism of Buprenorphine can be decreased when combined with Fluticasone furoate.]
[N05BE01, buspirone, The metabolism of Buspirone can be decreased when combined with Fluticasone furoate.]
[L01AB01, busulfan, The metabolism of Busulfan can be increased when combined with Fluticasone furoate.]
[L01XX27, arsenic trioxide, The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Fluticasone furoate.]
[N06DA03, rivastigmine, The therapeutic efficacy of Rivastigmine can be decreased when used in combination with Fluticasone furoate.]
[P01BE02, artemether, The metabolism of Artemether can be decreased when combined with Fluticasone furoate.]
[J01MA09, sparfloxacin, The risk or severity of tendinopathy can be increased when Fluticasone furoate is combined with Sparfloxacin.]
[S01GX07, azelastine, The metabolism of Azelastine can be decreased when combined with Fluticasone furoate.]
[L01XK03, rucaparib, The metabolism of Fluticasone furoate can be decreased when combined with Rucaparib.]
[S01AA26, azithromycin, The metabolism of Azithromycin can be increased when combined with Fluticasone furoate.]
[L04AC12, brodalumab, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Brodalumab.]
[L01EF02, ribociclib, The metabolism of Fluticasone furoate can be decreased when combined with Ribociclib.]
[A07EC04, balsalazide, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Balsalazide.]
[R03CC12, bambuterol, The therapeutic efficacy of Bambuterol can be decreased when used in combination with Fluticasone furoate.]
[L04AA36, ocrelizumab, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Ocrelizumab.]
[N07XX16, deutetrabenazine, The metabolism of Deutetrabenazine can be decreased when combined with Fluticasone furoate.]
[A10BX06, benfluorex, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Benfluorex.]
[H05BX05, calcifediol, The therapeutic efficacy of Calcifediol can be decreased when used in combination with Fluticasone furoate.]
[D05AX03, calcitriol, The therapeutic efficacy of Calcitriol can be decreased when used in combination with Fluticasone furoate.]
[A12AA04, calcium carbonate, The bioavailability of Fluticasone furoate can be decreased when combined with Calcium carbonate.]
[L04AC01, daclizumab, The risk or severity of adverse effects can be increased when Daclizumab is combined with Fluticasone furoate.]
[J01XX08, linezolid, The risk or severity of adverse effects can be increased when Linezolid is combined with Fluticasone furoate.]
[J05AE09, tipranavir, The metabolism of Fluticasone furoate can be decreased when combined with Tipranavir.]
[N07XX13, valbenazine, The metabolism of Valbenazine can be decreased when combined with Fluticasone furoate.]
[L04AB02, infliximab, The metabolism of Fluticasone furoate can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Fluticasone furoate can be decreased when combined with Midostaurin.]
[L01ED04, brigatinib, The metabolism of Brigatinib can be increased when combined with Fluticasone furoate.]
[L04AC14, sarilumab, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Sarilumab.]
[J01MA23, delafloxacin, The risk or severity of tendinopathy can be increased when Fluticasone furoate is combined with Delafloxacin.]
[L04AC16, guselkumab, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Guselkumab.]
[L01BC06, capecitabine, The risk or severity of adverse effects can be increased when Capecitabine is combined with Fluticasone furoate.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be increased when combined with Fluticasone furoate.]
[L01EH02, neratinib, The metabolism of Neratinib can be increased when combined with Fluticasone furoate.]
[L01XH01, vorinostat, The risk or severity of adverse effects can be increased when Vorinostat is combined with Fluticasone furoate.]
[L01EM02, copanlisib, The metabolism of Copanlisib can be increased when combined with Fluticasone furoate.]
[L01EF03, abemaciclib, The metabolism of Abemaciclib can be increased when combined with Fluticasone furoate.]
[R03AC17, bitolterol, The risk or severity of hypokalemia can be increased when Fluticasone furoate is combined with Bitolterol.]
[J05AG03, efavirenz, The metabolism of Fluticasone furoate can be decreased when combined with Efavirenz.]
[L04AC02, basiliximab, The risk or severity of adverse effects can be increased when Basiliximab is combined with Fluticasone furoate.]
[L01BA03, raltitrexed, The risk or severity of adverse effects can be increased when Raltitrexed is combined with Fluticasone furoate.]
[R03BA02, budesonide, The risk or severity of adverse effects can be increased when Budesonide is combined with Fluticasone furoate.]
[M01AB07, bumadizone, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Bumadizone.]
[L01EL02, acalabrutinib, The metabolism of Acalabrutinib can be increased when combined with Fluticasone furoate.]
[J05AX18, letermovir, The metabolism of Fluticasone furoate can be decreased when combined with Letermovir.]
[C01AA02, acetyldigoxins, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Acetyldigoxin.]
[A10BJ06, semaglutide, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Semaglutide.]
[N01BX04, capsaicin, The therapeutic efficacy of Capsaicin can be decreased when used in combination with Fluticasone furoate.]
[A10BK04, ertugliflozin, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Ertugliflozin.]
[V04CD06, macimorelin, The therapeutic efficacy of Macimorelin can be decreased when used in combination with Fluticasone furoate.]
[L02BB05, apalutamide, The serum concentration of Apalutamide can be increased when it is combined with Fluticasone furoate.]
[N03AF01, carbamazepine, The metabolism of Carbamazepine can be increased when combined with Fluticasone furoate.]
[L03AB06, interferon alfa-n1, The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Fluticasone furoate.]
[N03AX24, cannabidiol, The metabolism of Cannabidiol can be decreased when combined with Fluticasone furoate.]
[L04AA37, baricitinib, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Baricitinib.]
[C07AB08, celiprolol, The risk or severity of hypokalemia can be increased when Fluticasone furoate is combined with Celiprolol.]
[H01CC03, elagolix, The metabolism of Elagolix can be decreased when combined with Fluticasone furoate.]
[L01XX62, ivosidenib, The metabolism of Fluticasone furoate can be increased when combined with Ivosidenib.]
[N03AX17, stiripentol, The metabolism of Fluticasone furoate can be decreased when combined with Stiripentol.]
[J05AG06, doravirine, The metabolism of Doravirine can be decreased when combined with Fluticasone furoate.]
[L01EM04, duvelisib, The metabolism of Duvelisib can be increased when combined with Fluticasone furoate.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be increased when combined with Fluticasone furoate.]
[A10BB06, carbutamide, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Carbutamide.]
[M01AC05, lornoxicam, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Lornoxicam.]
[R03BB08, revefenacin, Fluticasone furoate may decrease the excretion rate of Revefenacin which could result in a higher serum level.]
[L01ED05, lorlatinib, The metabolism of Lorlatinib can be decreased when combined with Fluticasone furoate.]
[L04AA39, emapalumab, The metabolism of Fluticasone furoate can be increased when combined with Emapalumab.]
[L01AD01, carmustine, The risk or severity of adverse effects can be increased when Carmustine is combined with Fluticasone furoate.]
[L01EX13, gilteritinib, The metabolism of Gilteritinib can be increased when combined with Fluticasone furoate.]
[L01XJ03, glasdegib, The metabolism of Glasdegib can be decreased when combined with Fluticasone furoate.]
[L04AA43, ravulizumab, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Ravulizumab.]
[A06AX05, prucalopride, The metabolism of Prucalopride can be decreased when combined with Fluticasone furoate.]
[B01AC23, cilostazol, The metabolism of Cilostazol can be decreased when combined with Fluticasone furoate.]
[L04AA42, siponimod, The metabolism of Siponimod can be increased when combined with Fluticasone furoate.]
[J01FA09, clarithromycin, The metabolism of Fluticasone furoate can be decreased when combined with Clarithromycin.]
[L01EN01, erdafitinib, The metabolism of Erdafitinib can be increased when combined with Fluticasone furoate.]
[H02AB14, cloprednol, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Cloprednol.]
[L04AB01, etanercept, The metabolism of Fluticasone furoate can be increased when combined with Etanercept.]
[H02AB17, cortivazol, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Cortivazol.]
[L04AC18, risankizumab, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Risankizumab.]
[L01EM03, alpelisib, The metabolism of Alpelisib can be increased when combined with Fluticasone furoate.]
[L01EX15, pexidartinib, The metabolism of Pexidartinib can be increased when combined with Fluticasone furoate.]
[L04AA44, upadacitinib, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Upadacitinib.]
[L01EX14, entrectinib, The metabolism of Entrectinib can be increased when combined with Fluticasone furoate.]
[N07XX11, pitolisant, The serum concentration of Fluticasone furoate can be decreased when it is combined with Pitolisant.]
[J04AK08, pretomanid, The metabolism of Pretomanid can be increased when combined with Fluticasone furoate.]
[J01XX12, lefamulin, The metabolism of Lefamulin can be increased when combined with Fluticasone furoate.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be decreased when combined with Fluticasone furoate.]
[C03AA09, cyclothiazide, The risk or severity of electrolyte imbalance can be increased when Fluticasone furoate is combined with Cyclothiazide.]
[A10AE03, insulin, regular, pork, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Insulin pork.]
[J01DB01, cephalexin, The metabolism of Cephalexin can be increased when combined with Fluticasone furoate.]
[H02AB13, deflazacort, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Deflazacort.]
[G03DB05, demegestone, The serum concentration of Fluticasone furoate can be increased when it is combined with Demegestone.]
[L01FD01, trastuzumab, Trastuzumab may increase the neutropenic activities of Fluticasone furoate.]
[L01FD03, ado-trastuzumab emtansine, The metabolism of Trastuzumab emtansine can be increased when combined with Fluticasone furoate.]
[L04AX09, diroximel fumarate, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Diroximel fumarate.]
[L01EL03, zanubrutinib, The metabolism of Zanubrutinib can be increased when combined with Fluticasone furoate.]
[G03AC09, desogestrel, The serum concentration of Fluticasone furoate can be increased when it is combined with Desogestrel.]
[B06AX03, voxelotor, The serum concentration of Voxelotor can be increased when it is combined with Fluticasone furoate.]
[N03AX25, cenobamate, The serum concentration of Fluticasone furoate can be decreased when it is combined with Cenobamate.]
[S01XA12, dexpanthenol, The therapeutic efficacy of Dexpanthenol can be decreased when used in combination with Fluticasone furoate.]
[N05CM21, lemborexant, The metabolism of Lemborexant can be decreased when combined with Fluticasone furoate.]
[L01XX72, tazemetostat, The metabolism of Tazemetostat can be increased when combined with Fluticasone furoate.]
[L04AA53, teprotumumab, The risk or severity of adverse effects can be increased when Teprotumumab is combined with Fluticasone furoate.]
[S01AE06, gatifloxacin, The risk or severity of tendinopathy can be increased when Fluticasone furoate is combined with Gatifloxacin.]
[H02CA02, osilodrostat, The metabolism of Fluticasone furoate can be decreased when combined with Osilodrostat.]
[J05AE05, amprenavir, The metabolism of Fluticasone furoate can be decreased when combined with Amprenavir.]
[G04CB02, dutasteride, The metabolism of Dutasteride can be decreased when combined with Fluticasone furoate.]
[L04AA38, ozanimod, The metabolism of Ozanimod can be decreased when combined with Fluticasone furoate.]
[L01EE04, selumetinib, The metabolism of Selumetinib can be decreased when combined with Fluticasone furoate.]
[G03DB08, dienogest, The serum concentration of Fluticasone furoate can be increased when it is combined with Dienogest.]
[M01AH02, rofecoxib, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Rofecoxib.]
[L01XF03, bexarotene, The risk or severity of adverse effects can be increased when Bexarotene is combined with Fluticasone furoate.]
[C01BD07, dronedarone, The metabolism of Dronedarone can be increased when combined with Fluticasone furoate.]
[L01AA02, chlorambucil, The risk or severity of adverse effects can be increased when Chlorambucil is combined with Fluticasone furoate.]
[S03AA08, chloramphenicol, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Fluticasone furoate.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Fluticasone furoate.]
[D07XB03, fluprednidene, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Fluprednidene.]
[M01AC04, droxicam, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Droxicam.]
[M02AA27, dexketoprofen, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Dexketoprofen.]
[L04AA47, inebilizumab, The risk or severity of infection can be increased when Fluticasone furoate is combined with Inebilizumab.]
[R05CB11, stepronin, The risk or severity of adverse effects can be increased when Stepronin is combined with Fluticasone furoate.]
[C08CA17, levamlodipine, The serum concentration of Levamlodipine can be increased when it is combined with Fluticasone furoate.]
[R06AX22, ebastine, The metabolism of Ebastine can be increased when combined with Fluticasone furoate.]
[L01FX15, belantamab mafodotin, The excretion of Belantamab mafodotin can be decreased when combined with Fluticasone furoate.]
[L04AC19, satralizumab, The serum concentration of Fluticasone furoate can be decreased when it is combined with Satralizumab.]
[P01BA01, chloroquine, The metabolism of Chloroquine can be decreased when combined with Fluticasone furoate.]
[L01EX23, pralsetinib, The metabolism of Fluticasone furoate can be decreased when combined with Pralsetinib.]
[C03AA04, chlorothiazide, The risk or severity of electrolyte imbalance can be increased when Fluticasone furoate is combined with Chlorothiazide.]
[R06AB04, chlorpheniramine, The metabolism of Chlorpheniramine can be decreased when combined with Fluticasone furoate.]
[N05AA01, chlorpromazine, The therapeutic efficacy of Chlorpromazine can be decreased when used in combination with Fluticasone furoate.]
[A10BB02, chlorpropamide, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Chlorpropamide.]
[C03BA04, chlorthalidone, Fluticasone furoate may increase the hypokalemic activities of Chlorthalidone.]
[A11CC05, cholecalciferol, The therapeutic efficacy of Cholecalciferol can be decreased when used in combination with Fluticasone furoate.]
[V04CK02, cholecystokinin, The excretion of Cholecystokinin can be decreased when combined with Fluticasone furoate.]
[N02BA07, ethenzamide, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Ethenzamide.]
[C10AC01, cholestyramine resin, Cholestyramine may increase the excretion rate of Fluticasone furoate which could result in a lower serum level and potentially a reduction in efficacy.]
[G03DC06, ethynodiol, The serum concentration of Fluticasone furoate can be increased when it is combined with Etynodiol.]
[M01AB08, etodolac, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Etodolac.]
[M02AA06, etofenamate, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Etofenamate.]
[B06AC06, berotralstat, The metabolism of Fluticasone furoate can be decreased when combined with Berotralstat.]
[A16AX20, lonafarnib, The metabolism of Fluticasone furoate can be decreased when combined with Lonafarnib.]
[L01BB05, fludarabine, The risk or severity of adverse effects can be increased when Fludarabine is combined with Fluticasone furoate.]
[L02BX04, relugolix, The metabolism of Relugolix can be decreased when combined with Fluticasone furoate.]
[L04AD03, voclosporin, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Voclosporin.]
[P03AX07, abametapir, The serum concentration of Fluticasone furoate can be increased when it is combined with Abametapir.]
[M01AE05, fenbufen, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Fenbufen.]
[G04CB01, finasteride, The metabolism of Finasteride can be decreased when combined with Fluticasone furoate.]
[J01MB07, flumequine, The risk or severity of tendinopathy can be increased when Fluticasone furoate is combined with Flumequine.]
[R03BA03, flunisolide, The risk or severity of adverse effects can be increased when Flunisolide is combined with Fluticasone furoate.]
[S02BA08, fluocinolone acetonide, The risk or severity of adverse effects can be increased when Fluocinolone acetonide is combined with Fluticasone furoate.]
[R03CC15, formoterol, The risk or severity of hypokalemia can be increased when Fluticasone furoate is combined with Formoterol.]
[A10AF01, insulin, regular, human, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Insulin human.]
[L04AA50, ponesimod, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Ponesimod.]
[L03AB10, peginterferon alfa-2b, The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Fluticasone furoate.]
[A02BA01, cimetidine, The metabolism of Fluticasone furoate can be decreased when combined with Cimetidine.]
[J01MB06, cinoxacin, The risk or severity of tendinopathy can be increased when Fluticasone furoate is combined with Cinoxacin.]
[L01XX73, sotorasib, The serum concentration of Fluticasone furoate can be decreased when it is combined with Sotorasib.]
[L01EN03, infigratinib, The metabolism of Infigratinib can be increased when combined with Fluticasone furoate.]
[S03AA07, ciprofloxacin, The risk or severity of tendinopathy can be increased when Fluticasone furoate is combined with Ciprofloxacin.]
[L01XA01, cisplatin, The therapeutic efficacy of Cisplatin can be decreased when used in combination with Fluticasone furoate.]
[L04AA54, pegcetacoplan, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Pegcetacoplan.]
[H01AC07, somapacitan, The serum concentration of the active metabolites of Fluticasone furoate can be decreased when Fluticasone furoate is used in combination with Somapacitan.]
[C03DA05, finerenone, The serum concentration of Finerenone can be increased when it is combined with Fluticasone furoate.]
[L04AA48, belumosudil, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Belumosudil.]
[P01CA03, fexinidazole, The metabolism of Fexinidazole can be decreased when combined with Fluticasone furoate.]
[L04AA51, anifrolumab, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Anifrolumab.]
[H01AC09, lonapegsomatropin, The serum concentration of the active metabolites of Fluticasone furoate can be decreased when Fluticasone furoate is used in combination with Lonapegsomatropin.]
[L01EB10, mobocertinib, The metabolism of Mobocertinib can be decreased when combined with Fluticasone furoate.]
[N02CD07, atogepant, The serum concentration of Atogepant can be increased when it is combined with Fluticasone furoate.]
[M01AG01, mefenamic acid, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Mefenamic acid.]
[A10BB12, glimepiride, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Glimepiride.]
[A10BB08, gliquidone, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Gliquidone.]
[R03CC13, clenbuterol, The risk or severity of hypokalemia can be increased when Fluticasone furoate is combined with Clenbuterol.]
[J01FF01, clindamycin, The metabolism of Clindamycin can be decreased when combined with Fluticasone furoate.]
[N06AX25, St. John's wort extract, The metabolism of Fluticasone furoate can be increased when combined with St. John's Wort.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Ropeginterferon alfa-2b.]
[J04BA01, clofazimine, The metabolism of Fluticasone furoate can be decreased when combined with Clofazimine.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be increased when combined with Fluticasone furoate.]
[S01EA04, clonidine, The metabolism of Clonidine can be increased when combined with Fluticasone furoate.]
[J05AB17, brincidofovir, The serum concentration of Brincidofovir can be increased when it is combined with Fluticasone furoate.]
[C01EB24, mavacamten, The serum concentration of Fluticasone furoate can be decreased when it is combined with Mavacamten.]
[A10BX16, tirzepatide, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Tirzepatide.]
[A02BC08, vonoprazan, The metabolism of Vonoprazan can be decreased when combined with Fluticasone furoate.]
[L04AC22, spesolimab, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Spesolimab.]
[L04AA56, deucravacitinib, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Deucravacitinib.]
[A04AA01, ondansetron, The metabolism of Ondansetron can be decreased when combined with Fluticasone furoate.]
[N05AH02, clozapine, The metabolism of Fluticasone furoate can be decreased when combined with Clozapine.]
[A10BX01, guar gum, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Guar gum.]
[A10BK06, sotagliflozin, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Sotagliflozin.]
[H01AC08, somatrogon, The serum concentration of the active metabolites of Fluticasone furoate can be reduced when Fluticasone furoate is used in combination with Somatrogon resulting in a loss in efficacy.]
[L04AC21, bimekizumab, The metabolism of Fluticasone furoate can be increased when combined with Bimekizumab.]
[M01AX13, proquazone, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Proquazone.]
[M03AC05, hexafluorenium, The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Fluticasone furoate.]
[M04AC01, colchicine, The metabolism of Colchicine can be decreased when combined with Fluticasone furoate.]
[L04AA13, leflunomide, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Leflunomide.]
[A02AD04, hydrotalcite, The bioavailability of Fluticasone furoate can be decreased when combined with Hydrotalcite.]
[A10BX03, nateglinide, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Nateglinide.]
[N02BA16, imidazole-2-hydroxybenzoate, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Imidazole salicylate.]
[H01AC03, mecasermin, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Mecasermin.]
[L01BB07, nelarabine, The risk or severity of adverse effects can be increased when Nelarabine is combined with Fluticasone furoate.]
[A10AE04, insulin glargine, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Insulin glargine.]
[J01FA15, telithromycin, The metabolism of Fluticasone furoate can be decreased when combined with Telithromycin.]
[R03BA08, ciclesonide, The risk or severity of adverse effects can be increased when Ciclesonide is combined with Fluticasone furoate.]
[B01AC10, indobufen, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Indobufen.]
[M01AH03, valdecoxib, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Valdecoxib.]
[H01AX01, pegvisomant, The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Fluticasone furoate.]
[C01AA06, lanatoside C, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Lanatoside C.]
[N02CC05, almotriptan, The metabolism of Almotriptan can be decreased when combined with Fluticasone furoate.]
[M01AH04, parecoxib, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Parecoxib.]
[J02AC02, itraconazole, The metabolism of Fluticasone furoate can be decreased when combined with Itraconazole.]
[M01AA06, kebuzone, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Kebuzone.]
[L01EA01, imatinib, The risk or severity of adverse effects can be increased when Imatinib is combined with Fluticasone furoate.]
[J02AC04, posaconazole, The metabolism of Fluticasone furoate can be decreased when combined with Posaconazole.]
[S01BA03, cortisone, The metabolism of Fluticasone furoate can be increased when combined with Cortisone.]
[S01AE04, lomefloxacin, The risk or severity of tendinopathy can be increased when Fluticasone furoate is combined with Lomefloxacin.]
[M01AB09, lonazolac, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Lonazolac.]
[M02AA31, loxoprofen, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Loxoprofen.]
[A02AD02, magaldrate, The bioavailability of Fluticasone furoate can be decreased when combined with Magaldrate.]
[A06AD01, magnesium carbonate, The bioavailability of Fluticasone furoate can be decreased when combined with Magnesium carbonate.]
[H02AB15, meprednisone, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Meprednisone.]
[C03DA04, eplerenone, The metabolism of Eplerenone can be decreased when combined with Fluticasone furoate.]
[L04AA15, alefacept, The risk or severity of adverse effects can be increased when Alefacept is combined with Fluticasone furoate.]
[C03AA07, cyclopenthiazide, The risk or severity of electrolyte imbalance can be increased when Fluticasone furoate is combined with Cyclopenthiazide.]
[A10BF02, miglitol, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Miglitol.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be increased when combined with Fluticasone furoate.]
[N06AX07, minaprine, The therapeutic efficacy of Minaprine can be decreased when used in combination with Fluticasone furoate.]
[S01XA18, cyclosporine, Fluticasone furoate may increase the immunosuppressive activities of Cyclosporine.]
[N06BA07, modafinil, The metabolism of Modafinil can be decreased when combined with Fluticasone furoate.]
[C10AA07, rosuvastatin, The metabolism of Rosuvastatin can be increased when combined with Fluticasone furoate.]
[M02AA02, mofebutazone, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Mofebutazone.]
[M01AX22, morniflumate, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Morniflumate.]
[C03XA02, conivaptan, The metabolism of Fluticasone furoate can be decreased when combined with Conivaptan.]
[L01BC01, cytarabine, The risk or severity of adverse effects can be increased when Cytarabine is combined with Fluticasone furoate.]
[G04BE09, vardenafil, The metabolism of Vardenafil can be decreased when combined with Fluticasone furoate.]
[M01AH05, etoricoxib, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Etoricoxib.]
[L01AX04, dacarbazine, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Fluticasone furoate.]
[L01DA01, dactinomycin, The risk or severity of adverse effects can be increased when Dactinomycin is combined with Fluticasone furoate.]
[G03XA01, danazol, The metabolism of Fluticasone furoate can be decreased when combined with Danazol.]
[M03CA01, dantrolene, The therapeutic efficacy of Dantrolene can be increased when used in combination with Fluticasone furoate.]
[J04BA02, dapsone, The metabolism of Dapsone can be decreased when combined with Fluticasone furoate.]
[L01DB02, daunorubicin, The risk or severity of adverse effects can be increased when Daunorubicin is combined with Fluticasone furoate.]
[M01AX01, nabumetone, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Nabumetone.]
[N06AX06, nefazodone, The metabolism of Fluticasone furoate can be decreased when combined with Nefazodone.]
[C01DX16, nicorandil, The risk or severity of ulceration can be increased when Fluticasone furoate is combined with Nicorandil.]
[G03DB04, nomegestrol, The serum concentration of Fluticasone furoate can be increased when it is combined with Nomegestrol.]
[M03AC11, cisatracurium, The risk or severity of myopathy and weakness can be increased when Cisatracurium is combined with Fluticasone furoate.]
[D11AH02, pimecrolimus, The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Fluticasone furoate.]
[A07EC03, olsalazine, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Olsalazine.]
[C01AA07, deslanoside, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Deslanoside.]
[D07XC02, desoximetasone, The risk or severity of adverse effects can be increased when Desoximetasone is combined with Fluticasone furoate.]
[L01XA03, oxaliplatin, The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Fluticasone furoate.]
[M01AE12, oxaprozin, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Oxaprozin.]
[N03AF02, oxcarbazepine, The metabolism of Fluticasone furoate can be increased when combined with Oxcarbazepine.]
[S03BA01, dexamethasone, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Fluticasone furoate.]
[G04BD04, oxybutynin, The metabolism of Oxybutynin can be decreased when combined with Fluticasone furoate.]
[L04AB04, adalimumab, The metabolism of Fluticasone furoate can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, The metabolism of Gefitinib can be decreased when combined with Fluticasone furoate.]
[R05DA09, dextromethorphan, The metabolism of Dextromethorphan can be decreased when combined with Fluticasone furoate.]
[N03AC01, paramethadione, The metabolism of Paramethadione can be decreased when combined with Fluticasone furoate.]
[B01AC04, clopidogrel, The metabolism of Clopidogrel can be decreased when combined with Fluticasone furoate.]
[N05BA01, diazepam, The metabolism of Diazepam can be decreased when combined with Fluticasone furoate.]
[S02DA04, dibucaine, The therapeutic efficacy of Cinchocaine can be decreased when used in combination with Fluticasone furoate.]
[S01BC03, diclofenac, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Diclofenac.]
[A10BG03, pioglitazone, The serum concentration of Pioglitazone can be increased when it is combined with Fluticasone furoate.]
[L01DC04, ixabepilone, The metabolism of Ixabepilone can be increased when combined with Fluticasone furoate.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be increased when combined with Fluticasone furoate.]
[L01DB08, pirarubicin, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Pirarubicin.]
[R03CC07, pirbuterol, The risk or severity of hypokalemia can be increased when Fluticasone furoate is combined with Pirbuterol.]
[C03CA03, piretanide, The risk or severity of hypokalemia can be increased when Fluticasone furoate is combined with Piretanide.]
[P02CB02, diethylcarbamazine, The therapeutic efficacy of Diethylcarbamazine can be decreased when used in combination with Fluticasone furoate.]
[L02AA01, diethylstilbestrol, The serum concentration of Fluticasone furoate can be increased when it is combined with Diethylstilbestrol.]
[C08CA03, isradipine, The metabolism of Fluticasone furoate can be decreased when combined with Isradipine.]
[D07XC04, diflucortolone, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Difluocortolone.]
[N02BA11, diflunisal, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Diflunisal.]
[C01AA04, digitoxin, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Digitoxin.]
[C01AA05, digoxin, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Digoxin.]
[C10AX09, ezetimibe, The excretion of Ezetimibe can be decreased when combined with Fluticasone furoate.]
[L01XX24, pegaspargase, The risk or severity of adverse effects can be increased when Pegaspargase is combined with Fluticasone furoate.]
[C04AE04, dihydroergocristine, The metabolism of Dihydroergocristine can be increased when combined with Fluticasone furoate.]
[N02CA01, dihydroergotamine, The metabolism of Dihydroergotamine can be increased when combined with Fluticasone furoate.]
[L04AX04, lenalidomide, The risk or severity of adverse effects can be increased when Lenalidomide is combined with Fluticasone furoate.]
[A11CC02, dihydrotachysterol, The therapeutic efficacy of Dihydrotachysterol can be decreased when used in combination with Fluticasone furoate.]
[J05AE08, atazanavir, The metabolism of Fluticasone furoate can be decreased when combined with Atazanavir.]
[B01AC21, treprostinil, The serum concentration of Treprostinil can be increased when it is combined with Fluticasone furoate.]
[C08DB01, diltiazem, The metabolism of Diltiazem can be decreased when combined with Fluticasone furoate.]
[R03CC08, procaterol, The risk or severity of hypokalemia can be increased when Fluticasone furoate is combined with Procaterol.]
[N02BB04, propyphenazone, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Propyphenazone.]
[M01AB14, proglumetacin, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Proglumetacin.]
[G02AD02, dinoprostone, The excretion of Dinoprostone can be decreased when combined with Fluticasone furoate.]
[A03FA02, cisapride, The metabolism of Cisapride can be decreased when combined with Fluticasone furoate.]
[S01XA23, sirolimus, The metabolism of Sirolimus can be increased when combined with Fluticasone furoate.]
[C01BA03, disopyramide, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Disopyramide.]
[L04AA23, natalizumab, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Natalizumab.]
[N07AA03, distigmine, The therapeutic efficacy of Distigmine can be decreased when used in combination with Fluticasone furoate.]
[P03AA04, disulfiram, The metabolism of Disulfiram can be decreased when combined with Fluticasone furoate.]
[S02AA12, rifamycin SV, The metabolism of Fluticasone furoate can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Fluticasone furoate can be increased when combined with Rifapentine.]
[N05AX08, risperidone, The metabolism of Risperidone can be decreased when combined with Fluticasone furoate.]
[L04AA21, efalizumab, The risk or severity of adverse effects can be increased when Efalizumab is combined with Fluticasone furoate.]
[J01MB01, rosoxacin, The risk or severity of tendinopathy can be increased when Fluticasone furoate is combined with Rosoxacin.]
[L01EX01, sunitinib, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Sunitinib.]
[A04AD12, aprepitant, The metabolism of Fluticasone furoate can be decreased when combined with Aprepitant.]
[C03XA01, tolvaptan, The metabolism of Tolvaptan can be increased when combined with Fluticasone furoate.]
[L01XG01, bortezomib, The metabolism of Bortezomib can be increased when combined with Fluticasone furoate.]
[G04BE08, tadalafil, The metabolism of Tadalafil can be decreased when combined with Fluticasone furoate.]
[S01BC05, ketorolac, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Ketorolac.]
[C02KX02, ambrisentan, The metabolism of Ambrisentan can be decreased when combined with Fluticasone furoate.]
[N02BA06, salsalate, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Salsalate.]
[R03AC12, salmeterol, The risk or severity of hypokalemia can be increased when Fluticasone furoate is combined with Salmeterol.]
[C01CA07, dobutamine, The risk or severity of hypokalemia can be increased when Fluticasone furoate is combined with Dobutamine.]
[A03FA03, domperidone, The metabolism of Domperidone can be decreased when combined with Fluticasone furoate.]
[L01DB01, doxorubicin, The metabolism of Doxorubicin can be increased when combined with Fluticasone furoate.]
[C10AA01, simvastatin, The metabolism of Simvastatin can be decreased when combined with Fluticasone furoate.]
[B05XA02, sodium bicarbonate, The bioavailability of Fluticasone furoate can be decreased when combined with Sodium bicarbonate.]
[N02CC01, sumatriptan, The excretion of Sumatriptan can be decreased when combined with Fluticasone furoate.]
[V04CX07, edrophonium, The therapeutic efficacy of Edrophonium can be decreased when used in combination with Fluticasone furoate.]
[H01AA01, corticotropin, The risk or severity of adverse effects can be increased when Corticotropin is combined with Fluticasone furoate.]
[J01MA05, temafloxacin, The risk or severity of tendinopathy can be increased when Fluticasone furoate is combined with Temafloxacin.]
[L01AX03, temozolomide, The risk or severity of adverse effects can be increased when Temozolomide is combined with Fluticasone furoate.]
[M01AC02, tenoxicam, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Tenoxicam.]
[D01BA02, terbinafine, The metabolism of Terbinafine can be decreased when combined with Fluticasone furoate.]
[N06AX14, tianeptine, The metabolism of Tianeptine can be increased when combined with Fluticasone furoate.]
[C09AA02, enalapril, The excretion of Enalapril can be decreased when combined with Fluticasone furoate.]
[M01AG02, tolfenamic acid, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Tolfenamic acid.]
[C03CA04, torsemide, The metabolism of Torasemide can be decreased when combined with Fluticasone furoate.]
[H02CA01, trilostane, The risk or severity of edema formation can be increased when Trilostane is combined with Fluticasone furoate.]
[L01AA07, trofosfamide, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Trofosfamide.]
[J01MA04, enoxacin, The risk or severity of tendinopathy can be increased when Fluticasone furoate is combined with Enoxacin.]
[L01CA04, vinorelbine, The metabolism of Vinorelbine can be increased when combined with Fluticasone furoate.]
[S01FB02, ephedrine, Ephedrine may increase the excretion rate of Fluticasone furoate which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CA12, mepirodipine, The metabolism of Fluticasone furoate can be decreased when combined with Barnidipine.]
[S01EA01, epinephrine, The risk or severity of hypokalemia can be increased when Fluticasone furoate is combined with Epinephrine.]
[L01DB03, epirubicin, The risk or severity of adverse effects can be increased when Epirubicin is combined with Fluticasone furoate.]
[N05CF02, zolpidem, The metabolism of Zolpidem can be increased when combined with Fluticasone furoate.]
[M01AB04, zomepirac, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Zomepirac.]
[N03AX15, zonisamide, The metabolism of Zonisamide can be decreased when combined with Fluticasone furoate.]
[A10AB06, insulin glulisine, human, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Insulin glulisine.]
[N05CF01, zopiclone, The metabolism of Zopiclone can be decreased when combined with Fluticasone furoate.]
[L01XA02, carboplatin, The risk or severity of adverse effects can be increased when Carboplatin is combined with Fluticasone furoate.]
[A11CC01, ergocalciferol, The therapeutic efficacy of Ergocalciferol can be decreased when used in combination with Fluticasone furoate.]
[N02CA02, ergotamine, The metabolism of Fluticasone furoate can be decreased when combined with Ergotamine.]
[S01AA17, erythromycin, The metabolism of Fluticasone furoate can be decreased when combined with Erythromycin.]
[G03CA03, estradiol, The serum concentration of Fluticasone furoate can be increased when it is combined with Estradiol.]
[L01XX11, estramustine, The risk or severity of adverse effects can be increased when Estramustine is combined with Fluticasone furoate.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Fluticasone furoate.]
[L04AA03, lymphocyte immune globulin, anti-thymocyte globulin, equine, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Antilymphocyte immunoglobulin (horse).]
[J01MB04, pipemidic acid, The risk or severity of tendinopathy can be increased when Fluticasone furoate is combined with Pipemidic acid.]
[R03BA09, fluticasone furoate, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Fluticasone.]
[J01MB02, nalidixic acid, The risk or severity of tendinopathy can be increased when Fluticasone furoate is combined with Nalidixic acid.]
[N02AA01, morphine, The metabolism of Morphine can be decreased when combined with Fluticasone furoate.]
[L04AB05, certolizumab pegol, The metabolism of Fluticasone furoate can be increased when combined with Certolizumab pegol.]
[B02BX05, eltrombopag, The metabolism of Eltrombopag can be decreased when combined with Fluticasone furoate.]
[L04AA52, ofatumumab, The risk or severity of adverse effects can be increased when Ofatumumab is combined with Fluticasone furoate.]
[L01EX03, pazopanib, The metabolism of Pazopanib can be increased when combined with Fluticasone furoate.]
[L04AA06, mycophenolic acid, The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Fluticasone furoate.]
[M03AC03, vecuronium, The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Fluticasone furoate.]
[P01BA06, amodiaquine, The metabolism of Amodiaquine can be decreased when combined with Fluticasone furoate.]
[G03XC01, raloxifene, The excretion of Raloxifene can be decreased when combined with Fluticasone furoate.]
[N03AB05, fosphenytoin, The serum concentration of Fluticasone furoate can be decreased when it is combined with Fosphenytoin.]
[L03AB08, interferon beta-1b, The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Fluticasone furoate.]
[V03AB15, naloxone, The metabolism of Fluticasone furoate can be decreased when combined with Naloxone.]
[L04AC03, anakinra, The metabolism of Fluticasone furoate can be increased when combined with Anakinra.]
[S01XA11, nandrolone, The risk or severity of edema formation can be increased when Nandrolone phenpropionate is combined with Fluticasone furoate.]
[M02AA12, naproxen, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Naproxen.]
[A10BG01, troglitazone, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Troglitazone.]
[L01CD02, docetaxel, The metabolism of Docetaxel can be increased when combined with Fluticasone furoate.]
[A10BX02, repaglinide, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Repaglinide.]
[S01EB06, neostigmine, The therapeutic efficacy of Neostigmine can be decreased when used in combination with Fluticasone furoate.]
[N05AX14, iloperidone, The metabolism of Iloperidone can be decreased when combined with Fluticasone furoate.]
[J02AA01, amphotericin B, The risk or severity of hypokalemia can be increased when Fluticasone furoate is combined with Amphotericin B.]
[N06AX23, desvenlafaxine, The metabolism of Fluticasone furoate can be decreased when combined with Desvenlafaxine.]
[H05BX02, paricalcitol, The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Fluticasone furoate.]
[L01XX01, amsacrine, The risk or severity of adverse effects can be increased when Amsacrine is combined with Fluticasone furoate.]
[C08CA04, nicardipine, The metabolism of Nicardipine can be decreased when combined with Fluticasone furoate.]
[C08CA05, nifedipine, The metabolism of Nifedipine can be decreased when combined with Fluticasone furoate.]
[M02AA17, niflumic acid, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Niflumic acid.]
[C08CA07, nisoldipine, The metabolism of Nisoldipine can be decreased when combined with Fluticasone furoate.]
[C08CA08, nitrendipine, The metabolism of Nitrendipine can be decreased when combined with Fluticasone furoate.]
[J01XE01, nitrofurantoin, The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Fluticasone furoate.]
[N05CF03, zaleplon, The metabolism of Zaleplon can be decreased when combined with Fluticasone furoate.]
[C01CA03, norepinephrine, The risk or severity of hypokalemia can be increased when Fluticasone furoate is combined with Norepinephrine.]
[G03DC02, norethindrone, The serum concentration of Fluticasone furoate can be increased when it is combined with Norethisterone.]
[S01AE02, norfloxacin, The risk or severity of tendinopathy can be increased when Fluticasone furoate is combined with Norfloxacin.]
[G03AC07, norgestrienone, The serum concentration of Fluticasone furoate can be increased when it is combined with Norgestrienone.]
[C02KX01, bosentan, The excretion of Bosentan can be decreased when combined with Fluticasone furoate.]
[N06AA10, nortriptyline, The metabolism of Nortriptyline can be increased when combined with Fluticasone furoate.]
[S02AA16, ofloxacin, The risk or severity of tendinopathy can be increased when Fluticasone furoate is combined with Ofloxacin.]
[L04AC04, rilonacept, The metabolism of Fluticasone furoate can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Omeprazole can be decreased when combined with Fluticasone furoate.]
[R03CB03, metaproterenol, The risk or severity of hypokalemia can be increased when Fluticasone furoate is combined with Orciprenaline.]
[C01AC01, ouabain, The excretion of Ouabain can be decreased when combined with Fluticasone furoate.]
[A14AA08, oxandrolone, The risk or severity of fluid retention can be increased when Fluticasone furoate is combined with Oxandrolone.]
[J01MB05, oxolinic acid, The risk or severity of tendinopathy can be increased when Fluticasone furoate is combined with Oxolinic acid.]
[N02AA05, oxycodone, The metabolism of Oxycodone can be decreased when combined with Fluticasone furoate.]
[S01GA04, oxymetazoline, The absorption of Fluticasone furoate can be decreased when combined with Oxymetazoline.]
[A14AA05, oxymetholone, The risk or severity of fluid retention can be increased when Fluticasone furoate is combined with Oxymetholone.]
[S01BC02, oxyphenbutazone, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Oxyphenbutazone.]
[M03AC01, pancuronium, The therapeutic efficacy of Pancuronium can be decreased when used in combination with Fluticasone furoate.]
[G03DB06, chlormadinone, The serum concentration of Fluticasone furoate can be increased when it is combined with Chlormadinone.]
[H02AB05, paramethasone, The risk or severity of adverse effects can be increased when Paramethasone is combined with Fluticasone furoate.]
[J01MA03, pefloxacin, The risk or severity of tendinopathy can be increased when Fluticasone furoate is combined with Pefloxacin.]
[M01CC01, penicillamine, The risk or severity of adverse effects can be increased when Penicillamine is combined with Fluticasone furoate.]
[S01AA14, penicillin G, The excretion of Benzylpenicillin can be decreased when combined with Fluticasone furoate.]
[J07AF01, diphtheria toxoid vaccine, inactivated, The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Fluticasone furoate.]
[J07AM01, tetanus toxoid vaccine, inactivated, The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Fluticasone furoate.]
[N05CA01, pentobarbital, The metabolism of Fluticasone furoate can be increased when combined with Pentobarbital.]
[L01XX08, pentostatin, The risk or severity of adverse effects can be increased when Pentostatin is combined with Fluticasone furoate.]
[J07AJ, pertussis vaccine, The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Fluticasone furoate.]
[A10BA01, phenformin, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Phenformin.]
[B01AA02, phenindione, Fluticasone furoate may increase the anticoagulant activities of Phenindione.]
[N03AA02, phenobarbital, The metabolism of Fluticasone furoate can be increased when combined with Phenobarbital.]
[B01AA04, phenprocoumon, Fluticasone furoate may increase the anticoagulant activities of Phenprocoumon.]
[M02AA01, phenylbutazone, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Phenylbutazone.]
[S01GA05, phenylephrine, The risk or severity of hypertension can be increased when Fluticasone furoate is combined with Phenylephrine.]
[R01BA01, phenylpropanolamine, The risk or severity of hypokalemia can be increased when Fluticasone furoate is combined with Phenylpropanolamine.]
[N03AB02, phenytoin, The serum concentration of Fluticasone furoate can be decreased when it is combined with Phenytoin.]
[L04AB06, golimumab, The metabolism of Fluticasone furoate can be increased when combined with Golimumab.]
[S01AE05, levofloxacin, The risk or severity of tendinopathy can be increased when Fluticasone furoate is combined with Levofloxacin.]
[V03AB19, physostigmine, The therapeutic efficacy of Physostigmine can be decreased when used in combination with Fluticasone furoate.]
[L02BB03, bicalutamide, The metabolism of Bicalutamide can be increased when combined with Fluticasone furoate.]
[C08CX01, mibefradil, The metabolism of Fluticasone furoate can be decreased when combined with Mibefradil.]
[N05AG02, pimozide, The metabolism of Pimozide can be increased when combined with Fluticasone furoate.]
[C10AA05, atorvastatin, The metabolism of Atorvastatin can be decreased when combined with Fluticasone furoate.]
[J05AE01, saquinavir, The metabolism of Fluticasone furoate can be decreased when combined with Saquinavir.]
[S01BC06, piroxicam, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Piroxicam.]
[J01MA11, grepafloxacin, The risk or severity of tendinopathy can be increased when Fluticasone furoate is combined with Grepafloxacin.]
[J05AG02, delavirdine, The metabolism of Fluticasone furoate can be decreased when combined with Delavirdine.]
[C09CA04, irbesartan, The metabolism of Irbesartan can be decreased when combined with Fluticasone furoate.]
[D05AX05, tazarotene, The metabolism of Tazarotene can be decreased when combined with Fluticasone furoate.]
[A10BG02, rosiglitazone, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Rosiglitazone.]
[L02BG03, anastrozole, The metabolism of Anastrozole can be decreased when combined with Fluticasone furoate.]
[L04AC08, canakinumab, The metabolism of Fluticasone furoate can be increased when combined with Canakinumab.]
[C03AA05, polythiazide, The risk or severity of electrolyte imbalance can be increased when Fluticasone furoate is combined with Polythiazide.]
[J05AE03, ritonavir, The serum concentration of Fluticasone furoate can be increased when it is combined with Ritonavir.]
[A10BH03, saxagliptin, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Saxagliptin.]
[A10AD04, insulin lispro, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Insulin lispro.]
[C10AA08, pitavastatin, The metabolism of Pitavastatin can be decreased when combined with Fluticasone furoate.]
[P02BA01, praziquantel, The metabolism of Praziquantel can be decreased when combined with Fluticasone furoate.]
[S03BA02, prednisolone, The risk or severity of adverse effects can be increased when Prednisolone is combined with Fluticasone furoate.]
[H02AB07, prednisone, The risk or severity of adverse effects can be increased when Prednisone is combined with Fluticasone furoate.]
[P01BA03, primaquine, The metabolism of Fluticasone furoate can be decreased when combined with Primaquine.]
[N03AA03, primidone, The metabolism of Fluticasone furoate can be increased when combined with Primidone.]
[C01BA02, procainamide, The therapeutic efficacy of Procainamide can be decreased when used in combination with Fluticasone furoate.]
[S01HA05, procaine, The therapeutic efficacy of Procaine can be decreased when used in combination with Fluticasone furoate.]
[L01XB01, procarbazine, The risk or severity of adverse effects can be increased when Procarbazine is combined with Fluticasone furoate.]
[C10AB05, fenofibrate, The metabolism of Fenofibrate can be increased when combined with Fluticasone furoate.]
[G03DA04, progesterone, The serum concentration of Fluticasone furoate can be increased when it is combined with Progesterone.]
[R06AX26, fexofenadine, The excretion of Fexofenadine can be decreased when combined with Fluticasone furoate.]
[L01XH02, romidepsin, The metabolism of Romidepsin can be increased when combined with Fluticasone furoate.]
[N01AX10, propofol, The metabolism of Propofol can be decreased when combined with Fluticasone furoate.]
[C07AA05, propranolol, The metabolism of Propranolol can be decreased when combined with Fluticasone furoate.]
[H03BA02, propylthiouracil, The risk or severity of adverse effects can be increased when Propylthiouracil is combined with Fluticasone furoate.]
[R03DC03, montelukast, The metabolism of Montelukast can be decreased when combined with Fluticasone furoate.]
[N05AX12, aripiprazole, The metabolism of Aripiprazole can be decreased when combined with Fluticasone furoate.]
[P02CC01, pyrantel, The risk or severity of myopathy and weakness can be increased when Pyrantel is combined with Fluticasone furoate.]
[J06BB05, rabies immune globulin, human, The therapeutic efficacy of Rabies immune globulin, human can be decreased when used in combination with Fluticasone furoate.]
[N07AA02, pyridostigmine, The therapeutic efficacy of Pyridostigmine can be decreased when used in combination with Fluticasone furoate.]
[P01AX05, quinacrine, The metabolism of Quinacrine can be decreased when combined with Fluticasone furoate.]
[C01BA01, quinidine, The metabolism of Quinidine can be increased when combined with Fluticasone furoate.]
[P01BC01, quinine, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Quinine.]
[C02AA02, reserpine, The metabolism of Fluticasone furoate can be increased when combined with Reserpine.]
[J04AB02, rifampin, The metabolism of Fluticasone furoate can be increased when combined with Rifampicin.]
[G02CA01, ritodrine, The risk or severity of hypokalemia can be increased when Fluticasone furoate is combined with Ritodrine.]
[N02BA05, salicylamide, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Salicylamide.]
[A07EC01, sulfasalazine, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Sulfasalazine.]
[S01BC08, salicylic acid, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Salicylic acid.]
[N04BD01, selegiline, The metabolism of Selegiline can be decreased when combined with Fluticasone furoate.]
[L01FA03, obinutuzumab, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Obinutuzumab.]
[M05BX04, denosumab, The risk or severity of adverse effects can be increased when Denosumab is combined with Fluticasone furoate.]
[L01CD04, cabazitaxel, The metabolism of Cabazitaxel can be increased when combined with Fluticasone furoate.]
[L03AX17, sipuleucel-T, The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Fluticasone furoate.]
[C10AA04, fluvastatin, The metabolism of Fluvastatin can be decreased when combined with Fluticasone furoate.]
[L02AA03, ethinyl estradiol, The serum concentration of Fluticasone furoate can be increased when it is combined with Ethinylestradiol.]
[N04AA05, profenamine, The therapeutic efficacy of Profenamine can be decreased when used in combination with Fluticasone furoate.]
[N03AB01, ethotoin, The therapeutic efficacy of Ethotoin can be increased when used in combination with Fluticasone furoate.]
[M01AC06, meloxicam, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Meloxicam.]
[L01CB01, etoposide, The metabolism of Etoposide can be increased when combined with Fluticasone furoate.]
[L04AD02, tacrolimus, The serum concentration of Tacrolimus can be increased when it is combined with Fluticasone furoate.]
[A02BA04, nizatidine, The therapeutic efficacy of Nizatidine can be decreased when used in combination with Fluticasone furoate.]
[J01MA08, fleroxacin, The risk or severity of tendinopathy can be increased when Fluticasone furoate is combined with Fleroxacin.]
[R06AX11, astemizole, The metabolism of Astemizole can be increased when combined with Fluticasone furoate.]
[R06AX12, terfenadine, The metabolism of Fluticasone furoate can be decreased when combined with Terfenadine.]
[N06AB08, fluvoxamine, The metabolism of Fluticasone furoate can be decreased when combined with Fluvoxamine.]
[L04AA02, muromonab-CD3, The risk or severity of adverse effects can be increased when Muromonab is combined with Fluticasone furoate.]
[C10AA03, pravastatin, The excretion of Pravastatin can be decreased when combined with Fluticasone furoate.]
[V03AF02, dexrazoxane, The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Fluticasone furoate.]
[P02CA03, albendazole, The metabolism of Albendazole can be increased when combined with Fluticasone furoate.]
[C08CA02, felodipine, The metabolism of Felodipine can be decreased when combined with Fluticasone furoate.]
[M01AE04, fenoprofen, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Fenoprofen.]
[R03CC04, fenoterol, The risk or severity of hypokalemia can be increased when Fluticasone furoate is combined with Fenoterol.]
[N02AB03, fentanyl, The metabolism of Fentanyl can be decreased when combined with Fluticasone furoate.]
[R03CC02, albuterol, The risk or severity of hypokalemia can be increased when Fluticasone furoate is combined with Salbutamol.]
[L01BB06, clofarabine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Fluticasone furoate.]
[L04AA40, cladribine, The risk or severity of adverse effects can be increased when Cladribine is combined with Fluticasone furoate.]
[N02BG04, floctafenine, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Floctafenine.]
[J02AC01, fluconazole, The metabolism of Fluticasone furoate can be decreased when combined with Fluconazole.]
[J02AX01, flucytosine, The risk or severity of adverse effects can be increased when Flucytosine is combined with Fluticasone furoate.]
[H02AA02, fludrocortisone, The risk or severity of adverse effects can be increased when Fludrocortisone is combined with Fluticasone furoate.]
[D07AC08, fluocinonide, The risk or severity of adverse effects can be increased when Fluocinonide is combined with Fluticasone furoate.]
[H02AB03, fluocortolone, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Fluocortolone.]
[L01BC09, floxuridine, The risk or severity of adverse effects can be increased when Floxuridine is combined with Fluticasone furoate.]
[S01CB05, fluorometholone, The risk or severity of adverse effects can be increased when Fluorometholone is combined with Fluticasone furoate.]
[L01BC02, fluorouracil, The metabolism of Fluorouracil can be decreased when combined with Fluticasone furoate.]
[G03BA01, fluoxymesterone, The risk or severity of fluid retention can be increased when Fluticasone furoate is combined with Fluoxymesterone.]
[S01BC04, flurbiprofen, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Flurbiprofen.]
[L02BB01, flutamide, The metabolism of Flutamide can be decreased when combined with Fluticasone furoate.]
[L01BC03, tegafur, The metabolism of Tegafur can be decreased when combined with Fluticasone furoate.]
[M03AA01, alcuronium, The risk or severity of myopathy and weakness can be increased when Alcuronium is combined with Fluticasone furoate.]
[J05AE10, darunavir, The metabolism of Fluticasone furoate can be decreased when combined with Darunavir.]
[C03CA01, furosemide, The therapeutic efficacy of Furosemide can be increased when used in combination with Fluticasone furoate.]
[N05CF04, eszopiclone, The metabolism of Eszopiclone can be decreased when combined with Fluticasone furoate.]
[N06DA04, galantamine, The therapeutic efficacy of Galantamine can be decreased when used in combination with Fluticasone furoate.]
[M03AC02, gallamine, The risk or severity of myopathy and weakness can be increased when Gallamine is combined with Fluticasone furoate.]
[L01EA02, dasatinib, The metabolism of Dasatinib can be increased when combined with Fluticasone furoate.]
[N04BC06, cabergoline, The metabolism of Cabergoline can be increased when combined with Fluticasone furoate.]
[A10BJ02, liraglutide, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Liraglutide.]
[G03XA02, gestrinone, The serum concentration of Fluticasone furoate can be increased when it is combined with Gestrinone.]
[N01AH02, alfentanil, The metabolism of Alfentanil can be decreased when combined with Fluticasone furoate.]
[L01EH01, lapatinib, The metabolism of Lapatinib can be decreased when combined with Fluticasone furoate.]
[A10BB01, glyburide, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Glyburide.]
[A10BB09, gliclazide, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Gliclazide.]
[A10BB07, glipizide, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Glipizide.]
[C01BD04, dofetilide, The metabolism of Dofetilide can be increased when combined with Fluticasone furoate.]
[C02CA04, doxazosin, The metabolism of Doxazosin can be increased when combined with Fluticasone furoate.]
[H01AB01, thyrotropin alfa, The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Fluticasone furoate.]
[L01EX02, sorafenib, The metabolism of Sorafenib can be increased when combined with Fluticasone furoate.]
[B01AA12, fluindione, Fluticasone furoate may increase the anticoagulant activities of Fluindione.]
[P01BX01, halofantrine, The metabolism of Halofantrine can be decreased when combined with Fluticasone furoate.]
[N05AD01, haloperidol, The serum concentration of Haloperidol can be increased when it is combined with Fluticasone furoate.]
[N05AH04, quetiapine, The metabolism of Quetiapine can be decreased when combined with Fluticasone furoate.]
[A10AD05, insulin aspart, human, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Insulin aspart.]
[L01CE02, irinotecan, The metabolism of Irinotecan can be increased when combined with Fluticasone furoate.]
[S01XA14, heparin, The therapeutic efficacy of Heparin can be increased when used in combination with Fluticasone furoate.]
[G03DC01, allylestrenol, The metabolism of Allylestrenol can be increased when combined with Fluticasone furoate.]
[A07EC02, mesalamine, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Mesalazine.]
[L01XX03, altretamine, The risk or severity of adverse effects can be increased when Altretamine is combined with Fluticasone furoate.]
[R03CC05, hexoprenaline, The risk or severity of hypokalemia can be increased when Fluticasone furoate is combined with Hexoprenaline.]
[J05AG01, nevirapine, The metabolism of Nevirapine can be decreased when combined with Fluticasone furoate.]
[C08CA10, nilvadipine, The metabolism of Fluticasone furoate can be decreased when combined with Nilvadipine.]
[M02AA26, nimesulide, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Nimesulide.]
[C03AA03, hydrochlorothiazide, The risk or severity of electrolyte imbalance can be increased when Fluticasone furoate is combined with Hydrochlorothiazide.]
[S02BA01, hydrocortisone, The metabolism of Hydrocortisone can be decreased when combined with Fluticasone furoate.]
[D07AB02, hydrocortisone butyrate, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Hydrocortisone butyrate.]
[C03AA02, hydroflumethiazide, The risk or severity of electrolyte imbalance can be increased when Fluticasone furoate is combined with Hydroflumethiazide.]
[P01BA02, hydroxychloroquine, The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Fluticasone furoate.]
[L01XX05, hydroxyurea, The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Fluticasone furoate.]
[N05BB01, hydroxyzine, The metabolism of Hydroxyzine can be decreased when combined with Fluticasone furoate.]
[R02AX02, ibuprofen, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Ibuprofen.]
[L01DB06, idarubicin, The risk or severity of adverse effects can be increased when Idarubicin is combined with Fluticasone furoate.]
[L01AA06, ifosfamide, The metabolism of Ifosfamide can be increased when combined with Fluticasone furoate.]
[N06AA02, imipramine, The metabolism of Fluticasone furoate can be decreased when combined with Imipramine.]
[L01CD01, paclitaxel, The metabolism of Paclitaxel can be increased when combined with Fluticasone furoate.]
[R01AD07, tixocortol, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Tixocortol.]
[L01CE01, topotecan, The risk or severity of adverse effects can be increased when Topotecan is combined with Fluticasone furoate.]
[C03BA11, indapamide, Fluticasone furoate may increase the hypokalemic activities of Indapamide.]
[S01BC01, indomethacin, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Indomethacin.]
[L03AB04, interferon alfa-2a, The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Fluticasone furoate.]
[L03AB05, interferon alfa-2b, The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Fluticasone furoate.]
[N06AX17, milnacipran, The metabolism of Fluticasone furoate can be decreased when combined with Milnacipran.]
[L04AA25, eculizumab, The risk or severity of adverse effects can be increased when Eculizumab is combined with Fluticasone furoate.]
[A10BH01, sitagliptin, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Sitagliptin.]
[N05BA12, alprazolam, The metabolism of Alprazolam can be decreased when combined with Fluticasone furoate.]
[A10BH02, vildagliptin, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Vildagliptin.]
[C10AA06, cerivastatin, The metabolism of Cerivastatin can be decreased when combined with Fluticasone furoate.]
[C03BA02, quinethazone, Fluticasone furoate may increase the hypokalemic activities of Quinethazone.]
[L03AB09, interferon alfacon-1, The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Fluticasone furoate.]
[R03CC06, isoetharine, The risk or severity of hypokalemia can be increased when Fluticasone furoate is combined with Isoetharine.]
[S01EB07, isoflurophate, The therapeutic efficacy of Isoflurophate can be decreased when used in combination with Fluticasone furoate.]
[J04AC01, isoniazid, The serum concentration of Isoniazid can be decreased when it is combined with Fluticasone furoate.]
[R03CB01, isoproterenol, The therapeutic efficacy of Isoprenaline can be decreased when used in combination with Fluticasone furoate.]
[A10BJ01, exenatide, The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Exenatide.]
[H01AC01, somatropin, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Fluticasone furoate.]
[A02AB01, aluminum hydroxide, The bioavailability of Fluticasone furoate can be decreased when combined with Aluminum hydroxide.]
[L04AC07, tocilizumab, The metabolism of Fluticasone furoate can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, The therapeutic efficacy of Ketamine can be decreased when used in combination with Fluticasone furoate.]
[J02AB02, ketoconazole, The metabolism of Fluticasone furoate can be decreased when combined with Ketoconazole.]
[H02CA04, levoketoconazole, The metabolism of Fluticasone furoate can be decreased when combined with Levoketoconazole.]
[M02AA10, ketoprofen, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Ketoprofen.]
[V03AC03, deferasirox, The risk or severity of gastrointestinal ulceration and gastrointestinal irritation can be increased when Fluticasone furoate is combined with Deferasirox.]
[L04AA24, abatacept, The metabolism of Fluticasone furoate can be increased when combined with Abatacept.]
[C01CA22, arbutamine, The risk or severity of hypokalemia can be increased when Fluticasone furoate is combined with Arbutamine.]
[M01AE11, tiaprofenic acid, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Tiaprofenic acid.]
[N07AA30, ambenonium, The therapeutic efficacy of Ambenonium can be decreased when used in combination with Fluticasone furoate.]
[N03AX18, lacosamide, The metabolism of Lacosamide can be increased when combined with Fluticasone furoate.]
[C03CC01, ethacrynic acid, The risk or severity of hypokalemia can be increased when Fluticasone furoate is combined with Etacrynic acid.]
[L01DC03, mitomycin, The risk or severity of adverse effects can be increased when Mitomycin is combined with Fluticasone furoate.]
[G03AD01, levonorgestrel, The serum concentration of Fluticasone furoate can be increased when it is combined with Levonorgestrel.]
[S02DA01, lidocaine, The metabolism of Lidocaine can be decreased when combined with Fluticasone furoate.]
[N06BA13, armodafinil, The metabolism of Fluticasone furoate can be increased when combined with Armodafinil.]
[D06AX13, retapamulin, The metabolism of Retapamulin can be decreased when combined with Fluticasone furoate.]
[L01AD02, lomustine, The risk or severity of adverse effects can be increased when Lomustine is combined with Fluticasone furoate.]
[A07DA03, loperamide, The metabolism of Loperamide can be decreased when combined with Fluticasone furoate.]
[C10AA02, lovastatin, The metabolism of Lovastatin can be decreased when combined with Fluticasone furoate.]
[N05AH01, loxapine, The therapeutic efficacy of Fluticasone furoate can be decreased when used in combination with Loxapine.]
[G03DC03, lynestrenol, The serum concentration of Fluticasone furoate can be increased when it is combined with Lynestrenol.]
[L01EG01, temsirolimus, The metabolism of Temsirolimus can be increased when combined with Fluticasone furoate.]
[G04BX01, magnesium hydroxide, The bioavailability of Fluticasone furoate can be decreased when combined with Magnesium hydroxide.]
[A12CC10, magnesium oxide, The bioavailability of Fluticasone furoate can be decreased when combined with Magnesium oxide.]
[L01BA05, pralatrexate, The risk or severity of adverse effects can be increased when Pralatrexate is combined with Fluticasone furoate.]
[L01EA03, nilotinib, The metabolism of Fluticasone furoate can be decreased when combined with Nilotinib.]
[L01AA05, mechlorethamine, The therapeutic efficacy of Mechlorethamine can be decreased when used in combination with Fluticasone furoate.]
[M02AA18, meclofenamic acid, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Meclofenamic acid.]
[C01AA08, medigoxin, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Metildigoxin.]
[P01BC02, mefloquine, The therapeutic efficacy of Mefloquine can be decreased when used in combination with Fluticasone furoate.]
[L01AA03, melphalan, The risk or severity of adverse effects can be increased when Melphalan is combined with Fluticasone furoate.]
[N06DX01, memantine, The therapeutic efficacy of Memantine can be decreased when used in combination with Fluticasone furoate.]
[N02AB02, meperidine, The metabolism of Meperidine can be increased when combined with Fluticasone furoate.]
[N03AB04, mephenytoin, The metabolism of Mephenytoin can be decreased when combined with Fluticasone furoate.]
[L02BG01, aminoglutethimide, The therapeutic efficacy of Fluticasone furoate can be decreased when used in combination with Aminoglutethimide.]
[G03BB01, mesterolone, The risk or severity of edema formation can be increased when Mesterolone is combined with Fluticasone furoate.]
[N05AX13, paliperidone, The metabolism of Paliperidone can be decreased when combined with Fluticasone furoate.]
[A10BA02, metformin, The therapeutic efficacy of Metformin can be decreased when used in combination with Fluticasone furoate.]
[A14AA04, methenolone, The risk or severity of edema formation can be increased when Metenolone is combined with Fluticasone furoate.]
[H03BB02, methimazole, The metabolism of Fluticasone furoate can be decreased when combined with Methimazole.]
[L01BA04, pemetrexed, The risk or severity of adverse effects can be increased when Pemetrexed is combined with Fluticasone furoate.]
[L04AX03, methotrexate, The metabolism of Methotrexate can be increased when combined with Fluticasone furoate.]
[C03AA08, methyclothiazide, The risk or severity of electrolyte imbalance can be increased when Fluticasone furoate is combined with Methyclothiazide.]
[V04CG05, methylene blue, The metabolism of Fluticasone furoate can be decreased when combined with Methylene blue.]
[R03DA05, aminophylline, The metabolism of Aminophylline can be increased when combined with Fluticasone furoate.]
[H02AB04, methylprednisolone, The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Fluticasone furoate.]
[G03EK01, methyltestosterone, The risk or severity of edema formation can be increased when Methyltestosterone is combined with Fluticasone furoate.]
[N02CA04, methysergide, The metabolism of Methysergide can be increased when combined with Fluticasone furoate.]
[A03FA01, metoclopramide, The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Fluticasone furoate.]
[C03BA08, metolazone, Fluticasone furoate may increase the hypokalemic activities of Metolazone.]
[P01AB01, metronidazole, The metabolism of Metronidazole can be decreased when combined with Fluticasone furoate.]
[S02AA13, miconazole, The metabolism of Fluticasone furoate can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Aminophenazone.]
[N05CD08, midazolam, The serum concentration of Midazolam can be increased when it is combined with Fluticasone furoate.]
[G03XB01, mifepristone, The therapeutic efficacy of Fluticasone furoate can be decreased when used in combination with Mifepristone.]
[C09CA03, valsartan, The excretion of Valsartan can be decreased when combined with Fluticasone furoate.]
[L01XX23, mitotane, The serum concentration of Fluticasone furoate can be decreased when it is combined with Mitotane.]
[L01DB07, mitoxantrone, The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Fluticasone furoate.]
[L03AC01, aldesleukin, The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Fluticasone furoate.]
[C01BD01, amiodarone, The metabolism of Fluticasone furoate can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, The metabolism of Amitriptyline can be decreased when combined with Fluticasone furoate.]
